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ABSTRACT 
Quality of life (QoL) in cancer survivors is an important area of research.  While data are 
available about QoL and breast cancer, there is a paucity of research regarding older breast 
cancer survivors. The purpose of this research was to examine QoL in older women with early 
stage breast cancer, within the first year of post-treatment survivorship.  The specific aims of this 
study were to: 1) Describe the changes in overall QoL and the four QoL domains of Physical, 
Psychological, Social, and Spiritual well-being; 2) Examine the effects of a psychoeducational 
support intervention on QoL outcomes in older women; and 3) Describe nurses‘ perceptions of 
their interactions with older breast cancer survivors.   
A descriptive, longitudinal design was used to answer the research questions. Data for 
this study were drawn from the Breast Cancer Education Intervention (BCEI), a longitudinal 
psychoeducational support intervention for women with early stage breast cancer.  Fifty women 
from the BCEI who were 65 years of age and older were included in this sample, of whom 24 
were assigned to the Experimental (EX) Group and 26 were assigned to the Wait Control (WC) 
Group.  Data were collected at three time points: baseline, three months, and six months after 
study entry.  Measurement tools included the BCEI Demographics Form, the Quality of Life-
Breast Cancer Survey (QoL-BC), and field notes of the BCEI Research Nurses. The QoL-BC 
survey is a 50-item scale that measures QoL in women with breast cancer.  Descriptive statistics, 
Generalized Estimating Equation (GEE) methods and t-tests were used to answer research 
questions #1 and #2.  Content analysis was used to answer research question #3.  
Subjects reported good overall QoL at baseline, but QoL declined over six months.  
Physical and Psychological well-being declined from baseline to six months later.  Social well-
 iv 
being initially improved from baseline to three months but declined at six months. Spiritual well-
being initially declined at three months and improved at six months. There was insufficient 
power to detect a difference in the effects of the BCEI Intervention between the two groups.  
However, the decline in overall QoL was less in the EX Group. Field notes focusing on nurses‘ 
perception of their interactions with older women revealed four themes.  These themes include: 
continuing breast-related health, personal health issues, family health issues, and potential 
stressors. 
Results from this study suggest that: 1) changes in overall QoL and within the four QoL 
domains occur over time; 2) decline in overall QoL was lessened by the BCEI Intervention; and 
3) concerns after treatment are both breast cancer and non-breast cancer related.  Study findings 
can direct future research in the following areas: 1) identification of specific concerns within 
each QoL domain that could lead to an increase or decrease in well-being in older breast cancer 
survivors; 2) interventions tailored to the needs of older breast cancer survivors to maintain, 
improve, or lessen decline in QoL after treatment; and 3) reconceptualizing QoL in older breast 
cancer survivors to include non-cancer related factors. 
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CHAPTER 1: INTRODUCTION 
Breast cancer is the most common cancer diagnosed in women in the United States.  The 
mean age of women diagnosed with breast cancer is 61 with women age 75 to 79 having the 
highest incidence.  Today, there are more than 2.3 million women surviving with breast cancer.  
As the Baby Boomer generation ages and their life expectancy increases, the number of older 
women diagnosed and surviving with breast cancer is also expected to increase.  Throughout this 
dissertation, ―older‖ represents women age 65 and older. 
Evidence suggests that women with breast cancer experience adverse effects related to 
their cancer that can affect quality of life (QoL) after treatment.  Data also suggest that QoL after 
treatment may be influenced by non-cancer related stressors that occur before a diagnosis of 
breast cancer.   The majority of research regarding QoL in women with breast cancer focused on 
women with an average age of 50 years.  Despite the increased risk for breast cancer in aging 
women, less research attention has been paid to women age 65 and older.  The overall purpose of 
this research was to examine QoL in women with early stage breast cancer who are age 65 and 
older and are within the first year of post-treatment survivorship.    
The goal of this research was to add to the body of knowledge concerning QoL in older 
women after treatment for early stage breast cancer.  The research proposal in Appendix C 
includes extensive details of the study‘s overall purpose, specific aims, research design, methods 
and analysis. This dissertation used a secondary analysis based on data drawn from the Breast 
Cancer Education Intervention (BCEI), a longitudinal psychoeducational support intervention 
trial.  A descriptive, longitudinal design using mixed methods was used to examine QoL in older 
women with breast cancer and to answer the research questions. 
 2 
This dissertation followed the University of Central Florida alternate model and is 
comprised of three manuscripts that focus on older, early stage breast cancer survivors after 
treatment.  Consistent with the background and literature review, the first manuscript, entitled 
Quality of life in women age 65 and older surviving early stage breast cancer: A review of the 
literature, focuses on the state of the science related to women, age 65 and older, with early stage 
breast cancer after treatment.  The second manuscript, entitled A longitudinal study of quality of 
life in older women with early stage breast cancer in the first year of post-treatment 
survivorship, describes the Overall QoL and QoL within the domains of Physical, Psychological, 
Social, and Spiritual well-being in women age 65 and older with early stage breast cancer who 
are within the first year post-treatment.  This manuscript also describes the effect of the BCEI 
psychoeducational support intervention in these women.  The third manuscript, entitled Nurses 
perceptions of their interactions with older women with early stage breast cancer within the first 
year of post-treatment survivorship, explores nurses‘ perceptions of their interactions with 
women, age 65 and older, with early stage breast cancer.  
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 CHAPTER 2: QUALITY OF LIFE IN WOMEN AGE 65 AND OLDER 
SURVIVING EARLY STAGE BREAST CANCER: A REVIEW OF THE LITERATURE 
Introduction 
Quality of life (QoL) is recognized as a multidimensional concept with perception based 
on the subjective experiences of the individual assessing it.
1-5
  For the purposes of this literature 
review, QoL is defined as a personal sense of well-being that encompasses physical, 
psychological, social and spiritual dimensions.
6-8
  Other dimensions have also been identified and 
include health and functioning, socioeconomic,
9
 functional ability, family well-being, emotional 
well-being, treatment satisfaction,
2
 and  physical functioning.
1
 For persons surviving cancer, the 
period after treatment can be a complex time in which survivors experience physical and 
psychosocial effects,
10-14
 which in turn, may affect QoL. 
Quality of life is recognized as an important outcome of cancer treatment.  Improving 
quality of care and QoL in those affected by cancer are goals set forth by the National Cancer 
Institute‘s (NCI) Strategic Plan for Leading the Nation to Eliminate the Suffering and Death Due 
to Cancer.
15
  The National Institutes of Health (NIH) encourages using QoL endpoints in NIH-
funded clinical trials.  In addition, the National Institute of Aging‘s  (NIA) Action Plan for Aging 
Research: Strategic Plan for Fiscal Years 2001-2005
16
 recognizes the need to address 
knowledge deficits regarding the elderly, disease and aging.  One of the primary goals of its 
strategic plan is to improve health and QoL in older people. Older people with cancer have been 
identified as an unexplored population.
17-19
  In this paper, ―older‖ is defined as age 65 or older.  
Combined, these organizations outline a need for more research regarding QoL after cancer 
treatment.   
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The aging of Baby Boomer generation makes QoL research in older populations with 
cancer particularly salient.  Because of the growth expected in the 65 and older age group and 
because the incidence of cancer increases with age, the number of all cancers diagnosed annually 
is expected to double from the current rate of 1.3 million to 2.6 million by 2050.
17
  Currently, 
57% of all new cancer diagnoses and 71% of cancer-related deaths occur in people age 65 and 
older.
19  In women, breast cancer is the most common cancer.20  The mean age of all women 
diagnosed with breast cancer is 61, while women ages 75 to 79 have the highest incidence rate.
21
  
In brief, there are many older women living with breast cancer, and in the future, there will be 
many more. These figures make older women with early stage breast cancer a particularly 
important population to study. 
Today, there are more than 2.3 million women surviving with breast cancer.
21  Since 
more than 90% of all breast cancers are diagnosed in early stages, prior to metastasis,
22
  more 
older women will become cancer survivors in the near future.  After treatment, women are at risk 
for physical and psychosocial consequences that can affect QoL.   Physical effects include 
fatigue,
23
 pain, cognitive changes,
23
 lymphedema, sexual effects, pulmonary, neurologic, 
gastrointestinal,
12
 and cardiac effects.
12, 24, 25
  Psychosocial effects include fear of recurrence, 
depression, uncertainty in illness, and finding meaning in illness.
10
  The majority of research on 
QoL in breast cancer survivors has been conducted in samples of women with an average age 
near 50 years. 
6, 26-34
   Less research attention has been given to women over the age of 65 years. 
Since the number of older women who will receive a diagnosis of breast cancer is large 
and will increase, it is important to better understand the needs of this population.  Thus, the goal 
of this paper is to: 1) review the literature review concerning quality of life in women, age 65 
 5 
and older, surviving with early stage breast cancer after treatment; 2) describe implications for 
future research; and 3) describe implications for nursing practice.  
Methods 
A review of literature was conducted using Medline, CINAHL, PsychInfo and Ageline 
databases.  The literature search was conducted in several phases.  First, the search began by 
using the keywords: quality of life, breast cancer and older women.  No date limitations were 
used.  This search yielded fifty-four articles in CINAHL/PsychInfo, 127 articles in Medline and 
nine articles in Ageline, totaling 190 articles. Several articles were duplicated between the 
databases.  The title and abstract of each article were reviewed to determine if the articles met 
inclusion criteria. Articles were included if they: 1) were published in a peer-reviewed journal; 2) 
included an age group of 65 and older as either the only population or a specific comparative 
group; 3) focused on the post-treatment phase of breast cancer; 4) focused on women with early 
stage disease and; 5) were published in the English language.  Dissertations, editorials, and 
articles that focused on breast cancer in men were excluded.  Six articles met the inclusion 
criteria.   
Second, the search was expanded since so few articles were found.  The key words of 
breast cancer and older women were retained, and new keywords were added that related to 
aspects of QoL that had been previously reported in breast cancer survivors.
6, 30
  These additional 
keywords included: physical well-being, psychological well-being, social well-being, spiritual 
well-being, survivorship, coping, adaptation, fatigue, pain, lymphedema, sleep disturbances, 
insomnia, weight gain, menopause/menopausal symptoms, sexual functioning, cognitive 
functioning, social support, fear of recurrence, depression, relationships, employment, body 
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image, meaning in illness, religion, spirituality, hope, and uncertainty.  Each of these keywords 
was added to the previously used keywords, breast cancer and older women.  This search yielded 
an additional 408 articles in CINAHL/PsychInfo and 682 articles in Medline.  Duplicate articles 
were noted throughout the searches.  The new articles from this expanded search were reviewed 
according to the same inclusion criteria used in the first phase of the search. Five new articles 
were identified bringing the total number of articles retrieved to eleven. 
Third, the reference lists of the eleven included articles were hand searched and evaluated 
for relevance. Two more articles were identified bringing the total number of articles to thirteen.  
Fourth, this author also reviewed articles in her possession from previous work and identified 
one additional article that met the inclusion criteria for this review bringing the total number of 
articles to fourteen. This literature review will present the available knowledge concerning QoL 
of older women, age 65 and older, with early stage breast cancer after treatment. 
Findings 
Fourteen studies met inclusion criteria and are included in this discussion. Seven studies 
focused exclusively on women with breast cancer age 65 and older.  Four studies compared 
women with breast cancer age 65 and older to age-based controls.  Three studies were conducted 
that compared women, age 65 or older, to younger women with breast cancer.   
Women age 65 and older 
Seven studies examined QoL specifically in women with early stage breast cancer age 65 
and older.  These studies have focused on QoL outcomes in older women after surgery and the 
ability of older women to find meaning in illness.  See Table 1 for a summary. 
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Effect of surgery on QoL outcomes 
Four studies looked at the effects of treatment on outcomes of QoL.  De Haes and 
colleagues
35
 compared QoL in women with breast cancer age 70 and older (N=136) who had 
received lumpectomy plus tamoxifen or mastectomy as primary treatment. This was a 
randomized clinical trial.  QoL was measured using an unspecified QoL questionnaire that 
evaluated 9 domains.  Women completed this survey between two and twelve months after 
surgery.  Data were analyzed using Wilcoxon signed ranks test.  Results showed that regardless 
of treatment, women experienced similar levels of fatigue, physical and emotional functioning, 
fear of recurrence, social support, and leisure-time activities. Women with mastectomy reported 
significantly more arm problems (p=.004), and women who received breast-conserving treatment 
had better body images (p=.006).  This study concluded that older women who had conservative 
treatment had better QoL than women who had more extensive surgeries. 
 Using longitudinal design, Mandelblatt and colleagues
36
 examined the impact of axillary 
dissection (AD) in women, age 67 and older, who had early stage breast cancer (N=571). Post-
treatment QoL was a primary outcome of the study.  The Medical Outcomes Study-Short Form 
(SF-12) measured physical and mental functioning, while fear of recurrence was measured using 
two items from the Cancer Rehabilitation Evaluation Survey-Short Form (CARES-SF).  The 
study included an additional question involving the impact of breast cancer on life.  Subjects 
completed surveys at one and two years after surgery.  Data were analyzed using analysis of 
variance (ANOVA) and chi square distribution statistics.  Longitudinal data were measured 
using Generalized Estimating Equation (GEE) methods. Results indicate that 60% of the sample 
reported arm problems (i.e. swelling, loss of arm movement, and limitations of use) at some time 
during the study, and 83% of women who received AD reported arm problems.  In addition, 
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women with arthritis were more likely to report arm problems 2 years after surgery.  Women 
who received AD and reported arm problems reported lower physical (p=0.0001) and mental 
functioning (p=0.04) at both points of the study.  Finally, women who experienced arm problems 
indicated that the breast cancer had a more severe impact on their lives than women who did not 
have arm problems (p= 0.0006).  This study concluded that AD increased the risk of developing 
arm problems within two years and had negative effects on QoL. 
In another study, Mandelblatt and colleagues
37
 used a randomized cross-sectional design 
to describe the long-term impact of primary therapy on QoL and satisfaction in early stage breast 
cancer survivors age 67 and older (N=1,812).   Women who were three to five years post- 
treatment and received either breast conservation treatment (BCT) or mastectomy were included 
in this sample.  Physical functioning was examined using the SF-12.  Social and role function, 
vitality, and general health were examined using scales from the Medical Outcomes Survey 
Short Form-36 (SF-36).  Data were analyzed using chi square distribution, t tests, and logistic 
regression.  Results indicate that regardless of the treatment group, women did not differ 
significantly in any of the scales. Having a co-morbid illness prior to treatment affected physical 
outcomes (p=<.001).  Women with axillary dissection reported more arm problems, which 
negatively impacted all other outcomes (p=<.001). In addition, older women who felt they were 
not given a choice about treatment reported more pain, poorer mental health, and less satisfaction 
(p=.0001).   The study concluded that processes of care, not treatment, were important predictors 
of long-term QoL in these older women. 
In a longitudinal clinical trial, Figueiredo and colleagues 
38
 examined the effect of 
surgery preference and surgery received on body image and mental health in women age 67 and 
older (N=563).  Data were collected using the SF-36, CARES-SF, and two investigator- 
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developed questions.  Data were analyzed using chi square distribution, t tests, ANOVA, Pearson 
and Spearman rank correlation, path analysis and GEE methods.  Results indicated that physical 
appearance was important for 31% of the sample when making treatment decisions. In addition, 
younger women and those with fewer co-morbid illnesses were more likely to be concerned 
about appearance.  At one and two year follow-ups, women who received mastectomy had more 
concerns about body image (p<.0001) and worse mental health (p<.05) than women who 
received BCT.  Generally, if subjects did not receive the type of treatment preferred, they 
reported greater concern for body image and poorer outcomes related to mental health.  This 
study concluded that body image is important to older women, and receiving treatments 
according to preference about appearance was an important factor for positive mental health 
outcomes. 
In summary, four studies focused on QoL outcomes after primary treatment and 
suggested that conservative treatment leads to better QoL.  Women who receive more aggressive 
treatments such as mastectomy experience more arm problems, concerns with body image, and 
poor mental health.  Women who received axillary node dissection also report more arm 
problems, and this had a negative impact on QoL.  In addition, if older women felt involved in 
treatment decisions, they reported better mental health and satisfaction. 
Meaning in Illness 
Three qualitative studies explored meaning in illness after breast cancer.  In the first, Feher 
and Maly 
39
 used structured interviews and open-ended questions to examine religious and 
spiritual coping strategies in women age 65 and older (N=33) who were recently diagnosed with 
breast cancer.  Content analysis was used to analyze data.  All of the subjects in this study 
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indicated that their faith had been maintained or strengthened during illness. Three themes 
emerged during analysis.  First, women felt that their religious and spiritual faith helped give 
them the emotional support needed in order to cope with breast cancer and make meaning in 
their lives during illness.  Faith gave women a sense of companionship and being taken care of.  
Faith also provided emotional support and helped women control their fears, take comfort, and 
have a sense of well-being.  Second, older women used their associations with the church to 
maintain social connections with others.  Being associated with a church or religious community 
allowed women to keep in touch with others through volunteer work and their relationship with 
the leader of their church.  In addition, women liked being prayed for by others. Women felt 
protected, loved, and unafraid due to the presence of God in their lives.  Third, women were able 
to make meaning in their lives through their faith.  They felt that faith acted as a moral compass 
and gave them identity.  In addition, some women felt that their illness was in God‘s hands and 
out of their control.  They believed their illness was for a greater purpose.  Overall, women used 
religion and faith to cope with their illness. 
Utley 
40
 sought to discover the meaning of cancer in older, long-term breast cancer 
survivors using qualitative analysis.  Twenty women, age 65 and older who were five to twenty-
nine years past diagnosis, participated in three life history interviews.  Results showed that 
women experience three distinct and progressive phases of finding meaning in their illness.  The 
first phase viewed cancer as sickness and then death.  Women talked about expecting to feel sick 
if they had cancer and how their expectation did not correlate with how they really felt.  The 
second phase viewed cancer as an obstacle and something to overcome.  Women realized cancer 
was something they could live with.  In the third phase, cancer was viewed as transforming.  
Women realized that their lives changed and could see how cancer benefited them and their 
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lives.  The meaning of cancer evolved over time, and most women experienced a positive effect 
from having cancer. 
Through methods informed by grounded theory, Crooks 
41
 developed the theoretical 
model of Living Day by Day in which older women went through several phases before coming 
to terms with and finding meaning in their disease.  Twenty women, age 66 to 94 with early 
stage breast cancer, participated in this study.  Initially, women ―faced the music‖ by finding out 
about their diagnosis and taking action against it through treatment.  ―Getting back to normal‖ 
after treatment was a considerable task for older women.  In this phase, women acknowledged 
the physical changes that they experienced, such as pain or the loss of a breast, and strategized to 
assimilate these changes into their lives.  In addition, older women were able to realize that 
having cancer changed how other people viewed them as individuals.  As a result, older women 
protected family members by downplaying their own fears and concerns and sharing information 
about themselves with others in similar situations or with those who cared about their situation.  
―Getting perspective‖ is the third phase in which older women sought perspective on their 
disease and life expectancy.  Women made decisions for themselves based on their comparison 
of  themselves to other women in similar situations and those with different illnesses to 
determine if their problems were more or less significant. Older women used this strategy to 
affirm previous decisions and to determine how much effort should be given to concerns about 
the diagnosis and fears of recurrence.  Finally, ―being different than before‖ was the last phase 
identified by older women.  Women became aware of the isolation caused by the diagnosis and 
the need for time to make sense of the changes.  Older women examined their belief systems and 
focused on the important things in their life.  Ultimately, this process of finding meaning in 
illness allowed women to live each day to the fullest.   
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In summary, three qualitative research studies discussed meaning in illness in older early 
stage breast cancer survivors.  The next section of the review will focus on studies that compare 
women, age 65 and older, surviving with early stage breast cancer to age-based controls without 
cancer. 
Women age 65 and older and age-based controls 
Women age 65 years and older with early stage breast cancer were compared to women 
with and without cancer. Two studies compared older women with breast cancer with age-based 
controls without cancer, and two studies compared older women to both age-based controls 
without cancer and younger women with and without cancer.  These studies focused on symptom 
distress, physical functioning, and psychological well-being, which will be discussed in the next 
section.  See Table 2 for a summary. 
Symptom distress 
Using descriptive, correlational design, Heidrich and colleagues
42
 examined symptoms, 
symptom belief, and QoL in older women (age 65 or older) with chronic illnesses with (n=18) 
and without (n=24) breast cancer.  Symptom distress was measured by the Heidrich Symptom 
Bother Scale-Revised (SB-R); symptom belief was evaluated by asking women the origin of 
their symptoms; QoL was measured using the SF-36; and the Purpose in Life Scale was used to 
measure existential QoL.  The Center for Epidemiologic Studies Depression Scale (CES-D), 
State-Trait Anxiety Inventory, and Older Americans Resources Service Schedule of Illnesses 
(OARS) were also used.  Data were analyzed using Wilcoxon-Mann-Whitney U test and chi-
square distribution tests.  
 13 
Results showed that both groups of women reported multiple symptoms and low levels of 
symptom distress. Symptoms reported included pain, fatigue, aching, joint pain, dry mouth, 
weight gain, lack of concentration, weakness, constipation, and hot flashes.  Aching was the only 
symptom reported more often by women with breast cancer (p< 0.05).  Women in both groups 
attributed their symptoms to aging, chronic conditions, or unknown causes.  Women in the breast 
cancer group rarely associated their symptoms with breast cancer.  When older women were able 
to attribute symptoms to a cause, they found them less distressing than women who were not 
able to identify a cause for their symptoms.  In summary, symptom experience and symptom 
attribution were similar in both groups. Although women with breast cancer reported 
experiencing symptoms, they reported low levels of distress.  In addition, they rarely associated 
their symptoms with breast cancer, instead attributing symptoms to aging and other chronic 
conditions.   
Physical functioning 
Satariano and colleagues
43
 conducted a longitudinal study to examine instrumental 
functioning in women with breast cancer (n=422) compared to non-cancer peers (n=478). 
Women were divided into three age groups: age 55 to 64, 65 to 74 and 75 to 84 and were 
compared to non-cancer peers within their age group. Instrumental daily living was measured 
using the Instrumental Activities of Daily Living (IADL) survey at three and twelve months after 
diagnosis.  Data were analyzed using Ridit analysis. Results showed that at three months post-
diagnosis, women with cancer, ages 55 to 64 and 65 to 74 reported more instrumental 
functioning problems (e.g. housekeeping, preparing meals, shopping) compared to controls 
within their age group.  Women ages 75 and older reported the fewest instrumental functional 
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problems compared to similar-aged controls: these women named transportation as the most 
problematic issue.  At twelve months, women ages 55 to 64 were more similar to their control 
group, but women ages 65 to 74 continued to report less independence than their control group.  
Women with cancer, ages 75 to 84 were again not significantly different from their control group 
in respect to instrumental functioning or independence at the twelve month time point.   
Kroenke and colleagues
44
 (2004) examined physical and psychosocial changes due to 
breast cancer using non-cancer comparison groups of women of different ages.  The total sample 
was obtained from the Nurses‘ Health Study and the Nurses‘ Health Study II and consisted of 
122,969 women, of which 1,082 had breast cancer.  Comparative groups for this prospective, 
longitudinal study included younger (ages 40 and younger), middle-aged (41 to 64 years), and 
older women (ages 65 and older).  Measurement tools included the SF-36 and the CARES-SF.  
Data were analyzed using linear regression methods.  Results indicated that the youngest women 
with breast cancer experienced the most significant declines in physical roles, social functioning, 
bodily pain and mental health compared to their non-cancer peers (p< 0.05).  Both groups of 
older women experienced statistically significant declines in physical functioning, role 
limitations due to both physical and emotional problems, and bodily pain (p< 0.05).  However, 
older women without breast cancer showed about half the decline as their peers with breast 
cancer.  Physical declines in the oldest groups were similar regardless of disease state.  These 
researchers suggest that the declines were related to age instead of treatment or the disease itself.  
This study concluded that older women fare better than younger women in physical and 
psychosocial domains after diagnosis.  
 15 
Psychological well-being 
Using a 2x2 cross-sectional design, Heidrich 
45
  examined the influence of age and type 
of illness on health and functioning, self-interpretive mechanisms, and psychological well-being.  
Women with breast cancer (n=86) and osteoarthritis (n=102) were divided into two age groups 
for comparison: young-old (ages 60 to 74) and old-old (ages 75 and older).  Multiple instruments 
were used in this study and included the OARS ADL measure for functional health status; 
Heidrich‘s Symptom Bother Scale; a social comparison scale; a social network index to assess 
social integration; single-item questionnaires to assess illness perceptions; the CES-D; 
Rosenberg‘s Self- Esteem Scale; and Ryff‘s scales of psychological well-being.  Data were 
analyzed using analysis of co-variance (ANCOVA) and multivariate analysis of covariance 
(MANCOVA).    
Results indicated that age did not influence outcomes such as health, functioning and 
psychological well-being.  However, type of illness did influence these outcomes.  Compared to 
women with breast cancer, women with arthritis reported more symptom bother and problems 
with activities of living (p= 0.0001).  Women with arthritis also reported their illness as less 
controllable and more severe and chronic (p< 0.001) than women with breast cancer. Women in 
both groups compared themselves with other women they knew, making upward and downward 
comparisons to help discern their own appraisal of psychological well-being. These appraisals 
influenced psychological outcomes.  Women who made upward comparisons had better 
psychological well-being.  This study indicates that older women with arthritis reported more 
symptom bother than women with breast cancer.  In addition, positive appraisal or comparisons 
influenced psychological outcomes. 
 16 
In summary, studies that compared older women with breast cancer to non-cancer age-
based controls suggest the following: 1) older women believe that the symptoms they experience 
after breast cancer are related to age or chronic illness, not breast cancer; 2) older women 
experience changes in functioning, but so do their non-cancer peers, suggesting that declines in 
physical functioning may be attributable to age, not treatment; 3) older women with arthritis 
report more symptom bother than women with breast cancer.  The next section of the review will 
focus on differences between older and younger women with breast cancer. 
Older women compared to younger age groups 
Three studies compared older and younger women with breast cancer. These studies 
examined functional status, cognitive functioning, and overall QoL. Please see Table 3 for a 
summary. 
Functional status 
Fehlaur, Tribius, Mehnert, and Rades (2005) compared functional status based on age at 
diagnosis in long-term breast cancer survivors.  The effects of adjuvant treatment on health-
related QoL (HR-QoL) were also examined.  The sample consisted of 370 women treated with 
lumpectomy, axillary node dissection, and radiation. Women were grouped according to time of 
follow-up (either seven or twelve years), age at time of therapy (<50 years, 50-65 years, and >65 
years), and type of treatment.  Measurements included the European Organisation for Research 
and Treatment of Cancer‘s (EORTC) Quality of Life Questionnaire (QLQ-C30) and the EORTC 
Breast Cancer Module (QLQ-BR23).  Data were analyzed using two-way multivariate analysis 
of variance (MANOVA) and post-hoc Scheffe tests.  
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Results indicated that at seven and twelve years from treatment, the oldest women at the 
time of treatment reported worse physical functioning (p<0.001) and more body pain (p<0.01) 
compared to younger women.  Older women had significantly more arm symptoms (p=0.005) at 
twelve years, and their illness had less financial impact (p=0.006) compared to younger women.  
Global HR-QoL scores improved significantly for older women at the twelve year follow-up 
(p=0.006) despite these concerns.  The type of treatment did not have an impact on HR-QoL in 
this study.  This study concluded that age at time of therapy is related to differential disturbances 
in HR-QoL.  
Cognitive functioning 
Cognitive functioning in older women after treatment for early stage breast cancer has 
been examined in the literature.  Cimprich
46
 examined the effect of age and type of surgery on 
attentional fatigue in women (N=74) with early stage breast cancer. This study had three groups: 
younger (ages 25 to 45), middle-aged (ages 46 to 64) and older (ages 65 to 74) women.  The 
capacity to directed attention (CDA) was measured before and after surgery (lumpectomy or 
mastectomy).  Four measures of CDA were used, which tested the subjects ability to block a 
competing stimulus when they focused on a task.  Data were analyzed using ANOVA, t tests, 
and multiple regression. 
Results indicate that older women had significantly lower total attention scores than 
younger women at baseline (p< 0.05).  Older women also experienced significant losses in 
overall attention performance (p= 0.04) and total attention scores (p<.05) over time compared to 
younger women.  Within the older group, women who received mastectomy also showed 
significantly greater loss in total attention scores compared to women of the same age who 
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received breast conservation treatments (p= 0.05). More extensive surgeries led to more attention 
deficits.  This study concluded that age and type of surgery affected the capacity to direct 
attention in older women with early stage breast cancer.   
Overall quality of life 
Using a cross-sectional design, Cimprich and colleagues 
47
 examined the relationship 
between age at diagnosis and QoL in long-term breast cancer survivors (N=105).  Women were 
divided into groups that represented life stages: younger women (ages 45 and younger), middle 
age (ages 46 to 65) and older (ages 66 and older).  Quality of life outcomes were measured by 
using the Quality of Life-Cancer Survivors (QoL-CS) instrument, which focuses on physical, 
psychological, social, and spiritual well-being.  Data were analyzed using ANOVA and multiple 
regression. 
Results indicate that that older women have significantly worse physical well-being 
scores (p= 0.008) than middle-aged women but significantly better social well-being scores (p= 
0.025) than the youngest women. Within the physical domain, older women reported 
significantly (p< 0.05) more problems with fatigue, pain, constipation, and sleep changes 
compared to younger women.  Within the psychological domain, older women reported 
significantly less (p< 0.05) distress at diagnosis and treatment but better outcomes related to 
changes in appearance than younger women.  Within the social domain, older women reported 
significantly lower impact (p< 0.05) on sexuality, employment, and family distress than younger 
women.  In the spiritual domain, older women also reported significantly fewer (p<.05) positive 
changes as a result of breast cancer than younger women and more uncertainty for the future 
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compared to middle-aged women.  This study concluded that life stage at the time of diagnosis 
had a significant impact on long-term QoL in breast cancer survivors. 
In summary, studies that examined age-related differences in women with breast cancer 
showed the following.  Compared to younger women, older women reported: 1) worse physical 
well-being and functioning; 2) less distress from diagnosis; 3) better outcomes for appearance; 4) 
less distress related to sexuality; 5) less distress related to employment; 6) less family distress; 7) 
more decline in cognitive functioning; and 8) fewer positive changes from breast cancer.   
Discussion 
It is surprising that the literature review yielded so few articles that specifically focused 
on women, age 65 and older with early stage breast cancer.  However, these fourteen articles 
provide a beginning foundation for knowledge concerning this population in five areas.  First, 
studies have shown the benefits of conservative surgical treatment for breast cancer and keeping 
older women involved in their treatment choices.  Overall, older women who receive breast 
conservation treatments report fewer QoL concerns than women who received mastectomy and 
axillary dissection.  Older women who were treated conservatively report fewer arm problems
35
 
and better physical functioning
37
 than older women who received mastectomy.  The experience 
of having arm problems negatively affected other QoL outcomes.
36, 37
  In addition, older women 
consider their physical appearance when making treatment decisions,
38
 leading to better 
outcomes.  Women who felt that they had treatment options reported better mental health and 
satisfaction compared to women who felt that they were not involved in decisions related to their 
treatment.
37
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Second, studies have examined physical symptoms, physical functioning, and physical 
well-being in older women after treatment for early stage breast cancer.  While older women 
reported more physical symptoms compared to younger women,
47
 they report a similar number 
of symptoms compared to women of the same age with other chronic illnesses.
42
  In addition, 
older women with breast cancer report less symptom bother than older women with arthritis.
45
  
Older women with breast cancer rarely attribute their symptoms to breast cancer but instead 
attribute symptoms to aging and other chronic illnesses.
42
  Older women also report worse 
physical well-being
47
 and worse physical functioning
48
 compared to younger women. However, 
in studies that used age-based controls without cancer, these declines were also noted in older 
women of the same age without cancer. 
43, 44
  These findings suggest that older women naturally 
experience declines in physical functioning.  Breast cancer is not necessarily the cause of these 
declines. 
Third, it has been reported that older women with early stage breast cancer report fewer 
psychological effects compared to younger women.  Older women report being less distressed at 
diagnosis and through treatment and report fewer concerns with changes in their appearance 
compared to younger women.
47
 
Fourth, several social differences have been noted between older and younger women 
with early stage breast cancer.  Compared to younger women, older women report that breast 
cancer has less of an impact on sexuality, employment, family distress,
47
 and finances.
48
  In 
addition, older women experience greater cognitive losses and a reduced attention span 
compared to younger women with breast cancer.
49
 
Finally, spirituality in older women with early stage breast cancer has been explored.  
Older women report that faith assists with coping and emotional support and allows them to 
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maintain a social connection with others.
39
  Through faith, older women are able to find meaning 
in having breast cancer,
39-41
 which allows older women to live each day to the fullest.
41
  
Conflicting information is presented related to the ability of older women with breast cancer to 
note the positive effects having cancer has had on their lives.  While, qualitative studies have 
reported that older women experienced positive effects from having breast cancer,
40
 quantitative 
studies report that older women experience fewer positive changes compared to younger women 
with breast cancer.
47
 
 
Implications for Research 
Despite current findings, several areas were identified for future research. Given the 
limited research concerning older women, it is possible that there are factors within this older 
population that have not yet been identified that may have an impact of QoL.  More research will 
help eliminate knowledge gaps and identify these factors in older women. 
First, while we do know that older women experience side effects and symptoms, the 
extent of the symptom experience is unknown. How specific symptoms affect aspects of 
everyday life or how older women manage side effects is also unknown.  Problems such as 
fatigue, pain, lymphedema, functional limitations, and fear of recurrence need to be further 
explored so that healthcare providers can assist older women in managing their concerns to 
improve or maintain QoL. 
Second, the impact of co-morbid illnesses in older women after treatment for breast 
cancer is unknown.  Research demonstrates that the presence of co-morbidity affects screening 
50
 
and treatment 
51, 52
 of breast cancer, but it is not known how co-morbidities influence QoL in 
older women after treatment for breast cancer. Only three studies in this review addressed co-
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morbid illnesses.  Women with arthritis were more likely to report arm problems after surgery;
36
 
having a co-morbid illness prior to treatment negatively affected physical outcomes;
37
 and 
women with fewer co-morbid illnesses were more likely to be concerned about their appearance 
after surgical treatment for breast cancer.  It is likely that older women will have at least one co-
morbid illness by the time they are diagnosed with breast cancer,
19
 and knowing how to manage 
the effects of treatment within the context of other illnesses will be crucial to improving QoL in 
these women. 
Third, appropriate interventions for older women with breast cancer have not been 
explored.  This information is important because older women may have different educational 
needs and learning styles than younger women.  Crooks
41
 stated that the older women in her 
study rejected the written materials offered by health care providers. Older women felt that 
providers were not interested in them as people when they were given written material without a 
verbal explanation.  The current method of giving patients copious amounts of reading material 
about managing their symptoms may be ineffective in older populations. 
Finally, the use of various standardized measurement tools, each of which examine and 
measure different dimensions of QoL in older women, makes comparison of these studies 
difficult.  Opportunity exists to duplicate or confirm the results of these studies using 
measurement tools that have been previously used in this population.  This may help support 
results of prior studies. 
Implications for Nursing Practice 
Through this research, several implications for nursing practice can be offered.  First, 
older women who receive more conservative surgical treatments, such as lumpectomy 
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experience fewer side effects and better outcomes than women who receive mastectomy.  Since 
women over the age of 55 are more likely to receive mastectomy,
53
 nurses may use this 
information to identify older women at risk for side effects caused by the treatment.  Once 
identified, educational programs or guidelines can be developed to assist these women in 
reducing or managing their symptoms and improving QoL. 
 Second, older women want to be involved in treatment decisions, especially those that 
impact their appearance.  In nursing and the health professions, there may be a misperception 
that older women are not concerned about their appearance or body image, which may lead to a 
lack of patient involvement in treatment decisions.  Nurses should consider that many older 
women are interested in preserving their appearance and may want to know all of the treatment 
options available to them.  In addition, education may need to be provided on the use of 
prosthetics and reconstructive surgery in order to help older women preserve their appearance. 
Third, while it has been reported that older women experience more physical symptoms 
compared to younger women with breast cancer, it has also been reported that older women 
experience similar symptoms to older women without breast cancer but with other chronic 
illnesses.  In addition, older women may not demonstrate the level of distress regarding their 
symptoms that nurses expect.  During follow-up visits after treatment, nurses may need to 
explore the symptoms of older women in order to help them manage their concerns. Education 
regarding symptom management should be specifically tailored to help older women maintain or 
improve their physical functioning and QoL.  However, tailoring interventions to older women 
may also be challenging when basing the intervention on research that has dealt with younger 
populations, which highlights the need for research based on older women. 
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Fourth, psychosocial findings related to older women with breast cancer suggest that 
older women experience fewer effects compared to younger women.  Despite these findings, 
nurses should still consider the individuality of the experience of having breast cancer and 
explore the psychosocial impact of diagnosis and treatment in all women with breast cancer in 
order to provide appropriate counseling and interventions. 
Fifth, faith is important to many older women with breast cancer.  It should be recognized 
that some older women draw upon their faith for support and coping.  Nurses may want to 
incorporate faith into their assessment of patient coping methods.  In addition, nurses may 
consider discussing the positive changes that breast cancer may have brought to the patients‘ 
lives. 
Conclusions 
This review of the literature has summarized what is currently known about QoL in older 
women, ages 65 and older, with early stage breast cancer. Currently, the literature suggests that 
older women: 1) have better QoL outcomes when they receive conservative surgical treatments 
such as lumpectomy; 2) want to be involved in decisions concerning their treatment; 3)  
experience more physical symptoms and declines in functioning compared to younger women, 
but experience similar symptoms and functioning compared to women of the same age with 
other chronic illnesses; 4) have fewer psychosocial concerns compared to younger women; and 
5) use faith to cope and find meaning in their illness. 
Despite current research, areas for future research exist related to older women with early 
stage breast cancer after treatment.  More research is needed to determine the extent of 
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symptoms in this population, the effect of co-morbid illnesses after treatment for breast cancer, 
and appropriate interventions to help older women improve their QoL. 
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 CHAPTER 3: A LONGITUDINAL STUDY OF QUALITY OF LIFE IN OLDER 
WOMEN WITH EARLY STAGE BREAST CANCER IN THE FIRST YEAR OF     
POST-TREATMENT SURVIVORSHIP  
Introduction  
Breast cancer is the most common cancer among women in the United States.
1
  Today, 
there are more than 2.3 million women alive who have survived breast cancer.
2
  The mean age of 
all women diagnosed with breast cancer is 61, and women between the ages of 75 to 79 have the 
highest incidence of the disease.
2
 As the Baby Boomer generation advances toward older age 
with increased life expectancy, the number of older women diagnosed with breast cancer is also 
expected to increase.
3
   
This paper defines ―older‖ as age 65 and older. Older women with breast cancer receive 
standard treatments such as mastectomy, lumpectomy, radiation, chemotherapy, and/or hormonal 
therapy.
4-7
  Older breast cancer survivors are at risk for adverse effects after treatment that may 
have an impact on quality of life (QoL).
8-14
  At diagnosis, older women may also experience 
other chronic illnesses in addition to breast cancer which may have further impact on QoL.
15
   
Research demonstrates that women of different ages diagnosed with breast cancer have 
different concerns and needs.
16, 17
  However, current research has recently begun to explore these 
needs in women with breast cancer who are age 65 and older and in the first year of survivorship.  
The purpose of this paper is to report the results of a study of QoL in older, early stage breast 
cancer survivors in the first year of post-treatment survivorship.  The specific aims were to: 1) 
Describe changes that occur over time in overall QoL and the QoL domains of Physical, 
Psychological, Social and Spiritual well-being for women with breast cancer aged 65 and older 
in the first year of post-treatment survivorship; 2) Examine the effects of the BCEI 
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psychoeducational support interventions on QoL outcomes among older women with breast 
cancer. 
Literature Review 
Data show that cancer and its treatment affect QoL in breast cancer survivors; however, 
the effect on QoL in older women is unclear.   Many studies that examine QoL report the 
average age of the participants as 50 years.
18-27
  Such data can not be generalized to an older 
sample.  Exclusion or lack of participation of older women in clinical trials has led to a 
knowledge deficit in many areas regarding older women with breast cancer.  This literature 
review is limited to research that specifically included women age 65 and older in their samples.   
Several studies have focused on QoL outcomes in older women after surgical treatment 
for early stage breast cancer.  These studies indicate that older women who receive conservative 
treatments such as lumpectomy experience fewer arm problems,
28-30
 fewer concerns with body 
image,
28, 31
 and better mental health
28
 compared to women who receive mastectomy and axillary 
lymph node dissection. In addition, older women reported better mental health when they felt 
involved in making their treatment decisions.
30
  
Other studies have focused on physical outcomes in older women after treatment for 
early stage breast cancer.  Physical effects, such as fatigue,
28, 32
 arm problems related to axillary 
dissection, such as lymphedema, swelling and  numbness,
30
 pain,
33
 concerns with physical 
functioning,
34
 weight gain, constipation,
32
 dry mouth, weakness, and hot flashes,
32
 have been 
reported by older women.  Compared to younger women, older women report more physical 
symptoms.
35
  However, compared to women their own age with chronic illnesses other than 
breast cancer, older women with breast cancer report similar symptoms.
32
  In addition, older 
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women with breast cancer report being less bothered by symptoms than women with other 
chronic illnesses such as arthritis.
33
 
Declines in physical well-being and functioning have also been reported by older women.  
Compared to younger women, these declines in well-being and functioning are more severe in 
older women
35, 36
 but similar to declines experienced by older women without a history of breast 
cancer.
34, 37
 
Psychological effects reported by older women include concerns with emotional 
functioning,
34
 fear of recurrence, lack of social support,
28
 body image concerns,
28, 31
 and 
cognitive changes.
32, 38
  All of these effects may have an impact on QoL outcomes in older 
women with early stage breast cancer.  Older women have reported experiencing less distress at 
diagnosis and during treatment compared to younger women with breast cancer.
35
 
Socially, compared to younger women, older women report fewer concerns with 
sexuality, employment, family distress,
35
 and finances.
36
  In contrast, cognitive changes and 
deficits in concentration are more prominent in older women compared to younger women.
39
 
Spiritually, while the importance of faith and religion has been noted in many women 
with breast cancer, benefits related to religion and spirituality have been reported in older women 
with breast cancer.  Religion and faith give older women support, comfort, and a feeling of 
connectedness.
40
  Faith also helps older women cope and make meaning in their illness.
40
  
Conflicting information exists concerning the ability of older women to note positive changes in 
their lives after breast cancer.  Utley 
41
 reports that older women are able to see the benefits from 
cancer; however, Cimprich 
38
 reports that older women note fewer positive changes from their 
breast cancer diagnoses than younger women.  
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In summary, this literature review showed that older women experience multiple side 
effects and concerns after treatment for breast cancer.  Compared to younger women, older 
women report declines in their physical functioning; however, their non-cancer peers also 
experience physical decline.  Psychologically, older women report less distress at diagnosis 
compared to younger women.  Socially, older women face fewer financial concerns compared to 
younger women. Older women also report more cognitive changes compared to younger women. 
Spiritually, faith and religion are also important to older women and helps them to cope and 
make meaning of their illness.   
Theoretical Framework 
The Conceptual Model of Quality of Life in Aging Breast Cancer Survivors (QoL-
ABCS) was used to frame the present study.  The Model is shown in Figure 1. The QoL-ABCS 
uses the domains of Physical, Psychological, Social, and Spiritual well-being from the Quality of 
Life for Breast Cancer Survivors conceptual framework.
22, 42, 43
  The model uses the WHO 
(World Health Organization) definition of QoL as ―an individual‘s perception of their position in 
life in the context of the culture and value system in which they live and in relation to their goals, 
standards, and concerns.‖ 44 
The QoL-ABCS acknowledges that QoL is influenced by more than health-related 
factors.  Aging may also influence QoL in older women.  The QoL-ABCS accounts for both of 
these factors by demonstrating the influence of well-being and age on QoL.  This model 
maintains: 1) QoL is multi-dimensional, subjective and dynamic; 2) the domains of QoL are 
interactive with each other and one concept within a domain often influences another domain; 3) 
aging influences perception of QoL in survivorship; 4) perception of Physical, Psychological, 
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Social, and Spiritual well-being influences QoL in survivorship; 5) perception of QoL influences 
well-being in survivorship. 
Methods 
Research Design 
This study used a longitudinal repeated measures approach to examine QoL in older 
women with early stage breast cancer in the first year of post-treatment survivorship.  Data were 
drawn from a larger study, the Breast Cancer Education Intervention Study (BCEI). The BCEI 
was a longitudinal intervention trial that examined the effect of a psychoeducational support 
intervention for early stage breast cancer survivors.  Details of this study are described 
elsewhere.
45-47
  
Sample  
Subjects for this study included 50 women, age 65 and older from the BCEI.  Inclusion 
criteria included: 1) female; 2) histologically confirmed early stage breast cancer [Stage 0-II]; 3) 
completion of treatment; 4) within the first year post-treatment; and 5) able to communicate in 
English.  Subjects may have been on hormonal or anti-HER2 therapy at the time of study entry. 
Women with advanced or metastatic disease at the time of diagnosis were excluded from the 
study. All subjects were community dwelling. In this convenience sample, there were 24 older 
women assigned to the Experimental (EX) Group and 26 women assigned to the Wait Control 
(WC) Group.    
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Measurement Tools 
Demographics were obtained using the BCEI Demographic Tool. This 32-item tool 
includes items concerning sociodemographic characteristics (e.g., age, ethnicity, primary 
language, income, occupational status, religious affiliation) and treatment variables.
45
   
Quality of life was measured using the Quality of Life Instrument- Breast Cancer (QoL-
BC).  The QoL-BC scale is a 50-item scale that specifically measures QoL in women with breast 
cancer. The QoL-BC was adapted from the QoL-Cancer Survivors Scale (QoL-CS).
18, 23
  The 
QoL-BC uses a 10-point rating scale used to describe QoL problems or concerns within four 
identified QoL domains-Physical, Psychological, Social and Spiritual well-being.
23
  Scoring is 
based on a scale of 0 = best outcomes to 10 = worst outcomes.  Thus, the lower the total score, 
the better the QoL. Reliability for the QoL-BC was established using the QoL-CS, which 
indicated a test-retest reliability of 0.89 and a Cronbach‘s alpha of 0.93.  
In the BCEI, alpha coefficients for the total QoL and subscales were as follows:  
Overall QoL = 0.91; Physical well-being = 0.99; Psychological well-being = 0.96; Social well-
being = 0.84; and Spiritual well-being = 0.85.
45
  In the current study, the alpha coefficients for 
total QoL and each QoL subscale were: Overall QoL = 0.80; Physical well-being = 0.66; 
Psychological well-being = 0.93, Social well-being = 0.81; and Spiritual well-being = 0.78. 
Procedures 
Several steps were followed to obtain, clean, and analyze the data for this secondary 
analysis.  First, the investigator obtained written permission from the principal investigator of the 
BCEI Research Study (See Appendix D).  Second, Institutional Review Board (IRB) approval 
was obtained from the University of Central Florida‘s Office of Research and Commercialization 
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(See Appendix E).  Third, this investigator received eight de-identified data files in SPSS-v13
48
 
for subjects age 65 and older.  These files contained data collected at baseline (Time 1), month 3 
(Time 2), and month 6 (Time 3). Fourth, Dr. Xiaogang Su, a biostatistician, was asked to provide 
a statistical consultation for the Generalized Estimating Equation (GEE) portion of the analysis 
(See Appendix G). 
Finally, data files were examined for accuracy, missing data, and outliers prior to analysis 
using descriptive statistics.
49
  Frequencies were run on all variables to evaluate completeness of 
the data.  No unexpected missing data were noted.  However, two subjects who were age 65 and 
older did not complete the study.  One subject withdrew from the study prior to data collection at 
Time 2.  Another subject died prior to the final data collection (month 6) due to causes unrelated 
to breast cancer or participation in the study.  This resulted in complete data for forty-nine 
subjects at month 3 and forty-eight subjects at Time 3. 
Data Analysis 
Descriptive statistics including frequencies, means, and standard deviations (SD) were 
used to describe overall QoL and the four QoL domains. Generalized Estimating Equation 
methods,
50, 51
 which are useful in analyzing correlated longitudinal data, were used to evaluate 
the overall effect of the BCEI intervention. Two-sample and paired t tests were used to further 
analyze between group differences and within group longitudinal changes.  Bonferroni type 
adjustments were also made. In the t tests, three inferences were made for each variable, bringing 
the significance level to .017 (.05/3).  Descriptive statistics and t tests were run by the 
investigator using SPSS-v13
48
 software. GEE analysis was run using software developed in  
R 
52
 by Dr. Xiaogang Su, the biostatistician consultant.  
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Research Question # 1 describes the changes that occurred over time in overall QoL and 
the QoL domains of Physical, Psychological, Social, and Spiritual well-being for older breast 
cancer survivors in the first year of post-treatment survivorship.  Descriptive statistics, including 
means and standard deviations, were used to answer this research question.  Overall QoL for the 
entire sample was determined by using the overall mean score of the combined subscales (i.e., 
Physical, Psychological, Social, and Spiritual well-being) from the QoL-BC scale.  Subscale 
scores were determined by using the combined mean scores for all items within each subscale. 
Research Question # 2 used GEE analysis to examine the effects of the BCEI 
psychoeducational support interventions on QoL outcomes among older breast cancer survivors 
in the first year of post-treatment survivorship.  Without adjusting for covariates, GEE methods 
were used to examine the effects of the BCEI intervention using the outcome variables of overall 
QoL and the four QoL subscales.  Two-sample and paired t tests were also used to make detailed 
between and within group comparisons for overall QoL and subscale scores for the EX and WC 
Groups.   
Results 
 The results section will first describe the baseline characteristics of the sample.  The 
answers to each specific research question follow. 
Characteristics of the Sample 
Demographic characteristic of this sample consisted of 50 older breast cancer survivors in 
the first year of post-treatment survivorship. The mean age of this sample was 72.1 years (SD: 
5.12) with a range of 65 to 83 years.  The majority of the sample was Caucasian (82%) and 
reported English (92%) as their primary language.  Slightly less than half of the sample reported 
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an educational level of college or better (44%).  The majority of the sample reported being 
Christian of varying denominations (98%). More than half the sample was married (56%).  Most 
subjects (80%) were not employed; 8% worked full-time and 12% worked on a part-time basis.  
Approximately half the sample (44%) had an annual family income of $30,001 or more, and 
42% had an annual family income of $30,000 or less.   
Disease- and treatment-related demographics indicated that 70% of the sample was 
diagnosed with Stage I breast cancer, and 30% was diagnosed with Stage II.  Women were 
treated with lumpectomy (72%), mastectomy (24%), or bilateral mastectomy (2%).  Other 
treatment included chemotherapy (18%), radiation therapy (78%), and hormonal therapy (84%).  
Table 4 lists a complete summary of demographic statistics. 
Baseline demographic and cancer treatment characteristics were compared to determine 
whether there were any significant differences between the EX and WC groups.  No statistically 
significant demographic differences were noted between the two groups.  Table 5 lists a 
complete summary of the demographic characteristics of each group. 
Quality of Life in Older Breast Cancer Survivors 
Research Question # 1 described the changes that occur over time in overall QoL and the QoL 
domains of Physical, Psychological, Social, and Spiritual well-being for older breast cancer 
survivors in the first year of post-treatment survivorship.  
At baseline, mean overall QoL was 2.38 (SD = 0.1.02).  At Time 2, it was 2.48 (SD= 
1.20), and at Time 3, 2.58 (SD = 1.33).  Overall QoL worsened at Time 2 and continued to 
worsen at Time 3. Table 6 presents the mean QoL scores and standard deviations.  Figure 2 plots 
the mean overall QoL scores over time.  
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Changes in the QoL subscale scores were noted for the entire sample.  Table 6 presents 
the mean subscale scores and standard deviations.  Physical well-being declined from baseline to 
Time 2 and Time 3.  Psychological well-being declined from baseline to Time 2 and Time 3.  
Social well-being improved at Time 2 but declined at Time 3. Spiritual well-being declined at 
Time 2, then improved at Time 3.  Figure 3 plots the mean QoL subscale scores over time. 
Research Question # 2 examined the effects of the BCEI psychoeducational support intervention 
on QoL outcomes among women with breast cancer aged 65 and older in the first year of post-
treatment survivorship.   
 At baseline, there were no significant differences in the mean scores for overall QoL 
between the EX and WC Group.  In addition, there were no significant differences for overall 
QoL at any time point between the two groups. Table 7 shows the mean overall QoL scores for 
each group over time and the results of independent sample t-tests for overall QoL.  Figure 4 
plots the changes in the mean overall QoL scores for each group over time.  
At baseline, there were no significant differences in the mean scores for the four QoL 
subscales (i.e., Physical, Psychological, Social, and Spiritual well-being) between the EX Group 
and the WC Group.  In addition, there were also no significant differences for any of the QoL 
subscales at any time point between the two groups.  Table 7 shows the mean QoL subscale 
scores for each group.  Figure 5 plots the mean changes in the four QoL subscales for both 
groups at each of the three time points. 
 GEE analysis indicates that there was no treatment effect or intervention effect over time 
between these groups of older women for overall QoL or for Physical, Psychological, Social, or 
Spiritual well-being.  Absolute Robust Z Scores ranged from -0.591 to 1.749 indicating no 
significant difference in intervention effects between the two groups. See Table 8 for a summary.   
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Within Group Differences: Overall QoL and QoL Domains 
 Within group differences were noted for both the EX and WC Groups.  Within the EX 
Group, significant changes were noted from baseline to Time 2 for Physical well-being, 
indicating a worsening of physical well-being, t(22)= -2.962, p=.007.  From Time 2 to Time 3, 
Physical well-being scores remained stable. In addition, the following changes occurred but were 
not statistically significant: 1) Overall QoL declined slightly, but steadily from baseline to Time 
3; 2) Psychological well-being gradually worsened from baseline to Time 3; 3) Social well-being 
improved at Time 2, then declined slightly at Time 3; 4) Spiritual well-being declined from 
baseline to Time 2 and slightly improved to above baseline scores at Time 3.    
Within the WC group, overall QoL steadily declined from baseline to Time 3.  Physical, 
Psychological, and Social well-being also declined from baseline to Time 3.  Spiritual well-being 
worsened from baseline to Time 2, then improved from Time 2 to Time 3.  None of these 
changes were statistically significant.  Figures 4 and 5 also plot the mean overall QoL and QoL 
subscale changes, respectively, for each group. 
Discussion 
Quality of Life in Older Women with Breast Cancer 
When examining the entire sample, mean scores for overall QoL and the four QoL 
domains reported by older breast cancer survivors within the first year post-treatment indicate 
that older women reported generally good baseline overall QoL and QoL within the domains of 
Physical, Psychological, Social, and Spiritual well-being.  However, they reported that QoL 
changes occur over time. Overall QoL slightly declined over a period of six months.   In 
addition, Physical and Psychological well-being declined over time. Social well-being initially 
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improved and then returned to baseline.  Spiritual well-being initially worsened before returning 
to baseline. 
  Declines in Physical and Psychological well-being may possibly be related to non-
cancer related experiences and events. The initial improvement in Social well-being may be 
related to participation in the psychoeducational support intervention study where the subjects 
received individualized attention. Likewise, the subsequent decline in Social well-being may 
have been related to fewer contacts with subjects at the end of the study. The initial decline in 
Spiritual well-being which was followed by improvement of Spiritual well-being may be related 
to the QoL-BC survey.   
Effects of the BCEI on Older Women with Breast Cancer 
 At baseline, mean scores for overall QoL were comparable for the EX and WC Groups.  
Over time, both groups reported a decline in overall QoL over time.  The sample size in this 
study was small; therefore, statistically significant differences between groups could not be 
established.  Data from the WC Group suggest that QoL in older women with breast cancer may 
naturally decline in the first year of post-treatment survivorship.  Data from the EX Group also 
suggest that QoL in older women declines after treatment. However, this decline was noted to be 
less pronounced in the EX Group compared to the WC Group.  It is possible that the potential 
effect of the intervention in older women with early stage breast cancer was to lessen the decline 
in overall QoL.
53
 The possibility that an intervention may lessen the decline of QoL in older 
breast cancer survivors after treatment is a new and important finding. 
 Within the four QoL domains, there were no significant differences between the groups at 
any time point. However, some differences are worth noting. Within the Physical domain, while 
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well-being declined for both groups during the six months of the study, QoL initially declined 
more sharply for the EX Group compared to the WC Group.  This decline may possibly be 
linked to participation in the intervention, which may have alerted subjects to physical problems 
related to breast cancer that they previously attributed to some other cause.  This new way of 
thinking about their symptoms may have prompted older women to report worsened physical 
symptoms related to their cancer at Time 2.  Within the Psychological domain, well-being also 
declined for both groups with the decline more notable in the WC Group.  Subjects within the 
EX Group may have been experiencing a psychological benefit directly related to their 
participation in the intervention. Within the Social domain, well-being appeared to improve for 
the EX Group at Time 2, perhaps indicating that the EX Group received immediate benefits from 
the personalized attention they received during the delivery of the intervention.  This response 
differs from the WC Group, which reported a steady decline in Social well-being over time.  
Within the Spiritual domain, both the EX Group and WC Group reported initial decline in 
Spiritual well-being; however, this decline was more pronounced in the WC Group.   
Overall, this study demonstrated that older women reported positive baseline overall QoL 
within the first year of post-treatment survivorship, but overall QoL declined slightly over time.  
Physical and Psychological well-being also declined over time. Social well-being initially 
improved, but, again, declined over time. Spiritual well-being initially worsened, but improved 
six months later. When examining the effects of a psychoeducational support intervention, both 
groups experienced a downward trend in overall QoL during the study period, with QoL in the 
EX Group showing a smaller decline compared with the WC Group.  The intervention appears to 
have lessened the decline in overall QoL for the EX Group compared to the WC Group.  At this 
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time, the small sample size makes definitive statements concerning QoL in older breast cancer 
survivors difficult to assert and future research is needed. 
Strengths 
Several study strengths are identified.  First, findings from this secondary analysis 
represent an important contribution to the literature and for future research since few studies 
specifically focus on older women with breast cancer.  While study results did not detect a 
significant intervention effect between the EX and WC Groups, there was an interesting 
attenuation in the decline of overall QoL reported by the EX Group.  The majority of cancer-
related QoL studies aim to improve QoL.  At baseline, both groups reported good overall QoL.  
However, over time, QoL declined more notably in the WC group.  Thus, an important 
conceptual contribution exists—researchers must consider the attenuation of decline in QoL 
rather than striving for significant improvement in QoL.  This study sets the stage for future 
research to use larger samples and observe subjects over longer periods of time in order to 
examine possible statistically significant differences and intervention effects in older breast 
cancer survivors.   
Second, study results can serve as a pilot for development of future interventions for 
older breast cancer survivors.  Knowledge gained from this study may help guide researchers in 
future development of age appropriate and tailored interventions that may help women maintain, 
improve or lessen decline in QoL.  In addition, this study provided data that can be used to 
determine power in future intervention studies with older breast cancer survivors. 
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Limitations 
Several weaknesses are also noted.  Limitations exist within the QoL-BC measurement 
tool.  While the QoL-BC has been applied to other groups of women with breast cancer of 
varying ages, the components of each domain may not adequately represent concerns of older 
breast cancer survivors during post-treatment survivorship.  While the QoL-BC tool had 
acceptable alpha levels in this sample, they were comparatively lower than in the parent BCEI 
study.  The alpha co-efficient for the Physical subscale was considerably lower than those 
reported in other studies. Domains, such as physical functioning reported in other studies,
34, 36, 37
 
are not represented in the QoL-BC tool and could not be directly measured for this sample.  
Finally, concerns for fertility and menstrual changes reported in younger women
18
 did not apply.    
Another limitation found with QoL-BC tool is that some items were non-directional.  For 
example, questions such as ―How much has your spiritual life changed as a result of your 
diagnosis?‖ and ―Has your illness or treatment caused changes in your self concept (the way you 
see yourself)?‖are non-directional and were problematic for interpretation.54  Rewording these 
items in future studies of older breast cancer survivors may make responses easier to interpret. 
While the QoL-BC survey has provided valuable information concerning older women with 
breast cancer, it requires further use in older samples to determine reliability.  In addition, the 
potential to develop instruments specific to older breast cancer survivors is needed. 
Implications for Research and Practice 
There are few studies that specifically focus on older breast cancer survivors.  Several 
areas of research are warranted for the future. First, future studies could focus on determining the 
extent of symptoms and their degree of distress in older breast cancer survivors. Second, future 
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research studies could focus on specific concerns within each QoL domain that may further have 
an impact on QoL among older breast cancer survivors. Third, future research may be developed 
to better understand the experiences that may contribute to decline in QoL for older women 
during their first year of post-treatment survivorship. Fourth, larger sample sizes and observing 
subjects over longer periods of time may provide a more accurate account of the natural history 
of QoL after treatment in older breast cancer survivors.  Fifth, outcomes of such studies may lead 
to the development of interventions specifically tailored to the needs of the older women 
surviving with breast cancer.  Finally, future research may strive to maintain QoL at higher 
levels than would naturally occur in older breast cancer survivors in the first year after treatment. 
In practice, nurses can use findings to further examine whether gradual declines occur 
over time among their own patients.  Nurses may also consider the education and support they 
provide for their patients.  Older breast cancer survivors may have differential educational and 
support needs after treatment. Nurses may consider tailoring their teaching to the needs and 
styles of older breast cancer survivors rather than providing generic information to all patients. 
Conclusions 
The findings of this study add to the body of knowledge concerning older breast cancer 
survivors in the first year of post-treatment survivorship.  It is one of the first reported studies of 
post-treatment interventions that included older breast cancer survivors.  A vital finding showed 
that the BCEI Intervention attenuated the decline of QoL in the EX Group compared with the 
WC Group.  The findings of this study can serve as the basis for future intervention studies 
targeting the needs of older women. 
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CHAPTER 4: NURSES PERCEPTIONS OF THEIR INTERACTIONS WITH OLDER 
WOMEN WITH EARLY STAGE BREAST CANCER WITHIN THE FIRST YEAR OF 
POST-TREATMENT SURVIVORSHIP 
Introduction  
She again expressed concern about her problem not being from breast cancer, but from other 
situations in her life. - Excerpt from field note 
 
This statement and statements like it were recorded in field notes written by research 
nurses involved in a large randomized clinical trial which examined the effectiveness of a 
psychoeducational support intervention on quality of life (QoL) in women with early stage breast 
cancer. Such statements are the written accounts of the nurse‘s, or participant observer‘s, 
thoughts and perceptions at the moment of the interaction with the subject.  The aim of this study 
was to describe the perceptions of research nurses during interactions with women, age 65 and 
older with early stage breast cancer.  This study relies on the use of qualitative methods 
including participant observation in and content analysis of the field notes recorded during the 
psychoeducational support intervention. The purpose of this paper is to: 1) describe nurses‘ 
perception of their interactions with older breast cancer survivors in the first year post-treatment 
and 2) discuss research and nursing implications based on the knowledge gained from analysis.  
Background 
Older women are at increased risk of developing breast cancer.
1
  For the purposes of this 
study and discussion, older women will be defined as age 65 and older.  Fifty percent of women 
diagnosed with breast cancer are 61 years old or older
2
.  The majority of these diagnoses will 
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occur prior to metastasis, ensuring survival rates near 88%.
2
  The overall number of women with 
breast cancer is expected to increase as the Baby Boomer generation ages, making older women 
a particularly important population of study.  
Frequently, research focuses on post-treatment adverse effects, which impact QoL.
3-5
  
Little attention is given to stressors or experiences that are unrelated to breast cancer, but may 
impact QoL in older women with breast cancer.
6-8
   
Methods 
Design 
The present study is a qualitative, secondary analysis using data from the Breast Cancer 
Education Intervention (BCEI) trial. The BCEI was a longitudinal clinical trial that examined the 
effect of the BCEI psychoeducational support intervention for women with early stage breast 
cancer (N= 256), the details of which are described elsewhere.
9-11
  All participants had early 
stage breast cancer, completed treatment at least one month prior to enrolling into the BCEI, and 
were within the first year of post-treatment survivorship. 
In the BCEI, the Experimental group (n=129) received the intervention, which included 
three face-to-face educational and support sessions and three follow-up telephone education and 
support sessions during a six-month period. Sessions took place in the participant‘s home, 
workplace, doctor‘s office, or another site selected by the participant.9-11  
Throughout the BCEI trial and specifically during the intervention, research nurses 
recorded field notes.  These notes provided a record of the research nurses‘ encounters, as 
participant observers, in the intervention.  Research nurses also recorded details of the 
participant‘s diagnosis, prior treatment, current treatment and side effects at the time of the initial 
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interview.  For subjects in the Experimental Group, nurses recorded participant-identified 
problems discussed during the education and support sessions. Notations were also made if the 
participant brought up other topics during these encounters.  These field notes became the object 
of interest for this research study and had not been previously analyzed.   
The goal of the field note analysis was to describe the research nurse‘s perception of their 
observations of older women with breast cancer within the context of their participation in the 
BCEI.  Field notes have been widely used in qualitative research. 
12-14
   However, many studies 
have used field notes to supplement data obtained in structured or semi-structured interviews.
12, 
14
  Only one study analyzed the notes as primary source of data.
13
 For the purpose of this study, 
content analysis was used to analyze the field notes. 
Sample 
The sample for this study consists of the 24 women, age 65 and older who were in the 
Experimental Group of the BCEI. Field notes related to interactions with participants in the Wait 
Control (n=26) Group were excluded because the interaction and discussion between the nurses 
and participants was purposefully limited and brief in order to avoid contamination between the 
two groups. 
Procedure 
This secondary analysis consisted of several steps.  First, this investigator obtained 
written permission from the principal investigator of the BCEI Research Study (See Appendix 
D).  Second, Institutional Review Board approval was obtained from the University of Central 
Florida‘s Office of Research and Commercialization for the current study (See Appendix E).  
Third, this investigator received 50 de-identified Microsoft Word™ files for participants age 65 
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and older.  Each Microsoft Word™ file ranged from one to three pages in length.  Each file 
contained data collected during the BCEI at each point of contact between the research nurse and 
the participant.  These points of contact began with baseline data collection and ended 
approximately six months later when participants were no longer involved in the BCEI.  Fourth, 
these documents were loaded into Ethnograph (Ethnograph v5.08, Qualis Research), a software 
package that assists with the coding and sorting of data.   
Analysis 
Content analysis of the field notes was based on a systematic process
15
.  First, all data 
were read thoroughly prior to coding to gain an overview of the quality and content of the field 
notes.  Second, data were re-read; codes were generated using language closely reflecting the 
language used by the nurses in the field notes. For example, if the research nurse observed that 
the patient experienced a particular side effect or was concerned with an ill family member, 
codes specifically reflected this. Third, these codes were defined and grouped according to 
similarities.  For example, several participants were worried about the health of family members; 
hence, the overall code was called ―Family illnesses.‖ Fourth, like codes were examined and 
similar codes were combined, resulting in the final coding scheme. 
The following process supported evidence for confirmability.  First, the investigator 
asked a colleague to review five randomly selected field notes.  The colleague has been a 
professional nurse for more than twenty years. She is also a doctoral student with experience in 
qualitative methods.  Her research focuses on women with chronic illness and she has no 
oncology experience.  Second, the investigator explained that the aim of the study was to 
describe the nurses‘ perception of their interaction with older breast cancer survivors in the first 
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year post-treatment.  Third, the doctoral student reviewed the field notes.  She identified themes 
from the interactions and highlighted the themes.  Fourth, the investigator and doctoral student 
compared their individual themes from the interactions. Fifth, they discussed and agreed the 
codes were appropriate.  For example, one participant had a daughter with breast cancer.  The 
investigator coded the theme as ―daughter with breast cancer‖ and the doctoral student coded the 
theme as ―daughter illness.‖ These codes were thought to be consistent.  Finally, the investigator 
presented the final codes to her doctoral committee chair.  
Results 
Characteristics of the Sample 
Research nurses recorded field notes on events that occurred in a sample of 24 women. 
The average age of participants was 72 (range from 65 to 80).  Most subjects were Caucasian 
(79.2%), spoke English (87.5%), and had at least a high school/trade school education (66.7%).  
Over half of the participants were married (54%), and 50% lived with at least one other person in 
the household.  Most women (75%) were not employed.  Half of the participants (n=12) reported 
an income of $30,000 or below.  Disease-specific variables indicated that 70.8% had Stage I 
breast cancer.  Most received a lumpectomy (70.8%) and radiation therapy (83.3%) and did not 
receive chemotherapy (79.2%).  The majority (79.2%) were on hormonal therapy at the start of 
the study.  Table 9 provides a complete summary. 
Body of the Findings 
Data were summarized according to four main themes. These themes were: 1) continuing 
breast health; 2) personal health issues; 3) family illnesses; and 4) potential stressors. In the 
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following section, quotes from the field notes that denote the nurse‘s perception will be 
italicized, and ―double quotation marks‖ will be used.  Instances where the field notes indicated 
that the participant stated a particular word or phrase will also be italicized, and ‗singular 
quotation marks‘ will be used. 
Continuing breast-related health 
The field notes featured concerns with continuing breast-related health, which described 
the participants‘ experiences with new or ongoing concern related to their breast(s).  The field 
notes conveyed the participants‘ apprehension regarding mammography, breast symptoms, 
breast biopsy or surgery, future tests, waiting for test results, refusing more treatment, and breast 
reconstruction.  During the study period, seven women underwent mammography.  In most 
cases, the mammography showed no further evidence of disease. Nine participants experienced 
new breast symptoms such as a lump, hematoma, rash, open area or sore, and/or itching.  
Symptoms resolved spontaneously in all but two participants, who dealt with ongoing issues 
related to their breast.  Participants‘ reactions to continuing breast-related health varied. For 
example, one woman‘s oncologist discovered a breast lump. When speaking about her 
oncologist‘s recommendation to remove the lump, the woman described her reaction as ‗snags 
along the way are to be expected.‘  The field note revealed the nurse‘s perception that ―She has a 
very positive attitude and states she deals with life as it comes to her.‖  Another woman required 
a biopsy when a shadow was detected by mammogram.  The research nurse observed that the 
participant acknowledged experiencing a week of ―emotional ups and downs and felt better when 
the results were negative.‖ 
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Still another entry describes the anxiety that one woman experienced as she waited for 
her first follow-up mammogram and her extreme concern about going through treatment again. 
After her interaction with the patient, the nurse noted that ―the participant seems to think about it 
[recurrence] all the time.‖   
Personal health issues 
The field notes also captured concerns with personal health issues, or the participants‘ 
experiences with health issues unrelated to their breast cancer such as co-morbid illnesses, non-
cancer related illnesses, and falls.  Three women discussed managing co-morbid illnesses such as 
diabetes mellitus, irritable bowel syndrome, diabetic neuropathy, pain, and osteoporosis.  The 
field notes convey that participants were able to manage these illnesses in their lives.  For 
example, one woman had chronic hip, back and knee pain and used a walker to get around.  
Despite these chronic conditions and other cancer-related conditions, such as lymphedema, 
which developed during the study period, the research nurse repeatedly recorded her perception 
that the participant was able to remain ―optimistic‖ and ―have a positive attitude.‖  Despite both 
the chronic and new conditions that the participant encountered, she described herself as ‗in good 
spirits‟ and ‗holding her own‟.  The field note further reveals the research nurse‘s perception that 
this participant ―feels her QoL is excellent and nothing stops her.‖  
The field notes also describe nine participants with transient illnesses such as the 
common cold, high blood sugar, bronchitis, urinary tract infections, and headaches during the 
study period.  However, two women experienced potentially serious illnesses.   The research 
nurses observed that some women lived with serious health symptoms for several weeks before 
addressing the symptoms.  For example, one participant ignored chest pain for more than a 
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month because she was caring for her ill daughter.  The field note revealed the research nurse‘s 
perception that ―she has few concerns about herself, only for her daughter.‖ In a later entry, the 
nurse added her perception that the participant knows ―she has been so focused on her daughter 
that she has not been centered on herself.‖  
Family health issues 
The research nurses‘ field notes also captured family health issues, which described the 
participants‘ experiences with ill family members or recently deceased spouses.  During the 
study period, eight women had either an ill spouse or adult child and three women reported being 
a caregiver for ill family members.  The field notes convey participants‘ concern over the health 
of their family members and how it related to their own QoL.  Participants also expressed 
concern that their anxiety over the health of their loved ones was reflected in the QoL surveys 
that they were asked to complete during the study.  For example, one participant whose daughter 
was diagnosed with breast cancer expressed anxiety over her daughter‘s diagnosis.  The research 
nurse observed that the patient believed her ―anxiety related to daughter‟s diagnosis may be 
reflected in answers [on quantitative surveys].‖  Another participant had a daughter who was 
diagnosed with advanced lung cancer.  Throughout the study, the research nurse observed that 
this participant continually put aside her own health to care for her daughter.  In a field note 
entry, the research nurse observed that ―Her daughter continues to do poorly, which is the main 
cause of this patient‟s anxiety and low QoL scores.”   
Two participants discussed how the death or illness of their spouse affected their current 
QoL. One entry describes a woman‘s concern for her ill husband of 35 years.  During one of 
their interactions, the research nurse observed that the husband has debilitating chronic illnesses 
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and “most of patient concerns deal with these issues.‖ In a note for a participant whose husband 
recently died, the research nurse stated ―she [the participant] does not feel she has problems that 
can be only attributed to her breast cancer.‖ 
Finally, another entry in the field notes describes how a spouse‘s illness left one woman 
unaffected by her diagnosis of breast cancer.  During their interaction, the nurse observed that 
―When she was diagnosed with breast cancer- it did not have a great impact because she had 
experience with [her husbands] illness.‖  
Potential stressors 
The last theme captured in the field notes was potential stressors.  The field notes 
conveyed the participants experience and frustration with family issues, housing issues, stressful 
living situations, a change in physician, car issues, car crashes, holidays, ―little things‖ and 
hurricanes.  During the study period, potential stressors were mostly observed by the research 
nurses to be short-lived: however, two women dealt with ongoing stressors. For example, one 
participant had continuing issues with a tenant who lived in her home.  The nurse observed that 
the participant did ―Not think [the side effects were] cancer related as much as related to the 
stress of having the border.  She thinks it will resolve now that he is gone.‖   
Another field note describes the ongoing family issues of a participant living with two 
grandchildren and four great-grandchildren in a small house without air conditioning in Florida.  
The research nurse observed that this participant repeatedly discussed how bothersome the great-
grandchildren were and how her grandchildren ‗irritated‟ her.  One entry in the field note 
describes the research nurse‘s perception of how the participant felt ―hopeless in her life,‖ but 
also noted that the participant states that she was „like that even before her diagnosis.‘  The field 
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notes describe the research nurse‘s perception of how this participant was being pressured by her 
family to move closer to them, which would ultimately take the participant father away from her 
husband who was in a nursing home.  Throughout interactions with this participant, the research 
nurse observed that this woman seemed ―worn down‖ and ―overwhelmed‖ by life at times. 
In addition to the previously mentioned experiences, uncontrollable circumstances were 
also observed by the research nurses.  During the summer and fall of 2004 when these field notes 
were recorded, Florida experienced four major hurricanes.  The field notes describe the research 
nurse‘s perception of the frustration of three participants who experienced power outages, phone 
outages, and damage to their homes.  In one field note, the research nurse observed how one 
participant ―found the experience overwhelming‖ and was ―saddened by the experience.‖  In 
another field note, the research nurse observed that a participant who was without power for a 
week found the experience ‗unsettling.‘  
 
Discussion 
Content analysis of these field notes captured research nurses perceptions‘ of the 
experiences of women, age 65 and older, with early stage breast cancer within the first year post-
treatment.  These perceptions would not have been captured using standardized measures.  
Although the field notes were not originally intended for analysis, the thoughtful perceptions of 
the participants‘ comments and behaviors discovered in the data were rich.  In summary, these 
data were categorized according to four major themes: continuing breast-related health, personal 
health issues, family health issues and potential stressors.   
Research nurses noted that continuing breast-related health was a stressful experience for 
women with breast cancer.  They documented a variety of participant responses to continuing 
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breast-related health, ranging from little concern over new breast symptoms to a great deal of 
fear. Concern over breast symptoms and recurrence have been reported in the literature in 
women of all ages with breast cancer.
16
  
Research nurses also documented that personal health issues not related to breast cancer, 
such as co-morbid or chronic conditions, were experienced by this sample.  Eighty percent of 
Americans over the age of 65 have at least one chronic illness,
17  so it is surprising that co-
morbid conditions were noted in only three participants.  Everyday illnesses and serious health 
symptoms also occurred in the sample.  These findings indicate that older women may have 
other health concerns besides cancer.   
Research nurses observed that family health issues were also a concern for this sample.  
Understandably, these women were very concerned when a loved one became ill and discussed 
the anxiety family illness caused.  The field notes also report that several women were 
caregivers.  Caregiving itself is stressful,
18, 19
 which may lead to some of the anxiety women felt 
when caring for a loved one.   
In addition to capturing patients‘ concern for the health of loved ones, field notes also 
noted participants‘ concern that the stress or anxiety caused by their loved one‘s illness would be 
reflected in the quantitative surveys that measured their QoL.  These concerns indicate that some 
subjects seemed to feel that the study was only measuring cancer-related QoL instead of general 
QoL.  This uncertainty concerning what the QoL instruments were measuring raises questions 
about the validity of QoL measurements in older cancer survivors.   
When considering family health, nurses also observed that some older women felt that 
their QoL issues were related to experiences other than breast cancer. This finding has not been 
reported in preceding literature.  This observation suggests that breast cancer may not be the 
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biggest or most devastating event these women experience. Nurses observed that the experience 
of having breast cancer may be overshadowed by other events such as death or illness of a 
spouse or family member.   
Finally, nurses observed that the women in this study experienced a number of potential 
stressors in their lives.  While some of these stressors might be considered minor, significant 
consequences could result.   For example, several women experienced car troubles, which could 
potentially lead to isolation, loss of social support or missing important follow-up appointments.  
Other women faced stressors within their own homes and with people living with them. In these 
instances, women allowed people to live with them, which caused them stress.  This suggests 
that some older woman may place themselves in situations where some company or 
companionship is better than isolation.   
Some of the experiences found in this study have also been noted in the literature.  Life 
experiences and life stress have been examined in relation to their impact on QoL outcomes and 
survival.  While the mean age of participants in these studies was below 65 years, older women 
did participate.  These studies have noted life stressors in women with breast cancer and include: 
personal or family illness
8
, death of a loved one
6, 8, 20
, financial stressors
6, 8, 20, 21
, ended 
relationships
6
, conflicts with family
6
, children leaving home, alcoholic family members, 
moving
22
, and accidents, robberies, and like events
6
. 
Studies that have examined life stress have looked at the effect of stressors prior to 
treatment and their impact on QoL outcomes. Baider and colleagues
21
 compared women with 
breast cancer in different cultural settings, one to five years after diagnosis. They found that the 
number of stressful life experiences before diagnosis predicted psychological distress after 
treatment.
21
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Another study by Low and colleagues
8
 examined life stress, coping strategies, and 
adjustment in the year after treatment for breast cancer. This study was longitudinal and followed 
558 women over a twelve-month period.  The average age of participants was 58.1 years.  On 
average, women reported 1.34 stressful experiences in the year prior to treatment.  Results 
showed that women with more life stressors experienced more depression, less vitality, and more 
cancer-related distress at baseline however, life stress did not affect psychological adjustment 
over time.   
Golden-Kreutz and Anderson
6
 examined the effect of stress on depressive symptoms 
after breast cancer.  This was a prospective, longitudinal study of women (N=210) with stage II 
and III breast cancer.  The average age of the participant was 51 years.  The majority of subjects 
experienced at least one major life event in the twelve months prior to diagnosis.  Results 
showed that depression after treatment is due to perceptions of global distress, cancer-related 
distress, and stressful life events such as financial problems.   
In a secondary analysis of the previously mentioned study, Golden-Kreutz and 
colleagues
7
 examined stress at diagnosis in relation to its impact on QoL.  Women (N=112) were 
assessed at baseline, four and twelve months after diagnosis.  Most subjects experienced at least 
one life event in the year prior to diagnosis.  Results of this study show that life events, cancer-
related stress, and perceived global stress all contribute to declines in physical and psychological 
QoL.  Life stress was a predictor of QoL at 12 months.  According to the authors, these findings 
suggest that a diagnosis of cancer may have overshadowed the experience of stressful life events, 
delaying their impact on outcomes. 
Finally, one study examined the relationship between stressful life events and survival in 
women with breast cancer.  Maunsell and colleagues
22
 examined how stressful life events that 
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occurred in the five years prior to a diagnosis of breast cancer impacted survival.  The Cox 
Proportional Hazards model was used for analysis. Participants reported 3.7 stressful experiences 
in the five years before diagnosis.  The subjects (N=665) were followed for a seven-year period.  
Ultimately, stress from life events did not affect survival in women with local or regional breast 
cancer.   
In summary, breast cancer does not occur in isolation but takes place in women‘s lives at 
the same time women experience other events and concerns.  In this study, nurses observed that 
older women with breast cancer had concerns after their illness, including continuing breast-
related health issues, personal health issues, family illnesses, and potential stressors.  Prior 
studies examined the impact of life stressors and experiences that occur before the diagnosis of 
breast cancer and how they affect QoL after treatment.  These studies have shown that these 
stressors may negatively impact QoL after treatment.  The findings from this study mirror many 
of the findings reported in the literature concerning patient experiences and stressors.  The use of 
field notes to explore nurses‘ perceptions adds to the evidence that older women may experience 
events or concerns in their lives after breast cancer that may be related to QoL outcomes. 
Limitations 
This study has a number of limitations. First, field notes were written by research nurses 
who were participant observers during a psychoeducational support intervention clinical trial. 
However, at the time of the writing of the field notes, research nurses did not know that their 
notes would eventually be used in an analysis.  Therefore, research nurses were documenting 
their perceptions of their interactions with participants, but they were only documenting what 
they felt was important or notable at the time. This led to differences in the quality of and detail 
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within the field notes.  Despite this limitation, the field notes revealed evidence that older women 
experience concerns other than breast cancer after treatment.  
Second, researcher bias (influence that may produce a distortion of the results
23
) may be a 
factor in analysis.  This investigator was involved in the BCEI as a participant observer who 
recorded the field notes.  During analysis, the researcher recalled encounters with these women. 
For this reason, the researcher avoided reinterpreting the perceptions of other research nurses‘ as 
recorded in the field notes, and, instead, conducted the analysis based on the words written in the 
notes. This required frequent referral back to the field notes to make sure the results represented 
the research nurses‘ impressions at the time of the encounter, not the memories of the researcher. 
This form of analysis was essential in order to reduce or prevent misinterpretation of the data 
based on memory.   
Implications for Research and Practice 
There are several implications for research and practice.  First, researchers may consider 
delving further into the concerns of older women with breast cancer after treatment to achieve a 
holistic view of QoL in this population.  While this is a study with women with breast cancer, 
three of the four themes identified in the field notes were non-cancer related.  This fact 
demonstrates the complex nature of the lives of older women after treatment for breast cancer.  It 
is likely that all women who experience cancer continue to experience other events and concerns 
in life that are independent of having cancer.  Investigating age-related differences in women‘s 
lives during and after treatment for cancer may foster the development of specific interventions 
to manage to reduce stress in this population. 
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Second, the measurement of QoL in older women deserves further investigation.  Nurse 
observations in this study demonstrated that older women were concerned about stress and 
anxiety unrelated to breast cancer, affecting their answers in QoL surveys.  Some women in this 
study seemed to try to separate their breast cancer from the rest of their lives and were concerned 
that stresses from life events were influencing their responses about QoL and breast cancer.  This 
raises questions regarding the understanding of older women regarding what standardized 
measurement tools are trying to capture and how they formulate their answers to the questions 
asked in surveys.  Understanding the cognitive process of how older women formulate answers 
to standardized surveys may improve the reliability and validity of measures. 
Clinically, it is important for all nurses to recognize the complexity of older women‘s 
lives when a diagnosis of breast cancer is received.   For oncology nurses, it is particularly 
important to realize that older women often have other age-related concerns, during and after 
their breast cancer treatment.  Clinically, the awareness that older women may experience issues 
and concerns related to continuing breast-related health, personal health issues, family illness and 
other potential stressors after treatment may help identify and manage concerns. In addition, 
response to these concerns may be individualized.  A holistic assessment consistent with geriatric 
and health-related concerns is advisable.  Awareness of these types of concerns after treatment 
for cancer also provides an opportunity for nurses, regardless of their specialty practice to 
collaborate in the care of older women to manage cancer and non-cancer related concerns after 
treatment that may affect QoL. 
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Conclusions 
In summary, this study described the research nurses‘ perceptions of their interactions 
with older women with breast cancer in the first year of post-treatment survivorship. Content 
analysis was used to analyze field notes.  Using field notes yielded rich findings concerning the 
lives of older women with breast cancer after treatment. Data suggest that older women have 
concerns due to continuing breast-related health, personal health issues, family health issues and 
other potential stressors, all of which may affect QoL.  Research implications indicate 
differential measurement of QoL in older women.  Clinical implications suggest that an 
assessment of older women‘s concerns is warranted. 
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 CHAPTER 5: CONCLUSION 
This dissertation draws several conclusions regarding QoL in women, age 65 and older, 
who have completed treatment for breast cancer.  First, the State of the Science demonstrates that 
fourteen studies focused on women, age 65 and older, after treatment for early stage breast 
cancer.  Together, these studies provide the basis of knowledge concerning this population.  
Current literature suggests that older women with early stage breast cancer: 1) report better QoL 
outcomes when they receive conservative treatments; 2) want to be involved in treatment 
decisions; 3) experience more symptoms and declines in physical functioning, compared to 
younger women; however, they experience similar symptoms and physical functioning compared 
to women of a similar age with other chronic illnesses; 4) have fewer psychosocial concerns 
compared to younger women; and 5) use faith to cope and find meaning in their illness. 
Second, results from the data-based quantitative study, which examined QoL in older 
women with early stage breast cancer in the first year of post-treatment survivorship, 
demonstrated that baseline overall QoL and QoL within the four domains is good. However, over 
time, overall QoL gradually declined.  In addition, Physical and Psychological well-being 
declined.  Social well-being initially improved before returning to baseline. Spiritual well-being 
initially declined before returning to baseline.  
In this study, there was insufficient power to detect a difference in the effects of the BCEI 
Intervention between the two groups. Overall QoL declined in both groups. However, the 
intervention attenuated the decline in QoL for the EX Group.  
Third, results from the data-based qualitative analysis of field notes, which examined 
nurses‘ perceptions of their interactions with women who participated in a psychoeducational 
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intervention for women with early stage breast cancer (BCEI), demonstrated that older breast 
cancer survivors have concerns both related and unrelated to breast cancer after treatment.  
Nurses‘ perceptions were organized into four themes: continuing breast-related health, personal 
health issues, family health issues and potential stressors.  These concerns may affect overall 
QoL. 
These findings offer several implications for research.  First, researchers may expand on 
the current knowledge base regarding QoL in older women after treatment.  Areas in need of 
further research that have been identified by this dissertation include: the symptoms experienced 
by older women after treatment; the extent of the symptom experience; the impact of co-morbid 
illnesses on survivorship; and the impact of non-cancer related experiences of older women after 
treatment.  All of these factors may impact QoL after treatment and merit further study. 
Second, while there was insufficient power to detect an intervention effect, the decline in 
QoL was less in the EX Group.  Future research may focus on other factors that could influence 
QoL in older breast cancer survivors.  In addition, there is considerable need for research, which 
may develop interventions tailored to the specific needs of older breast cancer survivors.  This 
dissertation serves as a pilot study and can provide data needed to determine power analysis for 
future intervention studies for older breast cancer survivors. 
Third, the most appropriate way to measure QoL in older breast cancer survivors has yet 
to be determined.  At this time, it is unclear which measurement tools and what dimensions of 
QoL are most appropriate for use in this older population.  In addition, this dissertation has raised 
questions concerning what is actually being measured in standardized surveys and how older 
women formulate their answers to survey questions.  The potential to develop instruments 
specific to older breast cancer survivors is vast.  
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Finally, this dissertation supports the reconceptualization of QoL in older women with 
breast cancer.  Quality of life in older women after treatment for early stage breast cancer is 
influenced by many factors.  These include Physical, Psychological, Social, and Spiritual well-
being as well as factors unrelated to breast cancer such as aging and other experiences after 
treatment.  Future research may consider the conceptualization of QoL after treatment as holistic 
rather than limited to adverse effects directly related to cancer. 
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APPENDIX A: TABLES 
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Table 1: Summary of studies focusing on women age 65 and older only with early stage 
breast cancer 
Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
De Haes et al. 
(2003) 
Compare effect of 
treatment on QoL in 
older women  
Population: 
N=136 
Age 70 or older, 
within 1 year of 
treatment 
Design: Randomized 
clinical trial 
 
 
Instruments: 
Unspecified QoL 
survey covering 9 
domains 
Analysis: 
Wilcoxon Sign 
Rank test 
 Women with 
mastectomy had 
more arm 
problems. 
 Women who 
received 
conservative 
surgery had better 
QoL 
Madelblatt et al. 
(2003) 
Evaluate long-term 
impact of primary 
treatment on QoL and 
satisfaction 
Population: 
N=1812, 
Age 67 and older, 3 to 
5 years post treatment, 
Design: -Randomized 
cross-sectional design 
Instruments: SF 
12, SF 36 
Analysis: Chi 
square 
distribution,  
t test, logistic 
regression 
 Having co-morbid 
illness affected 
physical outcomes 
 AD led to more arm 
problems which 
negatively 
impacted all other 
outcomes 
 Women not given 
choice regarding 
treatment had more 
pain, poor mental 
health and less 
satisfaction 
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Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Mandelblatt et al. 
(2002) 
Examine the impact 
of axillary dissection 
on QoL 
Population: N=571, 
Age 67 and older 
Design: Longitudinal 
Instruments: SF 
12, CARES-SF 
Analysis: 
ANOVA, chi 
square 
distribution,  
GEE 
  83% with AD 
reported arm 
problems 
 Women with AD and 
arm problems 
report lower 
physical and 
mental functioning 
 Cancer had more of 
an impact on life if 
arm problems were 
reported 
Figueiredo et al. 
(2004) 
Examine the effects 
of treatment 
preferences and 
treatment received on 
mental health and 
body image 
Population: 
N=563, Age 67 and 
older, 
within 2 years of 
surgery 
Design: Longitudinal 
clinical trial 
 
Instruments: SF 
36, CARES –SF,  
Analysis: Chi  
square 
distribution,  
t test, ANOVA, 
Pearson and 
Spearman rank 
correlation, path 
analysis, GEE 
 Physical appearance 
important to older 
women when 
making treatment 
decisions 
 Women with 
mastectomy 
reported body 
image concerns 
and worse mental 
health compared to 
women who 
received 
conservative 
treatment 
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Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Feher and Maly 
(1999) 
Examine spiritual and 
religious coping 
mechanisms among 
older women with 
breast cancer 
Population: N=33,  
new diagnoses  
Design: Qualitative,  
Instruments: 
Structured 
interviews, open 
ended questions 
Analysis: Content 
anlaysis 
 Faith assisted with 
coping 
 Faith provided 
emotional support 
 Faith allowed a 
social connection 
 Faith allowed 
women to make 
meaning in their 
lives 
Utley (1999) Discover the meaning 
of cancer older, long-
term breast cancer 
survivors 
Population: 
N=8, 
Age 65 to 77, 5 to 29 
years post diagnosis 
Design: Qualitative 
Instruments: Life 
history interviews 
Analysis: 
Qualitative 
analysis using 
heuristic approach 
 Meaning of cancer 
evolved over time 
 Women experienced 
a positive effect 
from cancer 
Crooks (2001) Discover new 
understandings of 
having breast cancer 
for older women 
Population: 
N=20 
Ages 66-94,  
Design: Qualitative 
Instruments: 
Interviews 
Analysis: 
grounded theory 
 Process of finding 
meaning allowed 
women to live each 
day to the fullest 
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Table 2: Summary of studies focusing on women with early stage breast cancer and age 
based controls without breast cancer  
Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Heidrich et al. 
(2006) 
Examine symptoms, 
symptom belief, and 
QoL of older women 
with and without 
breast cancer  
Population: N=42,  
Age 65 and older, 
Women with and 
without breast cancer 
Design: Descriptive, 
correlational 
Instruments: 
Heidrich 
Symptom Bother 
Scale, SF-36, 
CES-D, OARS 
Analysis: 
Wilcoxon Mann-
Whitney U test 
and chi square 
distribution 
 Similar symptoms 
experienced in both 
groups of women 
 Symptoms attributed 
to aging or other 
chronic illness, 
rarely to breast 
cancer 
 Not knowing cause 
of symptom led to 
poorer outcomes 
Satariano et al. 
(1989) 
Compare 
instrumental 
functioning of 
women with breast 
cancer with age based 
controls 
Population: N=900, 
3 age groups: 55-64, 
65-74, 75-84 
Design: Case control, 
longitudinal 
Instruments: 
IADL 
Analysis: Ridit 
analysis 
  Women age 65 to 74 
reported more 
problems with 
functioning than 
their age based 
controls 
  Women age 75 and 
older reported the 
fewest functional 
problems compared 
to their age based 
controls 
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 Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Kroenke et al. 
(2004) 
Explore functioning 
before and after 
cancer in women of 
different ages 
Population: N=1,082, 
3 age groups: 40 and 
younger, 41-64, 65+, 
women with and 
without breast cancer 
Design: Prospective, 
longitudinal  
 
Instruments: SF- 
36, CARES 
 
Analysis: Linear 
regression 
 Older women with 
breast cancer 
experienced similar 
declines in 
functioning when 
compared to their 
non-cancer peers 
 Functional declines 
attributed to aging, 
not breast cancer 
 Youngest women 
experienced the 
most significant 
functional declines 
compared to their 
non-cancer peers 
Heidrich (1996) Examine influence of 
age and illness type 
on health and 
functioning, 
interpretive 
mechanisms and their 
effect on 
psychological well-
being 
Population: N=188, 
women with breast 
cancer and 
osteoarthritis, 2 age 
groups: 60-74 and 75+ 
Design: 2x2, cross-
sectional  
Instruments: 
OARS, Heidrich 
Symptom Bother 
Scale, social 
comparison scale, 
social network 
index, CES-D, 
Rosenberg‘s Self 
Esteem Scale, 
Ryff‘s scales 
Analysis: 
MANCOVA, 
ANCOVA 
 Older women with 
arthritis report 
more symptom 
bother and 
problems with 
ADL‘s than 
women with breast 
cancer 
  Older women with 
arthritis report their 
illness as more 
severe and chronic 
than older women 
with breast cancer 
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Table 3: Summary of studies comparing older and younger women with early stage breast 
cancer 
Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Fehlauer et al. 
(2005) 
Examine functional 
status in women of 
different  ages at 
diagnosis and effects 
of adjuvant therapy 
on HR-QoL,  
Population: N=370, 3 
age groups: younger, 
than 50, 50-65, 66+ 
Design: Retrospective  
Instruments: 
EORTC QLQ-
C30, EORTC 
QLQ-BR23 
Analysis: 
ANOVA, post hoc 
Scheffe tests 
 Compared to 
younger women, 
older women 
reported worse 
physical 
functioning, more 
body pain, more 
arm symptoms, and 
less financial 
concern  
 QoL increased over 
time for older 
women despite 
concerns 
Cimprich et al. 
(2002) 
Examine relationship 
between age and QoL 
outcomes in long 
term breast cancer 
survivors 
Population: N=105, 3 
age groups: 45 and 
younger, 46-65, 66+, 
long-term survivors 
Design: Cross-
sectional 
 
Instruments: 
QoL-CS 
 
Analysis: 
ANOVA, multiple 
regression 
Compared to younger 
women, older women 
reported: 
 more fatigue, pain, 
constipation, sleep 
symptoms  
 less distress at 
diagnosis , better 
outcomes related to 
appearance 
 fewer concerns with 
sexuality, 
employment, 
family distress 
 Fewer positive 
changes and more 
uncertainty 
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Author and date Purpose Study Population 
and Design 
Instruments and 
Analysis 
Major Findings 
Cimprich (1998) Determine the effect 
of age and extent of 
surgery on cognitive 
function 
Population: N=74,  
3 age groups: 25-45, 
46-64, 65-74 
 
Design: Pre and post 
test 
Instruments: 
Measures of 
capacity to direct 
attention 
Analysis: 
ANOVA, t tests, 
multiple linear 
regression 
Compared to younger 
women, older women 
reported: 
 Lower attention 
scores at baseline 
 Experienced 
significant losses in 
attention 
performance and 
total attention 
scores 
 Older women who 
received 
mastectomy 
reported greater 
loss in attention 
than older women 
with breast cancer 
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Table 4: Demographic characteristics of the quantitative sample (N=50) 
Age Mean: 72.10 Range: 65-83 
Time since Diagnosis 
 
6 months or less 
7 months or more 
18 (36%) 
32 (64%) 
Race African American 
Caucasian 
Hispanic 
Native American 
3 (6%) 
41 (82%) 
4 (8%) 
2 (4%) 
Educational Level Grade School 
High School 
Trade School 
College 
Graduate School 
2 (4%) 
20 (40%) 
6 (12%) 
20 (40%) 
2 (4%) 
Religious Preference Catholic 
Christian 
Jewish 
6 (12%) 
43 (86%) 
1 (2%) 
Marital Status Married 
Divorced 
Widowed 
28 (56%) 
5 (10%) 
17 (34%) 
Lives Alone Yes 
No 
17 (34%) 
33 (66%) 
Employment Status Full-Time 
Part-Time 
Retired/Homemaker 
4 (8%) 
6 (12%) 
40 (80%) 
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Income $30,000 or less 
$30,001 or more 
Did not care to respond 
21 (42%) 
22 (44%) 
7 (14%) 
Disease Stage Stage I 
Stage II 
35 (70%) 
15 (30%) 
Surgery Type Lumpectomy 
Mastectomy 
Bilateral mastectomy 
36 (72%) 
12 (24%) 
2 (4%) 
Chemotherapy Yes 
No 
9 (18%) 
41 (82%) 
Radiation Therapy Yes 
No 
39 (78%) 
11 (22%) 
Hormonal Therapy Yes 
No 
42 (84%) 
8 (16%) 
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Table 5: Demographic characteristics of the Wait Control and Experimental Groups 
  Wait Control Group 
(n=26) 
 
Experimental Group 
(n=24) 
Age  72.19 (Range: 65-83) 72.0 (Range: 65-80) 
Time since Diagnosis 
 
6 months or less 
7 months or more 
11 (42%) 
15 (58%) 
7 (29%) 
17 (71%) 
Race African American 
Caucasian 
Hispanic 
Native American 
1 (4%) 
21 (80%) 
2 (8%) 
2 (8%) 
2 (8%) 
20 (83%) 
2 (8%) 
0 (0%) 
Educational Level Grade School 
High School 
Trade School 
College 
Graduate School 
0 (0%) 
9 (35%) 
3 (12%) 
12 (46%) 
2 (8%) 
2 (8%) 
11 (46%) 
3 (13%) 
8 (33%) 
0 (0%) 
Religious Preference Catholic 
Christian 
Jewish 
2 (15%) 
20 (76%) 
1 (4%) 
2 (8%) 
22 (92%) 
0 (0%) 
Marital Status Married 
Divorced 
Widowed 
15 (57%) 
3 (12%) 
8 (31%) 
13 (54%) 
2 (8%) 
9 (38%) 
Lives Alone Yes 
No 
9 (35%) 
17 (65%) 
8 (33%) 
16 (67%) 
Employment Status Full-Time 
Part-Time 
Retired/Homemaker 
2 (8%) 
1 (4%) 
23 (88%) 
2 (8%) 
3 (13%) 
19 (79%) 
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Income $30,000 or less 
$30,001 or more 
Did not care to respond 
9 (35%) 
13 (50%) 
4 (15%) 
12 (50%) 
9 (38%) 
3 (13%) 
Disease Stage Stage I 
Stage II 
18 (69%) 
8 (31%) 
17 (71%) 
7 (29%) 
Surgery Type Lumpectomy 
Mastectomy 
Bilateral mastectomy 
19 (73%) 
7 (23%) 
0 (0%) 
17 (71%) 
5 (21%) 
2 (8%) 
Chemotherapy Yes 
No 
4 (15%) 
22 (85%) 
5 (21%) 
19 (79%) 
Radiation Therapy Yes 
No 
19 (73%) 
7 (27%) 
20 (83%) 
4 (17%) 
Hormonal Therapy Yes 
No 
23 (88%) 
3 (12%) 
19 (79%) 
5 (21%) 
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Table 6: Descriptive summary statistics for Overall QoL and QoL domains 
 Baseline (N=50) Time 2 (N=49) Time 3 (N=48) 
 Mean S.D Mean S.D Mean S.D 
Overall QoL 2.38 1.02 2.48 1.20 2.58 1.33 
Physical 
Subscale 
1.29 .80 1.52 1.02 1.59 1.06 
Psychological 
Subscale 
2.65 1.50 2.74 1.69 2.96 1.83 
Social 
Subscale 
2.18 1.29 2.11 1.31 2.19 1.43 
Spiritual 
Subscale 
3.62 1.54 3.82 1.67 3.59 1.68 
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Table 7: Between group differences in Overall QoL and subscale scores using independent 
t-tests 
 Baseline Month 3 Month 6 
 WC EXP P 
value 
WC EXP P 
value 
WC EXP P 
value 
Overall QoL  
Mean 2.42 2.45 .900 2.60 2.50 .765 2.63 2.53 .772 
S.D. 1.06 .75 1.28 .90 1.44 .95 
Physical  
Mean 1.41 1.15 .241 1.50 1.55 .870 1.60 1.54 .773 
S.D. .94 .6 1.11 .94 1.17 .95 
Psychological  
Mean 2.64 2.66 .967 2.79 2.70 .856 3.05 2.86 .729 
S.D. 1.69 1.31 1.94 1.38 2.08 1.56 
Social  
Mean  2.14 2.24 .788 2.26 1.96 .432 2.32 2.04 .504 
S.D. 1.40 1.18 1.49 1.06 1.72 1.07 
Spiritual  
Mean 3.48 3.76 .529 3.84 3.80 .925 3.53 3.66 .778 
S.D. 1.45 1.65 1.62 1.75 1.68 1.72 
Note: Significance level based on Bonferroni‘s adjustment, p<0.017. 
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Table 8: GEE comparisons between groups: Overall QoL and QoL subscales 
  Robust Z Score 
Overall QoL -0.516 
Physical well-being 1.749 
Psychological well-being -0.601 
Social well-being -1.613 
Spiritual well-being -0.591 
 
Note: Effects of treatment are not considered significant if the absolute Robust Z Score is <2.0 
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Table 9: Demographic characteristics of the qualitative sample (N=24)  
Age 
 
Mean :72 years Range: 65 to 80 years 
Time since diagnosis 6 months or less 
7 to 15 months 
7 (29.2%) 
17 (70.8%) 
Race Caucasian 
Hispanic/Latina 
Other 
19 (79.2%) 
2 (8.3%) 
3(12.5%) 
Educational level High school/Trade school 
College  
16 (66.7%) 
8 (33.3%) 
Primary language English 
Other 
21 (87.5%) 
3 (12.5%) 
Religious preference Christian 
Catholic 
22 (95.8%) 
2(8.3%) 
Marital Status Married 
Divorced/Widowed 
13 (54.2) 
11(45.8%) 
Lives alone Yes 
No 
8 (33.3%) 
16 (66.7%) 
Employment status Not working 
Full-time 
Part-time 
18(75%) 
2 (8.3%) 
4 (16.7%) 
Income $30,000 or less 
$30,001 or more 
12 (50.0%) 
9 (37.5%) 
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Disease stage Stage I 
Stage II 
17 (70.8%) 
7 (29.2%) 
Surgery type Lumpectomy 
Mastectomy 
Bilateral mastectomy 
17 (70.8%) 
5 (21.8%) 
2 (8.3%) 
Chemotherapy Yes 
No 
5 (20.8%) 
19 (79.2%) 
Radiation therapy Yes 
No 
20 (83.3%) 
4 (16.7%) 
Hormonal therapy Yes 
No 
19 (79.2%) 
5 (20.8%) 
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APPENDIX B: FIGURES 
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Figure 1: Conceptual Model of Quality of Life in Aging Breast Cancer Survivors 
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Figure 2: Plot of means for whole group: Overall QoL  
Note: the higher the score, the worse the QoL 
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Figure 3: Plot of means for whole group: QoL domains  
Note: the higher the score, the worse the QoL 
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Figure 4: Plot of means for Overall QoL for WC and EX Groups 
Note: The higher the score, the worse the QoL 
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Figure 5: Plot of mean scores for WC and EX Groups for QoL domains  
Note: The higher the score, the worse the QoL 
Physical
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Month 0  Month 3  Month 6
Month
M
e
a
n
 s
c
o
re
WC
EX
Psychological
2.4
2.5
2.6
2.7
2.8
2.9
3
3.1
Month 0  Month 3  Month 6
Month
M
e
a
n
 s
c
o
re
WC
EX
Social
1.7
1.8
1.9
2
2.1
2.2
2.3
2.4
Month 0  Month 3  Month 6
Month
M
e
a
n
 S
c
o
re
WC
EXP
Spiritual
3.3
3.4
3.5
3.6
3.7
3.8
3.9
Month 0  Month 3  Month 6
Month
M
e
a
n
 S
c
o
re
WC
EX
 100 
 
APPENDIX C: DISSERTATION PROPOSAL 
 
 101 
Abstract 
 
 
Background: There are over 10 million cancer survivors alive today. In 2006, 
approximately 1.4 million people will be diagnosed with cancer and 565,000 are 
expected to die from their cancer.1  Currently, 57% of all new cancer diagnoses and 71% 
of deaths occur in people age 65 and older.2  Little is know about how cancer affects this 
elderly population.  
 
Aims: The overall purpose of this research is to examine quality of life in women with 
early stage breast cancer who are age 65 or older and are within the first year of cancer 
survivorship. Women of all ages diagnosed with breast cancer share common concerns, 
but also have unique needs. The specific aims of this dissertation are to: 1) Describe the 
overall quality of life of female breast cancer survivors age 65 or older; 2) Describe 
quality of life within the domains of physical, psychological, social and spiritual well-
being in female breast cancer survivors age 65 or older and; 3) Describe additional 
current life experiences that may relate to quality of life in older breast cancer survivors.  
 
Research Design and Methods:  A descriptive design for analysis using mixed 
methods will be used. Data will be obtained from a pre-existing data set, the Breast 
Cancer Education Intervention (BCEI) a longitudinal, psychoeducational Quality of Life 
(QoL) intervention for 256 breast cancer survivors in the first year of survivorship. This 
sample included an experimental (EX) group and a Wait Control (WC) group. QoL was 
measured over time. This dissertation will focus on the subset of older women (age 65 
and older) surviving with breast cancer.  Quantitative analysis of surveys using 
parametric and non-parametric statistics and qualitative analysis of field notes and 
narrative responses on surveys will occur.   
 
Relevance to Healthcare:  The goal of this dissertation research is to add to the body 
of knowledge in research concerning older women with breast cancer.  Information 
concerning the quality of life in older women with breast cancer may help form 
guidelines for treatment and follow-up care in this population during cancer 
survivorship.   
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 Quality of Life in Older Breast Cancer Survivors: A 
Descriptive Study 
 
Specific Aims 
There are over 10 million cancer survivors alive today. In 2006, approximately 1.4 
million people will be diagnosed with cancer and 565,000 are expected to die from their 
disease.1  Currently, 57% of all new cancer diagnoses and 71% of cancer deaths occur in 
people age 65 and older.2  Little is know about how cancer affects this elderly 
population.  
 This dissertation will focus on an understudied population in cancer care: older 
women with breast cancer.  Older or elderly women will be defined as being 65 years or 
older.  Approximately 212,920 new cases of invasive breast cancer will be diagnosed in 
2006 and 41,430 women will die of this disease1.  Within these new cases, it is estimated 
that women over that age of 65 will constitute over 88,000 of these new diagnoses and 
account for approximately 23,000 of the deaths attributed to breast cancer.3 
The overall purpose of this research is to examine quality of life in women with early 
stage breast cancer who are age 65 or older and are within the first year of cancer 
survivorship.  Data will be drawn from an existing cohort of women who participated in 
the Breast Cancer Education Intervention (BCEI), a longitudinal, psychoeducational 
Quality of Life (QoL) intervention for 256 breast cancer survivors in the first year of 
survivorship.  This sample included an Experimental (EX) group and a Wait Control 
(WC) group. QoL was measured over time. 
 
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or 
older.  
Research Question #1.1:  What is the QoL of older breast cancer survivors at 
baseline? 
Research Question #1.2: How does QoL change over time? 
Research Question #1.3: How does QoL compare between groups over time? 
 
Aim #2: Describe quality of life within the domains of physical, psychological, social 
and spiritual well-being in female breast cancer survivors age 65 or older.  
Research Question 2.1:  What is the QoL of older breast cancer survivors within the 
domains of physical, psychological, social and spiritual well-being at baseline? 
Research Question # 2.2: How does QoL within these domains change over time? 
Research Question # 2.3: How does QoL with these domains compare between 
groups over time? 
 
Aim #3: Describe additional life experiences that may relate to quality of life in female 
breast cancer survivors age 65 and older. 
Research Question #3.1: Describe other life experiences of older breast cancer 
survivors as described by research nurses. 
Research Question #3.2: Describe the types of medication used by older breast 
cancer survivors age 65 and older.  
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This research is relevant for several reasons.  Little is known about older women with 
early stage breast cancer, especially during survivorship.  These women have been 
largely understudied and are apt to be under-diagnosed, under-treated and under-
appreciated once treatment has ended and survivorship begins.  This in turn makes 
older women susceptible to late physical and psychosocial effects often encountered in 
survivorship.  With an increase in the population of older people on the horizon, 
guidelines for all aspects of cancer need to be developed in order to properly care for this 
population.  The dissertation seeks to increase the body of knowledge concerning older 
women with early stage breast cancer in order to assist in the development of guidelines 
and interventions appropriate for the unique needs of this growing population.   
 
 
Background and Significance 
Today, there are more than 2.3 million women surviving with breast cancer.3  
Currently, women have a one in 8 chance of developing breast cancer in their lifetime. 
Incidence of breast cancer increases with age. Within the next 10 years of their age, A 20 
year old woman has a 1 in 1,985 chance of being diagnosed with breast cancer while a 70 
year old woman has a 1 in 24 chance of being diagnosed with breast cancer.  This 
probability changes  depending on the presence of risk factors unique to each woman.3  
Fifty percent of women diagnosed with breast cancer are 61 years old or older3.   
While there is ample evidence that cancer and its treatment affect quality of life in 
breast cancer survivors, the impact of cancer and its treatment on the quality of life in 
older women surviving with breast cancer is unclear.   Research is often conflicting as 
some studies have concluded that quality of life in older women with breast cancer is 
poor while others conclude older women surviving with breast cancer suffer little 
negative effect from treatment.4-13 
The recognition of the need to focus on older populations is not new.14  The burden 
of cancer due to aging is now imminent and little is known about cancer in this 
population as a whole or within the specific cancers such as breast cancer.2, 15, 16  Further 
research is needed across all areas of cancer care and the elderly including screening, 
diagnosis, treatment, survivorship and quality of life.  Several organizations support this 
need for research. 
The National Institute of Aging (NIA) has compiled the Action Plan for Aging 
Research: Strategic Plan for Fiscal Years 2001-200517 which recognizes the need to 
address knowledge deficits regarding the elderly, disease and aging.  One of the primary 
goals is to improve the health and quality of life in older people.  To meet this goal, the 
NIA has developed research initiatives for studying diseases such as cancer focusing on 
older individuals. 
 The Institute of Medicine’s (IOM) report From Cancer Patient to Cancer 
Survivor: Lost in Transition18 describes the survivorship phase of cancer as neglected in 
research.  The IOM proposes essential components of survivorship care as: 1) 
prevention of new and recurrent cancer as well as late effects; 2) surveillance of new, 
recurrent and metastatic cancer as well as side effects; 3) interventions for the effects of 
cancer and its treatment; and 4) coordination of care between specialist and primary 
care providers to meet all the needs of the cancer survivor.  In addition, the IOM report 
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suggests developing a “Survivorship Care Plan” to meet the needs of cancer patients 
after treatment.  This Care Plan would summarize treatment, guide follow-up, suggest 
preventive practices for maintaining health, provide information of employment and 
health insurance, and detail the availability of psychosocial services within the patient’s 
community. An additional recommendation is to encourage health care providers to use 
“systematically developed evidence-based clinical practice guidelines” (p5) to help 
manage cancer and its effects.  Guidelines concerning cancer care in older adults do not 
exist at this time. 
 Quality of life in survivorship has been recognized as an important outcome of 
cancer treatment.  The National Cancer Institute’s (NCI) Strategic Plan for Leading the 
Nation to Eliminate the Suffering and Death Due to Cancer19 includes improving the 
quality of care and quality of life in those affected by cancer and encourages the use of 
quality of life endpoints in NIH funded clinical trials.   To further emphasize the 
outcomes of research, the NIH has developed the Outcomes Research Branch to help 
define the emerging field of outcomes research.  This field looks at relevant endpoints of 
treatments and interventions.  The endpoints include: survival, health-related quality of 
life, healthcare and economic burden.20  
This dissertation research involving older breast cancer survivors is significant for 
several reasons:  First, Americans are aging.  In 2000, 14.3% of women in the U.S. were 
over the age of 65.  By 2050, 22.6% of all women are projected to be over the age of 65.21  
Second, incidence of cancer increases with age. People over the age of 65 have nearly 10 
times the risk for developing cancer than those younger than 65.22   Due to growth and 
aging of our population, the number of cancer cases is expected to double from the 
current rate of 1.3 million to 2.6 million by the year 2050.15  Currently, the mean age of 
all women diagnosed with breast cancer is 61 while women age 75 to 79 have the highest 
incidence rate.3  As more women reach this age group, incidence rates will also increase.  
Additionally, many women will approach old age with a personal history of breast 
cancer.  Risk for recurrence will remain as well as risk for developing a second breast 
cancer.23 The cancer burden will substantially increase over the next 30 years.22 Third, 
the sheer number of older people who will be diagnosed with cancer will increase the 
demand for health care services.23  Healthcare professionals will be unprepared to 
appropriately care for these aging women.24, 25  Fourth, co-morbid conditions increase 
with age and this will impact care.23  The Centers for Disease Control26 (CDC) estimates 
that the average 75 year old has 3 chronic illnesses and uses 5 prescription medications.  
It is unclear how these illnesses and medications impact or interact with treatment for 
cancer. Fifth, women of different ages have different concerns and needs.27, 28  Due to 
the lack of research concerning older women with breast cancer, these needs are largely 
unknown.   
In summary, little is known about older women with breast cancer.  The current 
need for research is intensified by the fact that the already large number of older women 
surviving with breast cancer will dramatically increase in the near future. 
  
Literature Review 
The goal of this literature review is to support the importance of this dissertation 
research in adding to the body of knowledge in nursing concerning older women with 
breast cancer.  This literature review will focus on several areas: 1) aging, 2) breast 
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cancer, 3) survivorship, 4) quality of life, and 5) methods of research.  All of these topics 
will support the need for this research study. 
 
AGING 
Changing Demographics 
 The demographics of America are changing and soon, more elderly people will be 
alive and living longer than ever before. According to population projections, there is 
about to be a large increase in the number of elderly people in the United States.  As of 
2003, 35 million 
Americans were over 
the age of 65 (men: 
14.4 million, women: 
20.6 million) 
representing over 
12% of the 
population in the 
United States.  By 
the year 2030, the 
number of older 
Americans will grow 
to be 72 million 
representing 
approximately 20% 
of the total 
population.2, 30  In 
the year 2050, it is projected that 87 million people will be over the age of 65, 
representing 21% of the nations population.31  
The most rapidly growing group are Americans over the age of 85.29, 32  In 1995, 
those over the age of 85 were numbered at 3.6 million.  This number is expected to 
double by 2025 and increase 5 fold by 2050 totaling 18.2 million adults over the age of 
85.  The numbers of centenarians are also increasing. By 2050, estimates project 
800,000 people will be 100 years old or older compared to the 81,000 centenarians 
living in the 2000.29 Please refer to Table 1 for a summary.   
Life expectancy has also improved over time.30, 31  In 2000, the average life 
expectancy was 76.0 years (men: 74.1 years, women: 79.5 years).  Currently, the average 
65 year old can expect to live 17.9 more years (men: 16.3, women: 19.2),  the average 75 
year old can expect to live an additional 11.3 years (men: 10.1, women 12.1), and an 85 
year old has an additional life span of 6.3 years (men: 5.6, women: 6.7).30 By the year 
2050, the average person is expected to have an average life expectancy between 82 and 
84 years (see Table 2).30  Both the increase in the number of older people and the 
projected longevity of their lives over the next several decades support the importance of 
better understanding the needs of older cancer survivors in order to reduce adverse 
effects experienced in survivorship. 
 
 
       
Table 1: Summary Table for Aging Americans29 
 2000 2030 2050 
Total population 282 million 364 million 420 million 
Number of Americans age 
of 65 or older 
 
     Men 
     Women 
35 million 
(12%) 
 
14.4 million 
20.6 million 
72 million (20%) 87 million (21%) 
Number of Americans age 
85 or older 
3.6 million 9.6 million 18.2 million 
Number of Centenarians 81,000  800,000 
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Demographic 
Differences 
between Elderly 
Men and 
Women 
 The elderly 
are not a 
homogenous 
population.  Many 
differences exist 
between elderly men and women. Women make up approximately 59% of the 
population over the age of 65.  Older women are less likely to be married than men (44% 
compared to 75%) and more likely to be divorced or widowed.  Older women are also 
less likely to remarry after a divorce or the death of a spouse.  Forty percent of women 
over the age of 65 live alone while 41% live with a spouse.  At age 85, 60% of women live 
alone.   
Older Americans represented 3.3% of the overall workforce in 2003 and are 
projected to be 5% of the workforce in 2020. Women over the age of 65 continue to 
work.  Thirty five percent of women age 65 and older remain in the workforce compared 
to 59% of men of the same age.32  
 Poverty rates for adults over the age of 65 has recently declined from 10.2% to 
9.8%.33   Older women are more likely to be poor compared to men of the same age.  
Elderly women have a 12.2% rate of poverty compared to men at 7.5%. Fewer older 
women achieve economic security because they were more likely to either not work 
outside the home or work at jobs that do not allow them to collect the maximum benefit 
from Social Security (SS).  In addition, women are only able to collect 2/3rds of their 
husbands benefit if they are widowed.   
Social support for older women is also limited.  Since older women are likely to live 
alone, they must depend on other people for support instead of spouses.  The most likely 
caregiver or support person for older women is children living nearby.  Older women are 
also more likely to enter a nursing home than older men.32  
As a group, older people spend a considerable amount of money on healthcare.  It is 
estimated that 12.5% of expenditures are health-related.  This is more than double the 
amount spent by the average consumer.  The majority of these costs are for insurance 
(55%), medications (24%), medical care (17%) and medical supplies (4%).34 Almost all 
older people not living in an institution receive Medicare (96%) however Medicare only 
pays approximately half of medical costs.  Over 87% of elderly persons have some type 
of supplemental coverage.  Individuals living in nursing homes are usually covered by 
Medicaid (58%).34 
 
Chronic Disease in the Elderly 
Many older adults experience healthy aging but most will eventually experience 
illness and chronic disease.  Illnesses that contribute to morbidity and mortality include 
cerebrovascular disease, cancer, chronic lower respiratory diseases, 
pneumonia/influenza, diabetes, arthritis, and Alzheimer’s disease.  Many older 
Table 2: Life expectancy30 
 2000 2050 
Average life expectancy (at 
birth) 
76 years 
Men: 74.1 years 
Women: 79.5 years 
82-84 years 
(projected) 
Life expectancy for  
65 year old 
Men: 16.3 years 
Women: 19.2 years 
 
Life expectancy for  
75 year old 
Men: 10.1 years 
Women: 12.1 years 
 
Life expectancy for  
85 year old 
Men: 5.6 years 
Women: 6.7 years 
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Americans chronically suffer from one or more of these illnesses prior to their death.  
Chronic co-morbidities often seen in elderly populations include: gastrointestinal 
problems35, hypertension, heart conditions, cancer, chronic obstructive pulmonary 
disease (COPD), arthritis and diabetes.35, 36 Eighty percent of older Americans over the 
age of 65 have at least one chronic illness and 50% have 2 or more chronic conditions.37  
The presence of co-morbidities increases with age.36, 38 At the time of diagnosis, it is 
likely that cancer is not a person’s first chronic illness.2    
Cancer: Cancer is a major consideration in adults.   Currently, 57% of all new cancer 
diagnoses and 71% of deaths occur in people age 65 and older.2  Cancer is the second 
most common cause of death in persons age 65 and older following heart disease.30 
Approximately 1.4 million persons will be diagnosed 
with cancer in 2006.1 The cancers with the highest 
incidence in men are prostate, lung, colon and bladder 
cancer.  In women, breast, lung, colon and uterine 
cancer have the highest incidence.1 Overall, 76.9% of 
prostate cancer, 73.9% of colon cancer, 65.8% of lung 
cancer, 45.9% of ovarian and over 47.5% of breast 
cancer diagnoses occur in individuals over age 65.  In 
addition, 55.4% of women diagnosed with uterine 
cancer are age 65 or older (see Table 3).2, 38  Due to advances in cancer treatment, early 
detection and screening, cancer is considered a chronic illness contributing to morbidity 
and mortality in later life.36  As our population continues to grow, more older Americans 
will be diagnosed with cancer and need to be managed within the context of their cancer 
diagnosis and other co-morbid illnesses they most likely will be experiencing.36  
 
Comorbidity and Cancer: The presence of co-morbidities affects many aspects of 
cancer beginning with screening and diagnosis of cancer.    Heflin and colleagues39 
found that the relationship between the number of co-morbid conditions and the use of 
screening tests varied widely in older populations.  Additionally, screening rates 
decreased as age increased.  Compared to those without a co-morbid condition, women 
with hip fractures were less likely to receive mammograms; people with cognitive 
impairment were less likely to receive fecal occult blood testing; and those with 
hypertension experienced higher rates of clinical breast exams, Pap tests, FOBT and 
higher trends toward mammography.  Overall, co-morbid conditions were not related to 
lower incidence of cancer screening, however age was a determining factor in whether or 
not elderly people received screening for cancer.  Using age as a determining factor for 
screening is worrisome since many elderly are healthy and may be good candidates for 
cancer screening tests.  Using age as the determining criteria means many older adults 
may not receive the benefit of cancer screening when they are otherwise healthy.  
Conversely, many fear that older people with multiple co-morbid conditions may 
experience harm by participating in cancer screening activities. 
Comorbidity has also been associated with later diagnosis of cancer and greater 
mortality.  Although people with co-morbid illnesses have more exposure to physicians 
for the treatment of their illnesses, cancer screening may not be considered as important 
as the illnesses already being managed.40   Additionally, the symptoms of cancer may 
Table 3:  Incidence of cancer in 
adults over age 652, 38 
Overall 57% 
Breast 47.5% 
Uterine 55.4% 
Ovarian 45.9% 
Colon 73.9% 
Lung 65.8% 
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not be recognized by patients or practitioners or attributed to pre-existing conditions 
leading to missed or delayed cancer diagnosis.41  
Treatment of cancer is also affected by the presence of co-morbidities.  The National 
Comprehensive Cancer Network has published clinical practice guidelines for the 
detection and treatment of many common cancers.  These guidelines reflect what 
experts believe are appropriate practice in the treatment of cancer.  However, in the 
National Report to the Nation on the Status of Cancer, 1975-2002, Edwards and 
colleagues42 recognize age-related disparities for the treatment of cancer.  Cancer 
patients age 65 and older were treated below guidelines (less than was recommended) 
for breast, colorectal, lung, and ovarian cancer.  The presence of co-morbid illnesses 
influenced treatment decisions. 
The impact of co-morbidity on cancer treatment is of great concern to many involved 
in the care of older adults.39, 43-48   Many healthcare professionals are concerned that 
treatment for cancer may be too dangerous or debilitating depending on the number 
and type of co-morbidities a person has when they are diagnosed with cancer.  People 
with cancer who have either multiple or severe co-morbidities may experience poorer 
survival compared to patients with no co-morbidities.  The presence of co-morbidities 
can also have a negative impact on quality of life in persons diagnosed with cancer.46, 47  
People with a history of cancer tend to rate their health lower and their disability higher 
than those without a cancer diagnosis.  When another co-morbid illness is present, the 
chance a person will rate their health as poor increases 5 to 10 times what which would 
be expected.49 
In the future, it will be necessary to consider these co-morbid illnesses more closely 
to reduce morbidity.36, 49   Many researchers and health care professionals that work 
with the elderly are concerned with the inevitable increase in cancer diagnosis in the 
elderly over the next several decades.  They advocate for comprehensive geriatric 
assessment of older people diagnosed with cancer to determine the appropriateness of 
any given cancer treatment.46  It is agreed that age should not be the sole determining 
factor concerning treatment decisions.41, 50   Many older adults may be healthy enough 
to undergo standard treatments for cancer.  The goal of the geriatric assessment is to 
identify medical, functional and psychological problems that may be present in the older 
adult diagnosed with cancer and to develop a comprehensive care plan.46 Geriatric 
assessment is multidimensional and includes assessing function (activities of daily living 
and functional status), co-morbidity (number of illnesses and severity), socioeconomic 
issues (living conditions, presence of a caregiver, transportation), geriatric syndromes 
(dementia, depression, fall history, osteoporosis), medications (number of prescriptions 
and potential drug interactions), and nutritional status.24, 41, 50   Using a geriatric health 
assessment may more accurately allow physicians to identify frail patients24 and 
estimate risk associated with treatment for cancer and avoid treatments that may lead to 
functional disability.46  Balducci and Stanta24 also recommend asking several questions 
in addition to the geriatric assessment.  These question include: Will the patient die 
from the cancer?; Will the patient experience cancer-related morbidity? and; Will the 
patient be able to tolerate treatment without life-threatening complications?  These 
questions and a comprehensive geriatric assessment may help patients, family members 
and health care providers determine the best course of action for elderly people with 
cancer. 
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Aging Summary: The number of older Americans will double by the year 2030.  
While some will remain healthy, most will experience co-morbid illness including cancer 
at some point in their lifetime.  Age coupled with the presence of co-morbid illness 
impacts decisions concerning cancer screening and treatment. Comprehensive 
assessments of the elderly should be incorporated into decisions related to cancer in this 
population.  For women, considerations involving breast cancer heighten the need for 
such assessment.51 
 
BREAST CANCER  
 Breast cancer is the most common cancer diagnosed in women.1  Risk factors for 
breast cancer are well known and include: age, family history, age at first full-term 
pregnancy, length of menstrual history, post menopausal obesity, oral contraceptive and 
postmenopausal hormone use, high alcohol intake and low physical activity.3  Currently, 
women have a 1 in 8 chance of developing breast cancer in their lifetime. Incidence of 
breast cancer increases with age.  Fifty percent of women diagnosed with breast cancer 
are 61 years old or older3.  Women age 75 to 79 years old have the highest incidence rate 
(496.6 per 100,000 women) and women age 20-24 have the lowest rate of incidence (1.3 
per 100,000 women).  Although white women have higher incidence of diagnosis after 
the age of 35, African American women have a higher mortality rate from breast cancer 
which is consistent across all age groups.3 
 
 
 
 
Incidence and Survival 
Incidence is defined by the National Cancer Institute (NCI) as the “number of new cases 
of a disease diagnosed 
each year.”52  The 
incidence of breast 
cancer rose 4% yearly 
from 1980 to 1987 most 
likely due to increase 
screening efforts.  Since 
1988, rates have 
continued to rise but at a much lower rate of 0.3% per year.  Recently, women between 
the ages of 40 and 49 experienced a slight decline in incidence but women over the age 
of 50 continue to experience this slight increase in incidence.  
Mortality from breast cancer has been decreasing.  A mortality rate is defined by NCI 
as “the number of deaths, with cancer as the underlying cause of death, occurring in a 
specified population during a year.”53  From 1990 to 2002, mortality rates (the number 
of people who died from an illness) decreased 2.3% each year.  However, this reduction 
in mortality has mostly benefited white women.3 Several factors have been seen to 
influence survival at 5 years: age and stage at diagnosis.  The overall rate of survival at 5 
years is 88% however this survival rate changes according to extent of disease and are as 
follows: local (98%), regional (81%) and distant (26%).  Age differences also impact 5 
year survival rates.  Women diagnosed with breast cancer at age 40 or younger have an 
Table 4: Survival Rates for Breast Cancer3 
Survival at 5 years 
Overall 88% 
Local Disease  98% Age 40 and younger  82% 
Regional Disease 81% Ages 40-74 89% 
Distant Disease 26% Age 75 and older 88% 
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82% survival rate, women ages 40 to 74 have an 89% survival rate and women age 75 or 
older have an 88% chance at survival (see Table 4).3 
 
Screening  
Screening entails checking for a disease when there are no symptoms.52 Increased 
screening for breast cancer has led to tumors being found in early and localized stages.  
The American Cancer Society recommends that women age 40 and older receive an 
annual mammogram and an annual clinical breast exam.  The recommendation for a 
monthly breast self exam (BSE) was recently eliminated because it is recognized that 
many women find a lump outside of a structured self exam and awareness of changes in 
the body is more important than conducting a structured breast exam. However, women 
should still be educated about the benefit and technique of the breast self exam so they 
can perform one if they are interested in incorporating this into their monthly routine.3 
There has been a marked increase in mammography use over the past decade.  In 
2000, approximately 70% of women reported that they had been recently screened for 
breast cancer with mammography.  Screening rates varied per ethnic group: White 
(72%); Black (68%); Hispanic (63%), Asian/Pacific Islander (57%) and American 
Indian/Alaskan Native (52%).54 Annual screening rates also differ according to age.  
Women receive mammography and a clinical breast exam (CBE) at the following rates: 
age 40 (54.1%), 40-64 (54.9%), and 65+ (52.3%).  Rates are lower if women do not have 
a regular healthcare provider or are uninsured.3  Sixty four percent of women over the 
age of 65 receive screening by mammogram only and do not receive routine CBE.3 
Even though older woman are more likely to be diagnosed with breast cancer, 
controversy exists concerning the efficacy of screening for breast cancer in older 
populations.45, 55-57  This controversy exists because there is little research involving 
older women and screening for breast cancer.55  Screening rates have been shown to 
decline with age and physicians base their decision to screen women on an assessment 
of risk and benefit.57 Additionally, physician recommendation for screening varied 
widely according to age.  In women between the ages of 50 and 74, providers 
recommended mammography at least every other year (51%) and yearly (45%).  In 
women over age 75, screening was recommended annually for 80% of the women, 5% of 
the physicians did not recommend screening and 10% had no policy regarding 
screening.56  Physicians reported that issues such as cost, comorbidity, functional status 
of the women, lack of guidelines, questionable value of the test and patient resistance as 
influencing their decision to recommend screening.56 
The National Comprehensive Cancer Network’s (NCCN) Breast Cancer Screening 
and Diagnosis Guidelines58 support the ACS recommendations on breast cancer 
screening and offers considerations for screening the elderly.  As older women are more 
apt to develop breast cancer, screening guidelines should apply to all women.  However, 
if an elderly woman has serious co-morbid conditions that would preclude treatment, 
screening for breast cancer should not be used. 
McPherson and colleagues45  specifically studied the effect of mammography on 
survival in older women with co-morbidity and breast cancer.  Results showed a 
significant reduction in mortality for all older women, even those who had mild or 
moderate co-morbidity.  However, for older women with multiple or severe co-morbid 
illnesses, survival was not improved.  These findings suggest that it may not be effective 
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to screen older women with the presence of severe co-morbidity who may not benefit 
from detection of breast cancer and treatment.  But treating older women, regardless of 
age may be effective if their level of co-morbidity is low.45, 57 
 
Diagnosis 
The NCCN has published guidelines concerning the diagnosis of invasive breast 
cancer.59  Invasive cancer is defined as cancer that has spread beyond its point of origin 
and into neighboring tissues.52 Current guidelines for the diagnosis of invasive breast 
cancer includes: diagnostic mammography, pathology review, evaluation of estrogen 
(ER) and progesterone (PR) receptor status, Her-2 receptor status and various blood 
chemistries.59  
 Differences have been noted in the use of these guidelines in younger and older 
women. Compared to younger women, older women receive fewer diagnoses by 
mammogram and needle localization.60  Some older women had no histological 
assessment of their disease.  Estrogen receptor status was also unknown in 74% of the 
population.61   
 Overall, the presentation and nature of breast cancer at diagnosis in older women is 
blurred.  While some researchers have reported that older women have more advanced 
disease at diagnosis,60, 61 others have found that women over the age of 70 had similar 
disease characteristics as younger women, but more favorable histological 
characteristics with lower grade disease and less negative ER-receptor status.62  Gennari 
and colleagues63 compared the presentation of elderly postmenopausal women with 
younger postmenopausal women.  Older women had larger tumors and greater lymph 
node involvement than younger women.  Elderly women also demonstrated more 
ER/PR positivity, less tumor vascularization and less Her-2 neu expression than 
younger women. 
Singh and colleagues64 examined the natural history of breast cancer in women who 
did not receive systemic therapy.   No difference in tumor size was noted between age 
groups; however, women over the age of 70 had less lymph node involvement.  It is also 
reported that older women have fewer lymph nodes removed.  Controversy exists over 
the benefit of axillary lymph node dissection in older women with breast cancer.  In 
early stage disease, there was no significant difference in mortality, recurrence and 
survival between older women (mean age 70 years) who had an axillary lymph node 
dissection and those who did not. Additionally, no evidence was found to support some 
views that breast cancer in the older woman was more indolent than in younger 
women.65 
 
Treatment 
 According to guidelines published by the National Comprehensive Cancer 
Network treatment for breast cancer is dependent on tumor size, lymph node 
involvement, estrogen receptor (ER), progesterone receptor (PR) and Her-2 status, and 
the presence of metastatic disease.59  Women with early stage invasive breast cancer can 
opt for total mastectomy or breast conservation therapy which includes lumpectomy 
and radiation therapy.  The extent of radiation therapy and the receipt of adjuvant 
chemotherapy are dependent on axillary nodal involvement, size of the tumor and 
ER/PR status. Adjuvant hormonal therapy depends on ER/PR status.  In addition, 
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women who are Her-2 neu positive should receive trastuzumab.  The NCCN guidelines 
do not make recommendations regarding chemotherapy in women over the age of 70 
stating that data were insufficient to make a determination regarding the safety and 
efficacy of chemotherapy in this population.  The guidelines state that use of 
chemotherapy in older women should be individualized and co-morbid conditions 
should be taken into consideration.59  Women with advanced disease also receive a 
combination of the treatments already mentioned however, breast conservation therapy 
is not recommended.59   
Overall, it is agreed that older women have more variable treatment than younger 
women and are often under-treated or treated with less than standard treatment for 
their disease.60, 61, 66-72  Bouchardy and colleagues61 noted no standardization of 
treatment in older women.  Women opted for no treatment (12%); Tamoxifen only 
(32%); breast conservation surgery and radiation (7%) and mastectomy (14%).  
Tamoxifen was given to women regardless of their estrogen receptor status.  These 
researchers determined that 50% of these women had suboptimal treatment which 
contributed to increased mortality related to breast cancer.  In this sample, forty seven 
percent (47%) of older women (age 80 and older) received standard treatment 
compared to 91% of women age 50 to 79 years.  In a study to determine concordance 
with established guidelines, Giordano and colleagues68 determined that age was 
associated with under-treatment.  Older women were less likely to receive definitive 
surgery, post-lumpectomy radiation, adjuvant chemotherapy and hormonal therapy.  
Women age 75 and older were particularly vulnerable to not being treated according to 
guidelines. 
Surgery: In a study that examined factors associated with surgical options for breast 
cancer, Chagpar and colleagues73 found that age was an independent predictor of 
surgery type.  Women over the age of 55 were more likely to receive mastectomy 
compared to breast conservation therapy.  If older women received breast conserving 
surgery, they were also less likely to receive radiation therapy.60, 63 
Chemotherapy: The use of chemotherapy in older women with breast cancer is 
inconsistent.  Du and colleagues74 noted a decrease in the use of chemotherapy with age.  
Women  age 65-69 received chemotherapy 54% of the time while women over the age of 
85 received chemotherapy 3% of the time.74  In this study, chemotherapy was noted to 
significantly reduce mortality in women age 65 to 69, but have little impact in women 
over age 70.74  The reason for this difference is unknown.  
Muss and colleagues75 demonstrate that there is a survival benefit for older women 
who are healthy and receive chemotherapy.  Benefit was comparable to that of younger 
women. However, overall survival was worse for women over age of 65 due to death 
from causes other than breast cancer. 
Woodward and colleagues70 also observed that older women were less likely than 
younger women to receive chemotherapy as part of their treatment.  Women age 50 to 
65 were 6 times as likely not to receive chemotherapy and women over the age of 65 
were sixty two times as likely not to receive chemotherapy when compared to women 
under age 50.  They concluded that age bias contributed to the under-treatment of this 
patient population.  
 Older women also receive fewer referrals to medical oncologists.  Thwin and 
colleagues71 report that 79% of women over the age of 65 were referred to a medical 
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oncologist compared to 88% of younger women.  Health status evaluated by the surgeon 
was associated with referrals.  Women perceived to have poor health status received 
fewer referrals. 
Hormonal therapy: Tamoxifen may be the only consistent treatment given to 
women over the age of 65.76 However, older women with co-morbid conditions and 
estrogen receptor (ER) negativity were less likely to have discussed this option with 
their doctors.77  In one study, women over age 70 were less likely to receive 
chemotherapy but more likely to receive hormonal therapy.62  Interestingly, women who 
were neutral or negative in their belief that Tamoxifen was beneficial often stopped 
taking it before the end of 5 years.  Women were at risk for stopping the drug if they held 
these beliefs and if they had 4 or more positive lymph nodes.78   
Aromatase inhibitors instead of or in combination with Tamoxifen have also been 
used as adjunct therapy in older women.79   Mouridsen and Chaudri-Ross80 
demonstrated the effectiveness of the aromatase inhibitor letrozole compared to 
Tamoxifen.  Letrozole was as effective as Tamoxifen in postmenopausal women of all 
ages.  However, older women (age 70 or older) who took letrozole had more benefit as 
time to progression was significantly longer in this group (12.2 months) compared to the 
Tamoxifen group (5.8 months).  Older women in the letrozole group also experienced 
significantly longer survival compared to the Tamoxifen group. 
No information was found concerning the use of trastuzumab specifically in older 
women.  NCCN guidelines do not restrict its use in older women.59 
Misperceptions regarding breast cancer in older women:  Many of the variances in 
diagnosis and treatment can be attributed to misperceptions of health care professionals 
and the patients themselves.  These include beliefs that: breast cancer in the elderly is 
less aggressive; the elderly have limited life expectancy due to other chronic co-morbid 
conditions; and breast cancer is not as big of a problem compared to other causes of 
mortality.60 Other misperceptions include beliefs that older women accept cancer as a 
part of life and expect to experience losses related to cancer, older women would be 
better off with surgeries such as mastectomy, and the loss of breast tissue is not 
significant to older women.81  
Additionally, many health professionals assume older women could not or do not 
want to make healthcare decisions.81 Another assumption is that elderly women are frail 
and can not handle standard treatments.  Contrasting views exist in the literature.  
Cameron and Horsburgh28  compared issues faced by younger and older breast cancer 
survivors and found that older women were more hesitant and less likely to investigate 
changes they found in their breasts.  Older women also delayed talking with a doctor 
about new or unusual findings in the breast and were less involved than younger women 
in making treatment decisions.  Older women often did what the doctor told them 
needed to be done and did not remember being given choices for treatment.  Younger 
women were more apt to want to discuss treatment options and participate in decision 
making.   
 Crooks81 found divergent results in her study.  Older women stated they were 
interested in participating in their healthcare, but communicating with physicians was 
often challenging.  Women felt that surgeons and oncologists did not have the time to 
answer their questions or address their concerns and they did not feel educated enough 
about treatment options.  Older women did want to be involved in decision making, but 
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were often not given the chance.  It was noted that choices for treatment decreased as 
women aged.  The option for mastectomy versus lumpectomy decreased the older the 
woman was. Interestingly, women remembered being given information to read to help 
make decisions however older women perceived the written material without a verbal 
explanation as a lack of interest in them as a person and did not review the materials. 
Summary: Older women receive different treatment than younger women and are 
often under-treated or treated with less than standard treatment for their breast cancer.  
Older women are more likely to receive mastectomy compared to breast conservation 
therapy (BCT) however, when they do receive BCT, they are less likely to receive 
radiation therapy.  Older women are also less likely to receive chemotherapy.  Older 
women did receive hormonal therapy however; older women with co-morbid conditions 
were less likely to have this treatment.   
 
Surveillance 
 Surveillance and follow-up occurs after treatment for disease in order to monitor 
for side effects and recurrent disease. Current surveillance guidelines established by the 
NCCN include a history and physical every 4 to 6 months for the first 5 years; 
mammogram every 12 months (6 to 12 months post radiation therapy is breast 
conservation therapy was used), pelvic exam every 12 months if a uterus is present and 
for women on aromatase inhibitors bone health should be monitored.59  No exceptions 
were made for older women. 
Discussion of surveillance in the literature was limited to follow-up mammography.  
In 2001, Lash and Silliman82 investigated the medical surveillance of women over the 
age of 55 who had early stage breast cancer. Surveillance at the time of this study 
included annual physical exams and mammography. Results showed that older women 
(age 75 to 90) were less likely to receive appropriate follow-up and surveillance tests 
after treatment than younger women.82  In addition, the farther a woman was from 
treatment, the less likely she was to continue with follow-up.  Women age 75 to 90 were 
more likely to receive less than 4 years of continuous follow-up compared to women age 
55 to 64.  Doubeni and colleagues83 also report differences in surveillance based on age.  
Older women (age 75 +) were less likely to receive annual mammography than younger 
women especially if the older women had co-morbid illnesses.  Co-morbid illnesses did 
not have a significant impact on the use of mammography in younger women. 
Breast Cancer Summary: Age related differences related to screening, diagnosis, 
treatment and surveillance exist in regards to breast cancer. Older women have a higher 
likelihood of being under-screened, improperly diagnosed, and under-treated.  Older 
women also receive inconsistent follow-up after treatment compared to younger women.  
This review of the literature indicates a discrepancy between standardized treatment 
and practice in older populations.  Reasons for this disconnect have been suggested 
however more research is needed with this older population of women.  Research based 
evidence is clearly more desirable than professional opinion or speculation.51 
 
CANCER SURVIVORSHIP 
Anyone living with a history of cancer is a survivor.  Today, there are more than 10 
million cancer survivors in the United States 1 including 2.3 million women surviving 
with breast cancer.3  The National Cancer Institute’s Office of Cancer Survivorship states 
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that individuals are considered “a cancer survivor from the time of diagnosis, 
throughout the balance of his or her life.”  Since family member’s, friends and caregivers 
are impacted by cancer and the survivorship experience, they are included in this 
definition.84   
While survival is often associated with survival rates at 5 years often equating with 
cure of disease, it has also come to be known as a continuum in which patients with 
cancer experience physical and psychosocial issues after the acute phase of illness.85-91   
Physical effects in survivorship are numerous and include: fatigue92, pain, cognitive 
chnages,92 lymphedema, sexual effects, pulmonary,  neurologic, gastrointestinal,87 and 
cardiac effects.87, 93, 94  Psychosocial effects of survivorship include: fear of recurrence, 
depression, uncertainty in illness, and finding meaning in illness.90 
The survivorship literature shows how cancer survivors go through changes due to 
the experience of having cancer and these changes remain with them the rest of their 
lives.  One of the first people to explore survivorship in cancer was Mullan95  who 
describes “seasons in survival.”  These seasons are identified as: 1) acute survival, 2) 
extended survival and, 3) permanent survival.  Each season has its own struggles for the 
cancer patient.  The acute survival phase is focused on diagnosis and treatment of the 
disease. Individuals are confronted with their own mortality and are focused on coping 
with and managing the effects from treatments.  The extended survival phase begins 
after treatment when the cancer patient has less contact with their oncology team.  
Patients experience a multitude of physical and psychological effects as they try to 
reenter the world and often begin a “watchful waiting” period that is dominated by fear 
of recurrence.  The permanent phase of survival begins when the cancer patient can 
reasonably consider themselves cured or the chance of the disease coming back is 
remote.  In this phase, the survivor may become comfortable with the changes that have 
occurred but may also experience long-term effects.    
Dow96 expands on Mullan’s seasons of survival and discusses the adjustments 
survivors must make after treatment.  The immediate period after treatment is 
characterized as one of lessening acute side effects, and it is also a dynamic process 
which holds unique challenges for the survivor.  After diagnosis and treatment, support 
from health care professionals may not be readily available however; this is a time when 
survivors may need support most.  In addition, returning to “normal” may not be 
possible due to all the physical and psychological changes that have occurred.  Fear of 
recurrence may be extremely prominent for cancer survivors.  Lack of education 
concerning what signs to look for may be prevalent in this population.  Uncertainty is 
also an important factor for survivors.  On the positive side, cancer patient are often able 
to put their experience in perspective and move from surviving to “thriving.”  Some 
survivors find or renew faith and feel confident about the changes in their life.  These 
survivors do not define themselves by their cancer, but return to previous roles as wives, 
sisters and mothers.  Hopefully individuals adjust to the new physical, psychosocial and 
spiritual changes that occur in survivorship. 
Zebrack89 discusses the potential for cancer survivors to develop a new identity after 
the cancer experience.  As cancer patients integrate the experience of having cancer into 
their self-concept it may renew or change a person’s sense of self.  This new sense of self 
is challenged in survivorship during times of distress when survivors either meet or fall 
short of the expectations they have for themselves and their role in society.  Meeting 
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expectations leads to better quality of life while falling short of expectations lowers 
quality of life.  In addition, cancer survivors encounter situations everyday which can be 
reminders of their own experience with cancer and can reinforce or upset the new sense 
of self. 
Little, Paul, Jordens and Sayers97 also believe that surviving cancer changes personal 
identity.  Identity is defined in their study as the “sense” of being a certain type of 
person and includes “future memory” which people construct for themselves as life 
proceeds.  Cancer has the potential to interrupt this identity and future memories due to 
all the changes it brings both physically and psychosocially.  Some people are able to 
resume lives within the context of their new reconstructed identity others are unable to 
construct new identity and meaning into their lives leaving them feeling isolated. 
Deimling and colleagues (2006) examined the impact of cancer-related worries and 
psychological distress among cancer survivors and found that for many survivors 
cancer-related worries persisted for years after treatment.  In a sample of older adults 
with breast, prostate and colorectal cancers, who were an average of 10 years from 
diagnosis, survivors still worried about their cancer returning (32.5%), symptoms that 
might indicate recurrence (37.25%), a new type of cancer (30.5%) and future diagnostic 
tests that might lead to the diagnosis of another cancer or recurrence (39.5%) well after 
the 5 year “cure” date.   
Personal accounts from cancer survivors focus on finding a new balance after 
treatment.  Jenkins98 describes cancer as an event which has a great potential for 
learning and growth as well as a time for obstacles. She describes the difficulty of 
returning to a “normal” life and the persistence of fear of recurrence. 
Other researchers have looked at the meaning of quality of life in survivorship.  Dow 
and colleagues99  identified themes that depict the meaning of quality of life in the eyes 
of cancer survivors.  These themes include: finding a balance between independence and 
dependence; achieving a sense of wholeness which restores life purpose; search for 
meaning; managing physical symptoms; facing losses; controlling life instead of being 
controlled by the cancer; contrast between focusing on the now versus the future; 
survivorship viewed as a trajectory and dynamic concept; altered meaning of health; and 
survivorship as a family experience.  These themes demonstrate the complexity of the 
cancer survivorship experience and the potential for different issues to be important at 
different phases of survivorship. 
 Summary:  Anyone living with a history of cancer is a survivor.  Cancer survivors 
go through phases of survivorship, experience changes in their self-concept, reconstruct 
their identity and experience late physical and psychosocial effects. Survivorship is a 
unique and often complex experience in which quality of life is an important aspect. An 
aspect of survivorship that is lacking in the literature concerns differences between older 
and younger cancer survivors.  It is unknown if survivorship issues are the same for 
these different populations.  Research is needed to investigate survivorship in different 
populations. 
 
QUALITY OF LIFE 
Quality of life is an important aspect of survivorship and was first discussed in the 
literature in 1953.  This concept gained rapid popularity in the 1970’s and 1980’s and 
now over 92,000 articles in PubMed use “quality of life” as a keyword.  Quality of life is 
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a term that is used by both patients and health professionals. It is recognized as a 
multidimensional concept with perception based on the subjective experiences of the 
individual assessing it. 100-104  However, despite its extensive use in research, King and 
colleagues.102 suggest that there are “gaps in theory, research and practice” (p.27) 
related to quality of life.  Lack of a uniform definition of QoL may be the basis for these 
issues. 
Meeberg105 defines quality of life as a subjective experience that defines a feeling of 
overall life satisfaction.  The World Health Organization106 defines QoL as “an 
individuals perception of their position in life in the context of the culture and value 
system in which the live and in relation to their goals, standards, and concerns”.  
Ferrans and Powers107 define QoL as “the persons sense of wellbeing that stems from 
satisfaction or dissatisfaction with the areas of life that are important to him/her.”  
Ferrell and colleagues define quality of life as a personal sense of wellbeing which 
encompasses physical, psychological, social and spiritual dimensions.108-110   
In many instances the concept of QoL is clarified by researchers through “domains” 
or dimensions which are used to measure the concept.  Different researchers measure 
the concept in different ways. Ferrell and colleagues108-113 use 4 domains to help define 
the concept: physical, psychological, social and spiritual well-being.  Ferrens114 uses 
similar domains of health and functioning, socioeconomic, psychological/spiritual and 
family.  Other researchers such as  Cella and Tulsky101 use the domains of physical 
concerns, functional ability, family well-being, emotional well-being, spirituality, 
treatment satisfaction, future orientation, sexuality/intimacy, social functioning and 
occupational functioning to describe QoL.  Aaronson100 uses physical functioning, 
disease symptoms and treatment side effects, psychological status, social functioning, 
general health perceptions, physical suffering, self-care activities, outlook on life, 
meaningful activities and social relationships to describe QoL.  Measurement tools exist 
that correspond to each of these researchers conceptualization of quality of life.102  
These tools enable researchers to look specifically at the QoL of patients on both 
individual group levels.103  The different domains examined by researchers demonstrate 
the multidimensionality of the concept and the uniqueness of its conceptualization. 
King and colleagues102 suggest that the concept of quality of life may be discipline 
specific and concept analyses may need to take place in each discipline and then 
compared in order to determine how the term is used across disciplines.  In addition, 
King and colleagues102 suggest that QoL is dynamic and changing.  QoL should be 
measured on a continuum as QoL at one time point may not predict QoL at subsequent 
time points.  The evaluation of QoL takes place in social context and is only reflective of 
the appraiser’s cognitive view of their life at the time of the survey.104  
The conceptual framework for this dissertation is based the Conceptual Model for 
Quality of Life in Breast Cancer survivors (QoL-BC) that was developed by Ferrell and 
colleagues in 1996.  The QoL-BC model was adapted from previous conceptual models 
developed by Ferrell and colleagues that had been used in cancer survivors.112  While 
examining quality of life in long-term cancer survivors through the use of both 
qualitative and quantitative methods, the researchers were able to identify aspects of 
cancer that were specific to breast cancer survivors.111  This led to the development of 
the Quality of Life-Breast Cancer instrument and the conceptual model for Quality of 
Life in Breast Cancer survivors (QoL-BC). 
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This conceptual model (QoL-BC) consists of quality of life interacting with and being 
influenced by the domains of physical well-being, psychological well-being, social well-
being and spiritual well-being (See below). Each domain has been defined by the 
researchers and describes “concepts” or factors that influence the overall domain.  The 
definitions for the domains are as follows: 
Quality of life: Quality of life is a personal sense of wellbeing which encompasses 
physical, psychological, social and spiritual dimensions.108-110   
Physical well-being: “The control or relief of symptoms and the maintenance of 
function and 
independence.”115   
Concepts within this 
domain include: nausea, 
constipation, appetite 
changes, fertility and 
menstrual changes, sleep, 
pain, and fatigue. 
Psychological well-
being: “Seeking a sense 
of control in the face of 
life threatening illness 
characterized by 
emotional distress, 
altered life priorities, and 
fears of the unknown, as 
well as positive life 
changes”115  Concepts 
within this domain 
include: fear of 
recurrence and tests, usefulness, happiness and life satisfaction, coping, being in 
control, anxiety, depression, cognitive changes, distress from treatment and an overall 
perception of QoL. 
Social well-being: “a way to view not only the cancer or its symptoms, but also the 
person surrounding the tumor; it is the means by which we recognize people with 
cancer, their roles, and relationships.”115  Concepts within this domain include: family 
distress, personal relationships, support, employment and financial burden, sexuality, 
isolation and activity at home. 
Spiritual well-being: “the ability to maintain hope and derive meaning from the 
cancer experience that is characterized by uncertainty.  Spiritual well-being involves 
issues of transcendence and is enhanced by one’s religion and other sources of spiritual 
support.”115   Concepts within this domain include having hope, purpose in life, 
uncertainty, and religious and spiritual changes/ activity. 
The Quality of Life Model for Breast Cancer Survivors is a framework that is applied 
to all women with breast cancer.  At this time, it is unclear what concepts within each 
domain are relevant to older women with breast cancer. This framework will be 
modified for this dissertation.  Future research may examine how this framework 
directly applies to older women with breast cancer. 
Psychological Well Being
Usefulness
Happiness/Satisfaction
Coping
Control
Anxiety/Depression
Concentration/Memory
Pain
Fear of recurrence/tests
Overall perception of QOL
Distress of Diagnosis and Treatment
Spiritual Well Being
Hopefulness
Life Purpose
Positive/Spiritual Change
Religious/Spiritual Activity
Uncertainty
Social Well Being
Family distress
Personal relationships
Support/Others
Employment
Home Activities
Isolation
Financial Burden
Sexuality
Physical Well Being
Nausea
Constipation
Appetite
Menstrual changes/Fertility
Sleep
Aches/Pains
Fatigue
QOL
Original Quality of Life Model for Breast Cancer Survivors
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Rationale for a Quality of Life Framework 
Quality of life is a valid theoretical/conceptual framework for nursing to apply to 
many populations including older women with breast cancer because it is a holistic 
approach to assessing and evaluating the lives of these women after cancer.  
Additionally, a quality of life framework fits this student’s interests and research 
questions developed for the dissertation research. 
Many of the strengths of a quality of life construct for older women with breast 
cancer lie in its uses and are important for many reasons.  First, with cancer now being 
classified as a chronic illness, focus on outcomes of treatment has changed from 
quantity of life to quality of life.  Discomfort and disability due to treatments in a life 
that may extend many more years is simply unacceptable. Quality of life is a self-
reported measure that can compliment the clinically derived mortality rates used to 
determine if treatments are appropriate in cancer care.  In addition, research involving 
quality of life in older women with breast cancer can impact the development of 
treatment guidelines for this ever-growing population.  Second, older women comprise 
the largest group of women with breast cancer.  Due to the lack of knowledge previously 
mentioned concerning diagnosis and treatment in this population, quality of life in 
clinical trials and other research is an important outcome to determine best practice for 
these older women.  Older women treated for their breast cancer will be surviving with 
cancer and are at risk for long-term side effects.  It is crucial that quality of life in these 
women become a focus so they can live their lives independently and with as few side 
effects as possible.  Third, quality of life outcomes can provide a patient focused 
perspective of QoL after treatment and help guide the development and effectiveness of 
interventions designed to improve the lives of older women after treatment for breast 
cancer.   
 The remainder of this literature review will focus on quality of life in cancer 
survivorship using the domains established by Ferrell and colleagues. 
 
Quality of Life in Cancer Survivorship 
This review of the literature intends to provide the state of the science concerning 
issues related to quality of life in older women surviving with early stage breast cancer. 
An overview of quality of life issues will be provided and when available, information 
specific to women age 65 and older will be discussed.   
The literature that discusses quality of life (QoL) in older breast cancer survivors is 
far from comprehensive.  Many studies that examine QoL report the average age of the 
participants as being near 50 years. 108, 111, 112, 116-122   Unfortunately, these data can not be 
generalized to an older sample. Some studies have looked at differences between quality 
of life in younger and older women and provide information in regards to women in 
specific age groups.4, 5, 11, 116, 123-126  Other studies have focused specifically on older 
women with breast cancer 6, 9, 127-134.  Exclusion or lack of participation of older women 
in clinical trials has led to a knowledge deficit in many areas regarding the older women 
with breast cancer. 
 
Overall Well-Being:  Quality of life is often reported in relation to symptoms 
being experienced by survivors compared to controls.  For example: women who 
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continue to experience symptoms such as fatigue and menopausal symptoms reported 
poorer quality of life than non-cancer controls.135  
 Health-related quality of life (HRQoL) has also been compared to the general 
population.  Bardwell and colleagues136 noted that breast cancer survivors who averaged 
2 years from diagnosis reported high health-related QoL that was comparable to 
controls.  Poor physical HRQoL was related to poor psychosocial functioning, poor sleep 
quality, less physical activity and obesity.  Poor mental HRQoL was related to poor sleep 
quality, pain, gastrointestinal symptoms and more life events. 
 Arndt and colleagues137 also compared QoL of breast cancer survivors to controls 
at 1 and 3 years post-diagnosis.  At 3 years, the overall QoL in breast cancer survivors 
was comparable to controls. Women with breast cancer reported slightly worse physical 
functioning but larger deficits in role, emotional, social and cognitive functioning.  
Symptoms that persisted at 3 years included fatigue, pain, insomnia and shortness of 
breath.  These symptoms were more severe in younger age groups. 
 Vinokur and colleagues138 examined physical and psychological functioning and 
adjustment in breast cancer survivors.  They were surprised to find that women with 
early stage disease who had survived over 5 years show positive adjustment to disease.  
Compared to controls without a history of breast cancer, they had the same levels of 
physical functioning and reported similar psychological and social well-being as the 
control group.  Interestingly, these survivors rated their breast cancer experience as “a 
little” stressful compared to non-cancer controls who rated their most stressful 
condition to date as “somewhat” stressful.  The researchers speculate that it is the low 
severity of disease (early stage) that led to the excellent adjustment. 
 Additionally, how women with breast cancer perceive the side effect burden 
affects quality of life.  Longman, Braden and Mishel139 looked at psychological 
adjustment, side effect burden and quality of life in breast cancer survivors over time.  
The study demonstrated that negative feelings such as depression and anxiety persist 
and are burdensome for survivors. This negatively impacts quality of life. This finding 
was consistent at all time points in the study. 
Vacek and colleagues12 also looked at factors that influenced quality of life in breast 
cancer survivors.  This study compared women treated for breast cancer with a group 
that had benign breast biopsies.  This study was conducted over time to ascertain trends.  
Using the Quality of Well-Being Instrument, quality of life declined over time for the 
breast cancer survivors.  Presence of co-morbidity was related to significantly lower QoL 
scores.  Survivors who were married showed a slower decline in quality of life.  Older 
survivors had a more rapid decline in their quality of life scores. 
On the contrary, Kenefick9 reported that older women have better global quality of 
life scores than younger women and experience less symptom distress. Quality of life in 
older women has been shown to improve over time as well.5, 9  
Overcash140  conducted interviews with older women with breast cancer which 
resulted in descriptive qualitative data reflecting quality of life in these women.  Eight 
major themes emerged:  importance of God, importance of a positive attitude; no 
alteration in lifestyle; physician trust; caregiver to others; need to protect family; 
importance of health and importance of family.  Additionally, many of the women who 
participated in the study had active lives despite diagnosis and treatment. Overall, 
women were able to maintain their activity level in spite of breast cancer and being ill at 
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times.  This study emphasized that preconceived notions of older women being ill and 
dependent are exaggerated as older women are able to keep up with their active lifestyle 
despite having cancer. 
Summary: Women of all ages diagnosed with breast cancer share common concerns 
but also have unique needs.  Due to the heterogeneity of women, age related differences 
related to breast cancer occur from diagnosis into survivorship.  Overall, QoL seems 
positive.  Sammarco141 states that every woman will adapt to breast cancer and make 
choices based on their own personal history, psychosocial stage and current concerns 
based on their stage in life.  Survivors who are able to adjust to having cancer often have 
comparable QoL to non-cancer peers.  As a group, older women adjust well to breast 
cancer and often report better QoL scores than younger women.  However, those with 
co-morbid illnesses may report lower QoL. Older women remain active after diagnosis 
despite treatment and side effects and long-term effects.   
 
Physical Well-being: Any cancer survivor may experience a wide range of 
symptoms and side effects after diagnosis and treatment. Physical well-being is defined 
as “the control or relief of symptoms and the maintenance of function and 
independence.”115 
Fatigue: Fatigue is one of the most frequently reported symptoms.4, 6, 9, 13, 109, 111, 120, 
142-146 Fatigue has been noted to be a problem for breast cancer survivors both 
immediately after treatment145 and over time.9, 111, 146, 147  Ferrell and colleagues111 studied 
a group of cancer survivors an average of 6.6 years after diagnosis and noted that fatigue 
was the top physical issue for these survivors.  Servaes and colleagues146 also noted long-
term fatigue in breast cancer survivors.  In a sample of women who completed 
treatment an average of 29 months previously, 38% stated they were severely fatigued.  
Compared to survivors that did not have severe fatigue, these patients reported worse 
physiological well-being, more functional impairment, more sleep concerns, lower 
physical activity, poorer social support and social functioning.  No association was made 
between prior treatment received and current level of fatigue.  
Fan and colleagues135 also noted fatigue in long term breast cancer survivors 
compared to controls.  Hormonal therapy had a small effect on fatigue levels.  Women 
taking hormonal therapy tended to be more fatigued at 2 years but this effect was not 
statistically significant.  In addition, an association was found between fatigue and the 
severity of menopausal symptoms. 
Fatigue has been shown to decrease over time.  Fatigue has been reported as most 
severe during treatment but decreases one year after treatment.147  Fatigue affects 
overall quality of life and domains of quality of life.  Using the Medical Outcomes Study 
Short Form General Health Survey, Byar and colleagues147 noted that fatigue affected 
the physical, social, bodily pain, mental, vitality and general health domains. 
While looking at patterns of symptom distress in older women (mean age of 68 
years) after surgical treatment for breast cancer, Kenefick9 noted fatigue to be a 
persistent problem and the number one distressing symptom at each time point in the 
study.  Fatigue distress was measured after discharge and at 3 and 6 months. Fatigue 
related distress did improve over time most notably from discharge to 6 months.  
Fatigue was also repeatedly correlated with concentration over time. 
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Pain: Pain is one of the most frequently reported symptoms. 5, 6, 9, 10, 13, 121, 133, 143 Pain 
in breast cancer survivors can be due to surgery,148-150 lymphedema151 or co-morbid 
conditions such as arthritis8, 133  
Post-mastectomy pain (PMP) can be experienced by women with breast cancer well 
into survivorship.  MacDonald and colleagues150 examined women with chronic PMP 
approximately 9 years after their surgery.  Over half of their sample reported the 
persistence of PMP.  Younger women were particularly at risk.  Women who 
experienced PMP reported functional limitations and difficulty with activities of daily 
living as well as lower quality of life scores.  Pain can also be present in women who 
receive lumpectomy and breast conservation therapy and in women who elect breast 
reconstruction.148  
In comparative studies, it has been noted that both younger and older women 
experience pain124, but older women experience more pain.4, 5 
Lymphedema: Lymphedema (LE) and arm symptoms are frequently reported side 
effects of breast cancer treatment5, 10, 142, 143, 151-155  Women with any type of lymph node 
removal are at risk for LE however, those who receive axillary lymph node dissection 
experience more symptoms of LE than women with sentinel lymph node biopsies. 
Symptoms may include: numbness and tingling, firmness or tightness in the arm and 
larger arm size.155   Women with LE report frustration, anxiety, depression, changes in 
role functioning, pain, disability and poor social support.156  
Ridner153 found that women with lymphedema consistently scored lower on multiple 
QoL instruments compared to women without LE.  Symptoms associated with LE in this 
group included: altered limb sensation, decreased physical activity, presence of fatigue, 
psychological distress and loss of confidence in the body. Additionally, women’s 
perception of limb size, not objective or measured limb size, influenced the experience 
of having LE. 
Armer and Fu151 have studied the occurrence of lymphedema (LE) in older breast 
cancer survivors.  Incidence of LE for older women was lower (31%) when compared to 
incidence in younger women (41%).  The difference in incidence may be due to less 
extensive surgery in older women.   Women with and without documented diagnoses of 
lymphedema reported experiencing symptoms such as numbness, tenderness and 
aching in the affected arm.  Older women had a tendency to report these symptoms less 
than younger women.  With the projected number of older women that will be 
diagnosed with breast cancer over the next several decades there is a risk for both 
under-diagnosis and under-treatment of lymphedema in this growing population.152  
Menopausal Symptoms: Symptoms of menopause have been reported as a concern 
of women treated for breast cancer.135, 157-160 Fan and colleagues135 report that women 
who received chemotherapy (n=104) experienced more menopausal symptoms than the 
non-treated control group.  In this sample, the use of hormonal therapy did not impact 
menopausal symptoms. However, more women were treated for hot flashes as time 
progressed. 
Carpenter and Andrykowski158 also examined the presence and severity of 
menopausal symptoms in breast cancer survivors and its impact on quality of life.  The 
most commonly reported and most severe symptoms were: joint pain, fatigue, trouble 
sleeping and hot flashes/night sweats.  Other symptoms reported were vaginal dryness 
and painful sexual intercourse.  The total number of symptoms was related to years in 
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post-menopause. Women who experienced fewer years of menopause reported more 
symptoms.  Sixty percent of this sample reported 6 or more symptoms of menopause.  
Additionally, the more symptoms a women experienced and higher the severity of 
symptoms, the lower women rated their physical and emotional QoL. 
The presence of menopausal symptoms in breast cancer survivors has been 
compared to non-cancer controls and found to be similar in both groups.159, 160  Schultz 
and colleagues160 concluded that breast cancer and menopause were 2 separate issues 
and the menopausal symptoms women experienced may not have been breast cancer 
related. 
Hot flashes have also been noted in older breast cancer survivors.6 In a sample 
consisting of women over the age of 65 with a history of breast cancer, hot flashes were 
repeatedly named as one of the top ten symptoms experienced up to a year after 
diagnosis.   Out of 246 women, 3.3% ranked hot flashes as a concern.6 
Weight gain: Weight gain and weight changes have been linked to developing breast 
cancer161, 162 and to higher rates of recurrence and mortality in breast cancer.163, 164 Risk 
factors of weight gain in breast cancer survivors include time since diagnosis, receipt of 
adjuvant chemotherapy and high body mass index at time of diagnosis.  Additionally, 
women who did not exercise gained more weight.165 
Weight gain has been a reported concern of breast cancer survivors.93, 162-169 Weight 
gain can begin during chemotherapy167  and continue into survivorship as women take 
endocrine therapy.93, 168, 170 McInnes and Knobf169 analyzed weight gain and QoL in 
women who received adjuvant chemotherapy for early stage breast cancer.  In their 
sample, 78% had gained weight (average 9 lbs.) one year after treatment.  Women 
maintained this weight gain at 3 years.  Greater weight gain was seen in pre-menopausal 
women.  Women who took Tamoxifen gained more weight than women who did not, but 
this result was not statistically significant.  Although, weight gain did not affect overall 
QoL, women were distressed by the gain. 
Weight gain has been noted as a problem in older breast cancer survivors.  Heidrich 
and colleagues8 reported that weight gain was one of the 10 most distressing symptoms 
for older women after breast cancer however, none of the women in this sample 
attributed their weight gain as being cancer related.  Instead weight gain was attributed 
to chronic illness or the aging process. 
Insomnia: Insomnia and sleep disturbances have been examined in breast cancer 
survivors.  Disturbances in sleep often begin in treatment and persist into 
survivorship.147, 171  Savard and colleagues171 conducted a randomized clinical trail to 
evaluate the effectiveness of Cognitive Behavioral Therapy for insomnia in women with 
breast cancer.  Women who received the intervention reported better sleep than 
controls.  In addition, treated women also reported using less sleep medication, had 
decreased anxiety and depression and better global QoL than the control group. 
Women who report sleep disturbances also report more symptom distress.  Pain, 
fatigue, bowel problems, and lack of concentration were associated with insomnia.9 
Older women were noted to experience sleep changes however the literature does not go 
into great detail concerning this issue. 4, 6, 9, 172 
Physical Functioning: Physical functioning in breast cancer survivors is usually 
comparative and results vary widely.  Schroevers and colleagues126 found that women of 
any age with cancer experience difficulty with physical functioning.  However, at 8 years 
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after diagnosis, older cancer survivors were more likely to have more physical symptoms 
and limitations than younger women.  In addition, younger survivors were more likely 
to appreciate themselves and believe that life was more fulfilling compared to older 
survivors.126  
In a study looking at physical functioning in older cancer survivors, Cimprich and 
colleagues4 noted that older women report lower physical functioning compared to 
middle aged women and men of different ages. Older women reported more problems 
with fatigue, pain, constipation and sleep changes while younger women have more 
problems with menstrual and fertility issues.  The number of co-morbid illnesses also 
correlated to lower physical functioning. 
In a different study, Satariano and colleagues11 compared the functional status of 
women with breast cancer (ages 55 to 84) to controls without breast cancer using the 
Instrumental Activities of Daily Living (IADL) survey.  The IADL evaluates 
transportation, housekeeping, meal preparation and grocery shopping. Results showed 
that women with cancer, ages 55 to 74, had the most problems with functioning 
compared to controls within that age group.  The oldest women in their sample (age 75 
and older) reported the fewest functional problems compared to similar aged controls.  
Breast cancer in the oldest age group was not associated with poorer functioning.  
Interestingly, physical impairments and deficits in functioning were not always 
perceived by older breast cancer survivors as being attributable to having breast cancer.  
Aging and chronic illness were often reported as the cause of current symptoms.8 
In a study that looked at quality of life in long-term breast cancer survivors, women 
who were older at diagnosis reported worse physical functioning and more pain 
compared to younger women at both 7 and 12 years from treatment.  Older women also 
noted more arm symptoms than younger women.  However, global quality of life 
increased for older women at 12 years.5  
 Wenzel and colleagues117 reported that older women reported more health problems 
that were unrelated to their cancer and higher quality of life than younger women.   
Summary: Physical problems are common in breast cancer survivors.  Women 
experience fatigue, pain, LE, insomnia, weight gain, menopausal symptoms and 
decreases with physical functioning.  Older women report that fatigue persists over time, 
have more pain than younger women, fewer menopausal symptoms and more issues 
with physical functioning.  Age and chronic illness seem to be negatively associated with 
physical functioning however the data on physical functioning has shown conflicting 
results and may be sample specific. 
 
Psychological Well-being:  Psychological well-being is defined as “seeking a 
sense of control in the face of life threatening illness characterized by emotional distress, 
altered life priorities, and fears of the unknown, as well as positive life changes”115  
Fear of Recurrence: Fear of recurrence is extremely common among breast cancer 
survivors.10, 110, 111, 133, 143, 173, 174  In a study focusing on breast cancer and psychosocial 
well-being in early stage breast cancer survivors, Spencer and colleagues174 report that 
fear of recurrence is the number one concern of survivors.  Ferrell and colleagues110 
report that even though women fear recurrence, they are able to balance hope with these 
fears.  Women were hopeful that new treatments would be available if their cancer 
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returned.  Other fears such as fear of more treatment and instances of poor health have 
also been described by survivors.175   
While women with breast cancer share concerns with fear of recurrence,10, 143 older 
women seem to have less fear.10  Older survivors may experience these fears many years 
after diagnosis. Gil and colleagues 133 studied older women 5 to 11 years after treatment 
and found that on average, older women have 1.8 experiences per month that trigger 
feelings of uncertainty and fears of recurrence.  The most common trigger was hearing 
of some one else being diagnosed with cancer.  Other triggers included: new aches and 
pains or physical symptoms, information from the media and environmental factors 
that remind the survivor of their experience.  Uncertainty regarding breast cancer lasts 
well into survivorship. 
Cognitive changes: Cognitive changes have been reported as a problem for breast 
cancer survivors4, 123, 135, 172  Cimprich and Ronis172 compared attention and symptom 
distress in women with and without breast cancer.  When comparing attention in these 
groups at baseline, the breast cancer group had lower attentions scores than the control 
group.  At 3 months, the breast cancer group had gradually improved their attention 
scores.  However, loss of concentration was still a distressful symptom for breast cancer 
survivors even though their overall attention scores had improved.172 
Cognitive changes (loss of concentration) also occur in older breast cancer 
survivors.123, 172 Cimprich123  stated that the normal processes of aging results in the 
lowered ability of women to focus and concentrate.  As a result, older women are more 
at risk for attention fatigue after treatment for breast cancer.  In this study, older women 
had lower attention scores and lower attention performance over time compared to 
younger women,  Older women who received mastectomy were most affected by these 
cognitive changes. 
Depression: Depression impacts women with cancer in several ways.  Badger and 
colleagues176 specifically looked at the effect of depression burden and psychological 
adjustment and quality of life in women with breast cancer over time.  Women who 
reported a higher level of depression burden at baseline experienced poor psychological 
adjustment than women with low levels of depression burden.  In addition, women with 
high levels of depression reported lower overall quality of life.  Women with high levels 
of depression benefited from an intervention and were able to report improved quality 
of life compared to women who did not receive an intervention. 
Goodwin and colleagues166 looked at the effects of depression on diagnosis, 
treatment and survival of older women with breast cancer.  Results of their study 
showed that women who had a diagnosis of depression prior to the diagnosis with breast 
cancer were less likely to receive definitive treatment and had poorer survival rates.  The 
reasons for the poorer survival rates are unknown but may be due to adherence to 
appropriate screenings and medical recommendations.   
Effect of Symptom Distress: When studying the psychological well being of older 
women with chronic illnesses (breast cancer or osteoarthritis) Heidrich7 found that 
women with arthritis reported more symptoms and functional health problems than did 
women with breast cancer.  Women with arthritis also viewed their chronic illness as 
more severe, less controllable and more chronic than women with breast cancer.  
Women with arthritis were more bothered by symptoms and portrayed their physical 
health more negatively than women with breast cancer.  Women also compared 
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themselves with other women they knew and were able to make upward and downward 
comparisons.  These comparisons influenced psychological well-being.  
When comparing older women with and without breast cancer Heidrich and 
colleagues8 noted that both groups of women reported multiple symptoms but had low 
levels of symptom distress. In addition, women with breast cancer rarely associated 
their symptoms with breast cancer but instead attributed symptoms to aging and other 
chronic illnesses.  Women often rated the cause of their symptoms as unknown and this 
correlated with poorer social functioning and mental health, less energy, lower 
perception of purpose in life, and higher levels of depression and anxiety negatively 
impacting quality of life. 
Summary: Women with breast cancer often continue to fear recurrence, have 
cognitive changes, depression and symptom distress.  Older women seem to fear 
recurrence less than younger women.  Older women experience more cognitive changes 
possibly due to the changes of aging.  Depression has been linked to lower QoL in 
women with breast cancer and with poorer survival rates in older women. Compared to 
controls, older women with breast cancer seem to have better QoL than some women 
with other chronic illnesses such as osteoporosis and often fail to associate “symptoms” 
with their breast cancer, instead attributing symptoms to age and other chronic 
illnesses. 
 
Social Well-being: Social well-being is defined as “a way to view not only the 
cancer or its symptoms, but also the person surrounding the tumor; it is the means by 
which we recognize people with cancer, their roles, and relationships.”115  
Thewes and colleagues143 compared the psychosocial needs of older and younger 
breast cancer survivors and found that younger women had more unique needs.  
Younger women were more concerned with their careers and had a greater number of 
concerns about relationships, sex and fertility.  Younger women were more likely to 
want and seek out additional support from professionals than older women. Older 
women discussed not wanting information about their treatment as a way lessening 
anxiety.  Finally, younger women spoke about feeling very isolated as a young woman 
with breast cancer due to its rarity in women their age. 
Body Image: The effects of breast cancer on body image have been reported in the 
literature.  Ganz and colleagues124 found that women who received breast conservation 
treatment had significantly fewer problems with their body image compared to women 
who received mastectomy or reconstruction.  Pinto and Trunzo122 looked at body esteem 
among breast cancer survivors.  Women who exercised reported better body esteem and 
better mood states (less confusion, fatigue, and depression and higher vigor) than 
survivors who did not exercise.   
Although King and colleagues10 reported that older women have better body image 
than younger women, older women are still concerned about body image.  Figueiredo 
and colleagues128 found that body image was important for 31% of their sample (mean 
age 74 years) when making treatment decisions.  At 2 years after treatment, older 
women who had breast conservation surgery had better body image than women who 
received mastectomy.  Additionally, women who wanted breast conservation treatment 
and received mastectomy had the poorest body image.  Other studies have also shown 
that body image for the older woman improves over time.5  
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Employment:  Concerns regarding work and employment are most likely 
experienced by younger breast cancer survivors due to their age.  Maunsell and 
colleagues177 used qualitative methods to explore work problems after breast cancer in a 
small sample (n=13) of survivors.  Several concerns emerged from the interviews.  
Women worried about returning to work.  Some feared not being able to perform the 
tasks they did prior to treatment and others worried that the changes in their physical 
appearance would cause co-workers to look closely at their bodies.  Some women 
experienced changes in their job that they did not ask for.  Women were demoted, given 
modified tasks or lost their jobs.  Others felt their relationship with their boss and co-
workers changed.  Many women felt they had a decreased ability to do their jobs and 
cited fatigue and arm problems as the cause.  Work also became less of a priority after 
treatment and returning to work.  Bloom and colleagues178  also found that continuing to 
work created conflicts for women.  Due to fatigue, some women were too tired to work 
during treatment.  Some women found they had unsympathetic employers.  Other 
women quit their jobs and made a career change. 
In other studies, women used the return to work to gain a sense of normalcy and to 
relieve financial burdens incurred due to the breast cancer diagnosis.109  
Generally, it has been shown that older women have less concern over employment, 
work, and financial issues compared to younger women. 5, 27   
Sexuality and Sexual Functioning:  Ganz and colleagues124  examined sexual 
functioning in breast cancer survivors.  The majority of the sample was sexually active at 
the time of their participation in the study (60%).  The women at greatest risk for sexual 
dysfunction were post-menopausal women under the age of 50 and those who received 
chemotherapy. Tamoxifen was not noted to significantly contribute to sexual 
dysfunction in breast cancer survivors over the age of 50. 
Speer and colleagues130 also looked at sexual functioning in long-term (mean: 4.4 
years) breast cancer survivors.  Sexual functioning was not linked to type of treatment or 
hormone levels but, sexual functioning was significantly poorer in survivors compared 
to controls.  Survivors who were depressed had lower levels of sexual desire and 
survivors who had relationship distress reported poor arousal, lubrication, orgasm and 
sexual satisfaction.  In addition, survivors with poor body image also had low levels of 
sexual satisfaction. 
Information concerning the impact of breast cancer on sexuality in older women is 
uncertain.  Wyatt and Friedman13 report that sexual concerns were the highest reported 
quality of life concern among midlife and older women.  Cimprich and colleagues4 
report that although breast cancer impacts sexuality, that impact is low in older women.  
Spencer and colleagues174 also report that older women had less concern over sexual 
issues and partner related concerns than younger women.  
Relationships, Support and Social Functioning: The impact of breast cancer on 
relationships has been reported.  Holmberg and colleagues119 explored the impact of 
breast cancer on relationships and found breast cancer caused both physical and 
psychological changes in women impacted their relationships.  Women felt shame, 
undignified and embarrassed by the changes in their bodies and had difficulty looking at 
themselves.  Psychologically, they did not feel adequate in their role as woman or 
partner.  Women looked at themselves differently after breast cancer.  Women also 
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reported fatigue, vaginal dryness, loss of libido, and depression which they attributed to 
their decrease in desire and sexual response.   
Partners of the women with breast cancer expressed less concern over their partner’s 
appearance but more concern over their partner’s survival. Partners also expressed 
concern over reconstructive surgery fearing that it was an unnecessary operation or that 
it might cause their wife more pain and discomfort. 
Women without partners reported negative comments about their physical 
appearance from prior partners and feared these responses from future partners.  Un-
partnered women also found that breast cancer did not strengthen their relationships 
but may have hastened the demise of troubled relationships.  Partnered women believed 
cancer strengthened their relationships with their spouses. 
The changes in how women viewed themselves affected their sexual relationships as 
well as other relationships.  Friendships sometimes changed as women found close 
friends becoming more distant however, women were able to draw support from other 
friends and new relationships.  Variable responses from employers and co-workers were 
discussed.  Most women were supported, however some lost their jobs due to cancer 
related side effects and time needed off from work. 
Ganz and colleagues124 found that younger women encountered more difficulty in 
relationships than older women.  In addition, younger un-partnered women were very 
concerned about dating issues such as telling a date about their cancer or beginning a 
sexual relationship. 119, 124  
It has been reported that older women have better social functioning compared to 
younger women.10 134 Partners and adult children were found to be important sources of 
support for women.  Families that were able to adjust to the breast cancer predicted 
better mental health (less depression and anxiety) for the cancer survivor.179   Older 
women with limited social support were less satisfied with their lives180   Sammarco134 
reported that older women who have better social support also rate their overall quality 
of life as better.  Social support was correlated with less disease related uncertainty.  
Social support was also seen to lessen as women got older. 
Summary: Women with breast cancer experience similar issues and concerns related 
to body image, employment, sexuality, relationships and support.  Older women seem as 
concerned with body image and sexuality as younger women, but less concerned with 
employment issues.  Physical and psychological issues do impact relationships and 
younger women who do not have partners experience anxiety over future relationships.  
Older women report equal if not better support than younger women and this support 
correlates to overall quality of life. 
 
Spiritual Well-being: Spiritual well-being is defined as “the ability to maintain 
hope and derive meaning from the cancer experience that is characterized by 
uncertainty.  Spiritual well-being involves issues of transcendence and is enhanced by 
one’s religion and other sources of spiritual support.”115 
Religion and spiritual beliefs: When exploring the impact of breast cancer on 
spiritual well-being, Ferrell and colleagues110 found using formal religious practices and 
having spiritual beliefs helped support women in survivorship.  Women in their study 
were concerned with uncertainty and hope and discussed how cancer altered their 
priorities and life meaning.110  Cotton and colleagues181 also noted that having an active 
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religious life was significantly associated with spiritual well-being.  However, this study 
noted no significant difference in QoL between women who did and did not actively 
practice religion.   
Women also discussed having a relationship with God and being able to rely on God 
for support and guidance.  The presence of God was felt by many women in their lives 
and this made women feel supported.  Women used activities such as prayer, either 
their own prayers or prayers from others to help them cope with their illness.182  
Spiritual well-being has also been examined in relation to symptom distress.  
Manning-Walsh120 looked at psychospiritual well-being and symptom distress in cancer 
survivors.  Although symptom distress was reported as low by this sample, there was an 
inverse relationship between symptom distress and psychological, spiritual, and 
psychospiritual well-being. In addition, younger women had significantly lower 
psychospiritual well-being compared to older women. 
Manning-Walsh183 also examined spiritual struggle and its relation to quality of life.  
Women who had greater spiritual struggles reported lower quality of life and lower life 
satisfaction. 
Fehring and colleagues184 examined spiritual well-being, religiosity, hope, depression 
and mood states in older people with cancer. Being highly religious was found to be 
positively related to hope, mood and spiritual well-being and negatively related to 
depression and negative mood states. Older cancer survivors used religion and spiritual 
beliefs to cope and keep life in perspective.   
Feher and Maly127 also found that religion and spirituality helped older women to 
cope.  Women felt that their religious and spiritual faith helped give them the emotional 
support they needed in order to cope with the breast cancer and make meaning in their 
illness.  Their faith gave them a sense of companionship and being taken care of.  Faith 
gave older women emotional support, helped them control fears, take comfort and have 
a sense of well-being.  Older women also used their connections to the church to keep a 
social connection with others.  Being associated with a church or religious community 
allowed women to keep in touch with others through volunteer work and their 
relationship with the leader of their church.  Women also liked being prayed for by 
others. Women felt protected, loved and unafraid due to the presence of God in their 
lives. 
Meaning: Meaning has been examined in several ways: meaning in life and meaning 
in illness.  Gall and Cornblat182 examined meaning in breast cancer survivors and found 
that many women believed their cancer was serving a Divine purpose.  Albaugh185 also 
found that some women viewed breast cancer as a wake up call so they could find out 
what was really important in their lives.  Others thought God was asking something of 
them.  Some believed cancer was just a part of life and did not know why they got the 
cancer, but life had meaning despite this.  Meraviglia186 noted that meaning in life for 
breast cancer survivors was positively related to psychological well-being and negatively 
related to symptoms and physical well-being. 
Utley131 looked at meaning in illness in older long-term breast cancer survivors. 
Women were found to go through 3 distinct phases of meaning.  The first phase viewed 
cancer as sickness and then death.  In this phase women talked about expecting to feel 
sick if they had cancer and how their expectation did not correlate with how they really 
felt.  The second phase viewed cancer as an obstacle and something they had to get over.  
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In this phase they realized cancer was something they could live with.  In the third 
phase, cancer was viewed as transforming.  Women realized that their lives had changes 
and could see how cancer benefited them and their lives. 
Through grounded theory, Crooks81 developed the theoretical model of Living Day 
by Day in which older women went through several phases before coming to terms with 
and finding meaning in their disease.  Initially, women “faced the music” by finding out 
about their diagnosis and taking action against it (treatment).  “Getting back to normal” 
after treatment was a considerable task for older women.  In this phase, women 
acknowledged the physical changes they experienced such as pain or the loss of a breast 
and strategized to assimilate these changes into their lives.  In addition, older women 
were able to realize that having cancer changed how other people viewed them as 
individuals.  This caused older women to protect family members by downplaying their 
own fears and concerns and sharing information about themselves with others in similar 
situations or with those who were perceived as caring about their situation.  “Getting 
perspective” is the third phase in which older women sought perspective on both their 
disease and life expectancy.  Women made decisions for themselves based on their 
analysis or perspective.  Older women compared themselves to other women in similar 
situations and with different illnesses to determine if their problems were more or less 
significant compared to other women. Older women used this strategy to affirm that 
their previous decisions were correct and to determine how much effort should be given 
to concerns about the diagnosis and fears of recurrence.  Finally, “being different than 
before” was acknowledged by older women.  Women became aware of the isolation or 
aloneness caused by the diagnosis and the need for time to make sense of the changes 
that have occurred.  Older women also examined their belief systems and the important 
things in life were stressed.  Ultimately, this process of finding meaning in illness and 
the outcomes and changes it caused allowed women to reach a different level of living in 
which each day was lived to its fullest possible potential. 
Summary: Women who are religious use their faith as a source of support during all 
phases of cancer survivorship.  Higher faith often correlated with lower distress.  
Additionally, women often found meaning in their having breast cancer which led to a 
purpose in life.  Older women seemed to go through “stages” in order to find meaning in 
illness and could often see the benefit cancer had brought to their lives. 
 
RESEARCH METHODS 
 This section of the literature review discusses the methods to be used in this 
dissertation research.  This dissertation will be conducted using secondary analysis and 
mixed methods. 
 
Secondary Analysis:  Conducting original research from existing data is 
recognized as an important and legitimate method for conducting scientific inquiry.187-
189  Searches in national databases such as PubMed and CINHAL using the keywords 
“secondary analysis” reveal over 6,000 research studies in several disciplines conducted 
using secondary analysis.  Recognizing the utility of sharing research data, the National 
Institutes of Health (NIH) has implemented a policy concerning data sharing.190 The 
purpose of data sharing is to help expedite “translation of research results into 
knowledge, products, and procedures to improve human health.”   
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Using pre-existing data is a rigorous undertaking that requires astute research 
planning and data analysis.187 Pre-existing data can be used to answer questions other 
than those of the original study. Answering questions developed during an original 
study or that focus on a subset of a population are also appropriate uses.191  Existing 
data can be combined with other data sets to more thoroughly investigate a problem.189, 
192, 193  Using pre-existing databases is also a means to answer policy questions and 
influence policy decisions concerning healthcare.192  Some researchers advocate pairing 
data mining with secondary analysis in order to make new discoveries in patterns, 
correlations and trends.192    
Secondary analysis can be conducted from both quantitative and qualitative data.191, 
194-196  Advantages to conducting research using existing data are numerous.  A primary 
advantage is resource savings. Conducting research using independent data collection 
may not be feasible due to limitations in funding and resources.189  Using an existing 
data set requires less research funding due to lower staff needs and less time needed to 
conduct original research.189, 191 Research using pre-existing data eliminates the need for 
a researcher to affiliate with a large organization in order to receive the support needed 
to collect data from an adequate sample.  Using a pre-existing data set eliminates data 
collection problems and can be used with a variety of research designs.189, 196  
Additionally, quality issues and threats to reliability and validity in large well-known 
data sets are usually known by the primary researchers and documented.  The length of 
time it takes to report results is also shortened.192 
 Limitations of secondary analysis also exist.  The researcher needs to remember 
that the original data were collected for different purposes.  The existing data set must 
“fit” with the current research problem.187, 191 Methodological issues will exist if the 
secondary study or studies that are being combined are not theoretically or conceptually 
congruent with each other or the primary study.193  There may also be restraints on the 
amount of creativity a secondary analysis may provide due to limited available 
variables.189  Additionally, the quality of the data may be unknown.189  Missing data and 
other inaccuracies may affect the outcome of further analysis.189, 191 It is important to 
know how the data were collected and what limitations are present within the database 
so the researcher can determine if the database is appropriate to use for their own 
research purposes.192 Additionally, a historical bias may exist in the data.  Outdated data 
or changes in treatment patterns can impact the results of a secondary analysis and 
threaten internal validity.191, 192 193   
Other threats to reliability and validity involve the sample.   In large data sets, the 
sample may not be random.192 In addition, the desired population may be 
underrepresented in the existing data set189 or fundamentally different when looking to 
combine studies.193  Several issues regarding analysis are also discussed in the literature. 
Samples in the larger databases may be weighted leading to inaccurate conclusions.  
Researchers may need to seek advice concerning analytical approaches to evaluate their 
research questions.188  Other disadvantages include the time frame to gaining access to 
existing data, lack of existing data in a particular area of interest and a reluctance of 
researchers to share their hard-earned data.189   Finally, not understanding the nuances 
of the data being used in analysis can also be considered a weakness in secondary 
analysis.51 
 132 
Summary: Secondary analysis is a rigorous undertaking that uses pre-existing data 
sets in order to answer new research questions.  Although limitations exist, this 
student’s familiarity with the pre-existing data set is an advantage for the dissertation 
research.  In addition, the current research questions and conceptual framework fit well 
with data collected in the parent study, the BCEI. 
 
 Mixed Methods: Mixed method design includes both quantitative and qualitative 
methods in the research design and in data analysis.197-199  Using mixed methods can be 
used to answer different types of research questions in one study.197  It can also be used 
for a variety of research goals that include: developing instruments, explicating and 
validating constructs, generating hypothesis, illustrating, clarifying or amplifying 
analysis, understanding causal relationships and building, testing and refining theory.199   
Triangulation has also been associated with mixed methods however, Williamson200 
discusses triangulation as not being exclusive to mixing qualitative and quantitative 
methods, but with combining 2 of “something” such as 2 different studies using the 
same method or using 2 different researchers to collect and interpret data.  For this 
reason, the use of the word “triangulation” will be specifically avoided to limit confusion. 
Much of the discussion concerning the use of mixed methods centers around the 
possible incompatibility of paradigms each method is based in (see Table 5).201-205  
However, since the paradigm debate is not the purpose of this literature review, the 
controversy will be noted, but not discussed in detail.  Recognizing this debate, 
Giddings201 asserts that there is no need for methods (or researchers) to compete, but 
researchers need to integrate and carry out multi-methodological studies that meet their 
needs. Freshwater206 also supports mixed methods and states the goal is to find the best 
approach to answer the research question. 
 
 
Table 5: Differences between Quantitative and Qualitative Design207 
Assumption Quantitative (Positivist) Qualitative (Naturalistic) 
Ontologic (What is the 
nature of reality?) 
Reality exists.  Real world is driven by 
natural causes 
Reality is subjective and constructed by 
individuals 
Epistemologic (How is 
the researcher related to 
subjects?) 
The researcher is independent from those 
being researched 
The researcher interacts with research 
subjects.  Interactive process 
Axiologic (What is the 
role of values in inquiry?) 
Objectivity is the goal.  Values and biases 
are controlled 
Subjectivity is desired.  Values come into 
play 
Methodologic (How is 
the knowledge 
obtained?) 
-Deductive 
-Emphasizes discrete concepts 
 
-Results verify researchers “hunches” 
 
-Fixed, tightly controlled design 
-Emphasizes statistical analysis 
-Aims to generalize findings 
-Inductive 
-Emphasizes the entirety of a 
phenomenon 
 
-Results are grounded in subjects 
experiences 
 
-Flexible and context driven design 
-Emphasizes narrative information 
-Aims to find patterns in the data 
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Polit and Beck199 support the use of mixing methods for several reasons.  First: the 
mixed method approach is complementary in research because integrating multiple 
methods can overcome weaknesses of using a single research design.  Second: mixed 
methods may enhance theoretical insights given that qualitative and quantitative 
methods reflect different ways of viewing the world.  Third: mixed methods may provide 
an incremental approach in the research process in which  
feedback loops are used to create a body of evidence.  Fourth: mixed methods may 
enhance validity of study findings.  Cross validation can occur by using qualitative 
methods to confirm quantitative results.  Fifth: if results are incongruent, new research 
ideas and questions can emerge. 
Considerations for using mixed methods include: paradigm incompatibility, cost, 
researcher training, analytical challenges and publication biases.199  As discussed, 
researchers need to be aware of the paradigmatic differences between qualitative and 
quantitative research.  High cost and limited funding may prohibit the use of mixed 
methods.  Funding agencies may need to be educated on the benefits of this type of 
research.199  Finally, the researcher or research team should have expertise in both 
methods in order to be successful and be able to combine the data from both 
methods.197, 199  
Creswell and colleagues198, 208 acknowledge that using mixed methods is a rigorous 
undertaking and several methodological decisions need to be made.  Collecting the data 
is only the first step in using mixed methods.  Researchers need to state a logical reason 
for wanting to use multiple methods. In addition, researchers need to determine when 
to use these methods in their study: concurrently or sequentially. In a sequential 
approach, one method acts a basis for the next method of data collection or analysis.  In 
a concurrent approach, all data are collected at the same time and combined for results.  
When to integrate the data also needs to be decided. 
The use of mixed methods has already contributed to nursing research.  Ferrell and 
colleagues108-113, 121, 209 combined both quantitative and qualitative methods throughout 
the development of a series of Quality of Life Conceptual Models and empiric 
measurement tools to examine quality of life in numerous groups of cancer survivors.  
Cancer patients were asked about their experiences which led to the development of 
conceptual frameworks and quality of life measurement tools.  Subsequently, 
quantitative data was used to develop cancer specific conceptual models such as the 
Quality of Life- Breast Cancer conceptual model.  Their work continually validated and 
refined the content domains of both the models and empirical measurement tools. 
Rees and Bath210 also have used mixed methods to examine information sources for 
partners of women with breast cancer.  Subjects were interviewed; data was transcribed 
and interpreted by the researchers.  Subsequently, subjects were given surveys to 
complete; this quantitative data was then analyzed.  Their qualitative findings were 
supported by the quantitative data.  According to the researchers, the use of mixed 
methods created a “fuller picture” of the research topic than either method would have 
achieved on their own.  This study listed financial constraints as one of the limitations 
which prohibited the use of more than one researcher in the data analysis phase. 
Schulmeister and colleagues211 also used mixed methods to examine quality of life in 
patients receiving autologous stem cell transplant in an outpatient facility.  Telephone 
interviews were conducted and patients were asked to complete a QoL survey.  Results 
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showed that QoL initially decreased in these patients but rebounded to at least pre-
treatment levels at 6 months.  The researchers state that their use of mixed methods 
gave them a greater understanding of the patient’s treatment experience which could 
lead to appropriate individualized nursing interventions.  
According to Zebrack,104 in order to capture the true essence of QoL in an individual, 
using standardized quantitative instruments may not be enough. Methods that capture 
the subjective experience are also needed.  Powel and Clark212 also advocate for methods 
that enable patient experiences to be captured more thoroughly.  Allowing open ended 
questions allows patients to tell their story and presents a more complete picture of the 
experience for researchers.   
This dissertation will use mixed methods in order to capture issues that could not be 
captured on quantitative surveys.  It is expect that older women surviving with breast 
cancer also have other experiences that occur during this period of their lives that may 
affect their quality of life.  Qualitative analysis of field notes will aim to identify these 
experiences.   
 Summary: Using mixed methods in research provides several advantages.  Using 
both quantitative and qualitative methods may give a fuller picture of quality of life in 
older woman surviving with breast cancer. 
 
Literature Review Summary: This review of literature supports the urgency for 
research involving older women with cancer as our population ages and the number of 
breast cancer diagnoses in women is expected to dramatically increase.  It shows that 
women with breast cancer are a heterogeneous group and women of different ages have 
unique needs and concerns after being diagnosed with breast cancer that continue into 
survivorship and affect quality of life.  These differences are demonstrated in the often 
sparse or conflicting information related to older women surviving with breast cancer 
and the quality of their lives found in the literature.  This literature review also supports 
using secondary analysis for this dissertation and the benefit of using mixed methods in 
the research design.  Older women with breast cancer are not necessarily a more 
important group than others.  However, the paucity of research and empirically-based 
understanding of how to best meet the needs of this group make the topic and 
population a very important foci of study.51 
 
 
Preliminary Studies 
None 
 
 
Dissertation Research Design and Methods 
The overall purpose of this research is to examine quality of life in early stage breast 
cancer survivors, age 65 and older, who are within the first year of survivorship. This 
student’s dissertation research will use a descriptive design for analysis using mixed 
methods. Data will be drawn from a pre-existing data set, the Breast Cancer Education 
Intervention (BCEI) and will focus on the subset of older women (age 65 and older) 
surviving with breast cancer.  Please see the letter of permission from the BCEI Principal 
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Investigator (Appendix A).  The quantitative analysis of surveys and qualitative analysis 
of field notes will be used to answer the research questions.  Assumptions that will be 
the basis for this study stem from the literature review and include: 
1. Risk for breast cancer increases with age 
2. Older women may develop co-morbid illnesses as they age and cancer may not 
be their first illness  
3. Survivorship begins once a woman is diagnosed with cancer, however many 
people view “survivorship” as beginning after treatment  
4. The path from cancer screening to survivorship is variable in older women and 
this can impact quality of life in survivorship 
5. Survivorship is a complex time in which women with cancer may experience 
physical and psychosocial late effects from illness  
6. Women of different ages may have unique needs- older women are no 
exception 
7. Changes in well-being may constantly fluctuate depending on a woman’s 
current situation or experiences and this influences quality of life 
8. Older breast cancer survivors eventually adapt to having had breast cancer  
9. Quality of life related to having breast cancer influences quality of life of the 
aging woman which continues in survivorship 
 
 
The Parent Study- The Breast Cancer Education Intervention (BCEI): The 
parent study conducted by Dr. Karen Dow and colleagues established the effectiveness 
of the Breast Cancer Education Intervention (BCEI) in improving the QoL in early stage 
breast cancer survivors.213  This study used a randomized, two-group, longitudinal 
experimental design.  A total of 261 subjects enrolled and 256 completed the study. 
Subject Enrollment: Subjects were recruited through several means.  Most subjects were 
referred from local cancer centers and community oncology offices.  A small number of 
subjects were self-referred to the study.  A total of 261 women were enrolled into the 
study.  Four women in the experimental group withdrew from the study during the 
study intervention, one subject in the waiting control group died prior to receiving the 
intervention due to causes unrelated to the study.  Inclusion/Exclusion criteria: 
Eligibility was based on the following criteria: female age 21 or older; histologically 
confirmed early stage breast cancer (Stage 0-II) with no evidence of a second primary 
cancer or metastatic and recurrent disease; completion of treatment for their early stage 
breast cancer with the exception of hormonal treatments such as Tamoxifen or Arimidex 
and anti-HER2 therapy; live within 50 miles of their referring cancer center and be 
willing and able to participate in the BCEI.  Intervention description: Experimental 
subjects (EX) received 3 face to face Education and Support sessions, reinforcing 
written and audio materials followed by both telephone and face to face follow-up 
support sessions.  The Waiting Control (WC) group received 4 attention control 
telephone calls, 1 to 3 face to face Education and Support Sessions, reinforcing written 
and audio materials and 1 face to face follow-up support session.  The domains of 
interest for this study included overall quality of life, physical, psychological, social and 
spiritual well-being, mood and pain.  Sample characteristics:  The mean age was 54.4 
years (sd 11.58).  Eighty two percent of the subjects were Caucasian, 8.8% African-
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American/Black, 5.7% were Hispanic and 3.5 % were Asian, Middle Eastern or Native 
American.  English was the primary language (94.6%) followed by Spanish (3.8%).  The 
majority of subjects were either married or living with a partner (68.2%).  Sixty two 
percent were employed either full or part-time and 55% had an annual income of 
$50,000 or more.  47.5% were college educated.  60.5% of subjects received a 
lumpectomy, 69.3% received radiation therapy, 54% received combination 
chemotherapy, and 75.5% were on hormonal therapy.  No significant differences were 
noted between groups except the WC group had statistically higher college education 
(p<.05) compared to the EX group.   
 
Dissertation Aims and Research Questions 
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or 
older.  
Research Question #1.1:  What is the QoL of older breast cancer survivors at 
baseline? 
Research Question #1.2: How does QoL change over time? 
Research Question #1.3: How does QoL compare between groups over time? 
 
Aim #2: Describe quality of life within the domains of physical, psychological, social 
and spiritual well-being in female breast cancer survivors age 65 or older.  
Research Question 2.1:  What is the QoL of older breast cancer survivors within the 
domains of physical, psychological, social and spiritual well-being at baseline? 
Research Question # 2.2: How does QoL within these domains change over time? 
Research Question # 2.3: How does QoL with these domains compare between 
groups over time? 
 
Aim #3: Describe additional life experiences that may relate to quality of life in female 
breast cancer survivors age 65 and older. 
Research Question #3.1: Describe other life experiences of older breast cancer 
survivors as described by research nurses. 
Research Question #3.2: Describe the types of medication used by older breast 
cancer survivors age 65 and older.  
 
Conceptual Model and Framework 
  Conceptual models form a context for most studies, including those directed 
toward nursing.214  According to Polit and Beck214, conceptual models are more loosely 
constructed than theories but provide a “perspective regarding interrelated 
phenomenon” (p.116)  A conceptual model presents a “broad understanding of the 
phenomenon of interest and reflects the assumptions and philosophic views of the 
model’s designer (p.116).  Conceptual models are often accompanied by a visual 
framework to illustrate the conceptual linkages.  Fawcett215 states that the distinction 
between a theory and a conceptual model is the level of abstraction.  Conceptual models 
are more abstract than a theory.  Conceptual models also provide general guidelines for 
researchers to follow.  A model specifies a phenomenon by “identifying relevant 
concepts and by describing the connections among them” (p.88).  In addition, 
conceptual models can evolve either intuitively or deductively. 
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The Conceptual Model of Quality of Life in Aging Breast Cancer Survivors (see 
below) is intuitively developed and based on the experience of the investigator and the 
Quality of Life Model in Breast Cancer Survivors developed by Ferrell and colleagues.  
The new model maintains that quality  
of life is a personal sense of wellbeing which encompasses physical, psychological, social 
and spiritual dimensions.108-110  The literature review for this dissertation and the 
investigator’s own clinical and research experiences form the basis for the assumptions 
for this conceptual model. 
 
QoL in 
survivorship
Older
Woman
Breast 
Cancer 
Aging
Psych.
Well being
Physical
Well being
Social 
Well being
Spiritual
Well being
Conceptual Model of Quality of Life in Aging Breast Cancer Survivors
 
 
When an older woman is diagnosed with breast cancer several things influence how 
they will perceive their quality of life in survivorship.  This includes both aging and the 
domains of physical, psychological, social and spiritual well being. Changes in the 
domains of well being may occur and continue to influence quality of life in 
survivorship.   
 
The assumptions for this model include:  
1. Quality of life is multi-dimensional, subjective and dynamic  
2. The domains of quality of life are interactive with each other and one concept 
within a domain often influences another domain 
3. Aging influences perception of quality of life in survivorship 
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4. Perception of physical, psychological, social and spiritual well-being influences 
QoL in survivorship 
 
Although Ferrell and colleagues have defined and described the domains of physical, 
psychological, social and spiritual well-being in their conceptual model, this new model 
of Quality of Life in Aging Breast Cancer Survivors does not include the concepts within 
each domain.  For example, the physical domain includes concepts of fertility and 
menstrual issues which may not affect older women with breast cancer.  It is unclear if 
the concepts within the domains of well-being set forth by Ferrell and colleagues apply 
to an older population of women surviving with breast cancer.   
 
Sample Size 
 This dissertation 
research will be 
conducted using a pre-
existing data set to study 
a specific population of 
older women surviving 
with breast cancer.  The 
original BCEI obtained a 
sample of 261 women who were randomly selected to be in an Experimental (EX) group 
or a Wait Control (WC) group.  Randomization was paired and 129 women were placed 
in the EX group and 132 in the WC group.  For example, when one woman was placed in 
the EX group- her “pair” was automatically assigned to the WC group.  The groups are 
not exactly equal because women were randomized primarily due to age and race and 
sampling was not purposeful in order to achieve the same number of women for age or 
racial groups.  Women over the age of 65 were included in the randomization process 
and will become the sample of “older women” for this dissertation resulting in a 
convenience sample of 50 older women consisting of 24 EX subjects and 26 Wait 
Control subjects.  None of the women lived in a nursing home, all were community 
dwelling. 
 Effect size was calculated during data analysis of the BCEI and indicated a small 
effect at both 3 and 6 months of the study (See Table 6).213 
Data Collection Procedures   
 This dissertation will use the data set of the BCEI experimental research study.  
The Principal Investigator (PI) for the BCEI was contacted about sharing the data 
collected during the BCEI.  After discussion concerning the importance/relevance of 
studying the sub-population of older women- women age 65 and older (n=50) with 
breast cancer, the PI consented to share the de-identified data pertaining to women age 
65 and older with this doctoral student. This student was involved in the BCEI as the 
Project Director and has first hand knowledge concerning data collection, entry and 
cleaning.  
Data was collected during face to face and telephone interviews using a paper and 
pencil format. Subjects recorded their own answers on the surveys.  Research Nurses 
and an Administrative Assistant double checked all forms for missing data prior to data 
entry.  If missing items were identified, the subject was immediately contacted for the 
Table 6: Effect Sizes for Overall QoL, Physical, Psychological, Social, and 
Spiritual well-being213 
 3rd Month-baseline 6th Month-baseline 
 WC EX Effect 
Size 
WC EX Effect 
Size 
Overall QoL 
mean 
s.d. 
 
0.042 
0.752 
 
-0.309 
 0.834 
0.313  
-0.162 
0.765 
 
-0.405 
 0.879 
0.209 
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information. All raw collected data was kept in a locked file cabinet in the UCF BCEI 
research office.    
Data was entered into SPSS v11 and v12 by graduate research assistants as the data 
became available. Several of the surveys (Demographics, POMS, BPI, QoL-BC) were 
double-checked for accuracy by another research assistant who did not do the original 
entry.  Initial data check included checking 25% of the data.  This number was adjusted 
based on the findings.  If an unacceptable number of errors were found, an additional 
percentage of the sample was checked for errors.  If the error rate was acceptable, fewer 
subjects were double-checked. Initially a data accuracy threshold was set at 95% 
however, due to the volume of data points per patient this could have resulted in 
accepting an unacceptable high number of actual errors.  The criterion for accuracy was 
subsequently changed to 99%.216 
Due to the complexity and clinical interpretation needed for some forms such as the 
BCEI Finances Form, a Research Nurse completed 100% data-checks on this dataset 
and completed the primary data entry for questions which involved qualitative answers 
concerning current medications and out of pocket costs for those medications.  Another 
RN subsequently double-checked this data as well.  Overall, data was found to be over 
0.99% accurate. 
Data cleaning took place once all data was collected and entered. Initially, the data 
files were constructed by a designee of the study statistician.  These files were not 
descriptively labeled and were recoded during the initial data cleaning stage so variables 
represented the questions being asked of the subjects.  Data consists mostly of discrete, 
categorical and dichotomous variables.  Descriptive frequencies were run on all data 
files to find missing data, outliers and problematic data.  Only .02% of the data was 
missing.  Outliers and extreme values exist on some surveys which asked for qualitative 
data such as current medications and cost of the medications.  Extreme cost-related 
values were noted on the BCEI Finances Form however this data is not needed for this 
dissertation.  Nonsensical data was noted and corrected by referencing the original raw 
data. 
Data files were labeled according to the data collection instruments used.  Large data 
sets were separated into subscales so each subscale has its own data file.  For example, 
The Quality of Life- Breast Cancer instrument was divided into 4 files according to the 
subscales of physical, psychological, social and spiritual well-being.  10 quantitative files 
will be used and are listed as follows:  Demographics (1), POMS (1), BPI (1), QOL-BR 
(4), and BCEI Finances Form (3).   
Field notes written by the research nurses will also be used in data analysis but were 
not part of the initial data cleaning process. 
 
Data Collection Instruments (see Appendix B) 
BCEI Demographics Tool: Demographic information is important to describe the 
sample.  Information concerning age, religion, marital status, income, occupation, and 
treatment variables were collected. 
  The BCEI Demographic Tool has 17 items that include both closed (n=14) and open 
(n=3) ended questions.  Several closed ended questions also include an opportunity for 
an “other” answer in which subjects could state an answer if none of the given answers 
were acceptable.  This was included in items asking about ethnicity, primary language, 
 140 
religious affiliation, specific chemotherapy, hormonal and fatigue related drugs.  Open 
ended questions were for age, occupation and describing other cancers the subject may 
have had in the past. 
Profile of Mood States-Short Form: The Profile of Mood States- Short Form 
(POMS-SF) was used in the BCEI to measure mood disturbance. The POMS- SF 
contains 37 items and asks subjects to rate how certain descriptive words such as 
“fatigued”, “hopeless”, and “furious” describe them at the present time.  Subjects were 
asked to think about the past week (present time) and state if the given descriptive 
words describes them on a scale of “0- not at all” to “4- extremely well”.   
Both the original Profile of Mood States (POMS) and the POMS-SF have been used 
in cancer patients.  Normative data for both forms has been reported.217-222  The POMS 
was developed by McNair and colleagues220 to identify and measure transient and 
fluctuating mood states.  The POMS has been translated into several languages and is 
used in multiple populations.  There are six factorially-derived mood states. These 
include: tension-anxiety; depression-dejection; anger-hostility; vigor-activity; fatigue-
inertia; and confusion-bewilderment.  Normative data for the original POMS was based 
on 235 normal college students and 1000 outpatient psychiatric patients.220 No further 
information is available. Internal consistencies for this scale range from .84 to .95 
among the 6 factors.  Test-retest reliability ranged from .65 to .74 among the 6 factors.  
Concurrent validity was supported by comparisons with normative samples for the 
MMPI-2 and the Hopkins Symptom Distress Scale. 
Cassileth and colleagues218 used family members of cancer patients as the normative 
sample in their study.  Although total scores for the POMS can range from -32 to +200, 
scores can be reported as mean scores.  Higher scores mean greater disturbance in 
mood.  In these samples, mean scores for patients were 20.1 and mean scores for family 
members was 14.5.  The researcher’s state that this contrasts sharply with the norms 
reported by McNair in the POMS manual in which mean scores of college students were 
43.3 and mean scores for psychiatric patients was 77.5.  These researchers believe it is 
important to evaluate cancer patients against more normative norms such as general 
populations instead of extreme populations. 
A short form (POMS-SF) was developed by Shacham221 and norm referenced in 
cancer patients with pain.  The short form contains 37 items. Each of the original 
subscales was shortened by 2 to 7 items and internal consistency was retained.  
Cronbach’s alphas ranged from 0.80 to 0.91 for the subscales on the new short form.  
The short form also had high correlation to the original form (all reliability coefficients 
above r=.95). 
Baker and colleagues217 also psychometrically evaluated the POMS-SF in 428 cancer 
patients waiting for bone marrow transplantation. Reliability analysis showed 
Cronbach’s alpha of .78 to .91 among the 6 subscales.217 This compared favorably to the 
Cronbach’s alpha’s reported by Shacham (.80 to .91 among the 6 subscales). Convergent 
and discriminate validity was also shown through patterns of correlations between the 
subscales and other well known measures such as the CES-D. Confirmatory factor 
analysis supported the 6 factors for the POMS items. 217  These researchers concluded 
the POMS-SF developed by Shacham was an acceptable alternative to the original 65 
item form. 
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DiLorenzo and colleagues219 compared the POMS and the POMS-SF in a sample of 
breast cancer patient undergoing chemotherapy compared to a group of healthy women.  
Again, the POMS-SF highly correlated to the full-length POMS (range: r= .93 to .99).  In 
addition internal consistency was similar to the full-length POMS for both the breast 
cancer and healthy groups.  Cronbach’s alpha’s ranged from .73 to .97 in the healthy 
group and from .62 to .93 in the breast cancer group. 
Finally, the POMS-SF was used in the BCEI and the Cronbach’s alpha ranged 
between 0.95 and 0.99 for this scale213 (see Table 7). 
The POMS is a very easy form to complete.  One limitation is that subjects may not 
be familiar with all the descriptive words they are asked to describe themselves with.  
Words such as “peeved” and “weary” may be difficult to score if subjects do not know 
how to define these words in order to determine if they describe how they are feeling.223 
BCEI Brief Pain Inventory: Pain was measured in the BCEI using a modified 
version of the Brief Pain Inventory (BPI).  The BPI is a well established pain measure 
(originally known as the Wisconsin Brief Pain Questionnaire) that evaluates the 
intensity of pain and how it interferes in the life of the person experiencing it.  Pain 
relief is also addressed. The patient is asked to think about the last 24 hours when 
answering the questions. The 14 items used in the BCEI asks subjects if they are 
currently having pain related to their cancer (yes/no), the intensity of the pain (0-10 
scale), treatments/medications they currently take for their pain and how pain 
interfered with everyday activities such as walking, enjoyment of life, and everyday 
activities (0-no interference, 10-extreme interference).  Demographic questions and 
diagrams for describing pain were eliminated in the modified version. Questions that 
asked patients to “check” adjectives to describe their pain and reasons for pain were also 
eliminated 
The original BPI was specifically designed for use in people with cancer and other 
diseases. The original survey has 23 items.224  Reliability was assessed using test-retest 
with 2 samples.  Reliability was higher when the interval between completing the 
surveys was short (range of r= 0.59 to 0.93).  Validity was supported by correlating the 
amount of medications taken to higher pain ratings.225  
The BPI has been used to address pain specifically in breast cancer survivors after 
surgery226 and in other patients with cancer pain.227-229  Tittle and colleagues229 
validated the BPI for use with surgical patients with cancer.  In a mixed sample of 
surgical and medical patients (n-388), the BPI correlated with the Visual Analogue Scale 
for both populations (range r=0.71 to 0.73). Alpha coefficients for reliability were high 
for both groups (r= 0.95 for medical group and r= 0.97 for the surgical group.229 
  The BPI has good test-retest reliability over short intervals.224 Cleeland states that 
using the BPI may reduce response bias,224 however, bias may occur in samples of older 
women because older women may not want to “complain” about their pain for fear of 
being prescribed pain medication. 
The Cronbach’s alpha for subjects using this form in the BCEI was -0.85 to 0.95213 
(see Table 7). 
A limitation to using the modified BPI with an older sample of women with breast 
cancer is that the questionnaire is specific to cancer pain and does not allow the woman 
to identify the source of pain.  Many older women may experience pain for reasons other 
than cancer.  This could not be captured on the modified BPI.223   
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Quality of Life- Breast Cancer: The Quality of Life Instrument- Breast Cancer 
(QoL-BC) version is a 50 item scale that specifically measures quality of life in women 
with breast cancer based on a conceptual model of quality of life in breast cancer 
survivors using the domains of physical, psychological, social and spiritual well-being.108 
It was adapted from the Quality of Life-Cancer Survivors (QoL-CS) scale. Subjects are 
asked to use a scale from 0 to 10 to describe current problems and levels of distress 
within the domains of quality of life.    For example: “To what extent is fatigue a problem 
for you?”  0=no problem, 10= severe problem, and “How much anxiety do you have?”          
0= none at all, 10= a great deal.  Questions also address having hope and perception of 
positive changes due to cancer. Patient were asked to think about the last week or so 
(the present time) before answering. 
Reliability was established on the original QoL-CS using test-retest and internal 
consistency measures.  Test-retest reliability was r=0.89.  Overall reliability was 
established with a Cronbach’s alpha of 0.93.  Alpha coefficients for the subscales were 
acceptable at: physical well-being 0.77, psychological well-being 0.89, Social well-being 
0.81 and spiritual well-being 0.71.108  
Reliability for the QoL-BC scale was established in the BCEI. Cronbach’s alpha’s 
were 0.99 for overall QoL, 0.99 for physical subscale, 0.93 to 0.99 for psychological 
subscale, 0.71 to 0.99 for social subscale and 0.70 to 0.99 for the spiritual subscale213 
(see Table 7). 
 Content validity was supported by using expert nurses and quality of life 
researchers to review the tool.  Pearson’s correlations were also used to gauge the tool 
compared to the already established FACT-G tool.  Correlation was high in the subscales 
for physical, psychological and social well being.108  
 One limitation to this form is that although it has been successfully used in 
populations that include older women, it is uncertain to what extent the components of 
each domain (physical, psychological, social and spiritual) represent concerns of older 
(over age 65) women with breast cancer.  Domains such as physical functioning are not 
represented in this measurement and issues such as fertility and menstrual changes may 
not apply. 
 Another limitation to the tool is that some questions ask about change, but do not 
ask if the item has changed for the better or worse.  For example, one question asks 
“How much has your spiritual life changes as a result of your diagnosis?” and asks the 
subject to rate from 0= no change to 10= a great deal.  Another questions asks “Has your 
illness or treatment caused changes in your self concept (the way you see yourself)?” but 
again does not allow the subject to state if these changes were positive or negative.223 
BCEI Finances Form: A Finances Form, based on a measurement by Given, Given 
and Stommel,230 focuses on the financial burden of the woman with cancer and her 
family due to cancer related expenses.  Forty four questions ask subjects to report 
information on insurance, time off from work, out of pocket costs for breast cancer 
related expenses are collected and actions such as selling a house or filing for 
bankruptcy they have had to do in order to cover breast cancer related expenses.  
Information concerning out of pocket costs for prescription and over the counter 
medications is also collected. Subjects are asked first to answer questions based on their 
expenses since diagnosis, but in M3 and M6, they are asked only to report new expenses 
and experiences. 
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  In the 1994 study by Given, Given and Stommel230, family and patient out of pocket 
costs are evaluated for women with breast cancer.  Either patients or caregivers of 
deceased patients were interviewed.  Patients and family members were asked to report 
expenses that were non-reimbursable for the 3 months prior to the interview.  In 
addition, family labor costs based on the number of hours caregivers spent giving care 
were calculated.  Researchers then estimated the cost of care. 
No evidence of psychometric evaluation, reliability or validity can be found in the 
literature. This information seems to have been garnered from interviews and an 
original survey instrument for reporting finances does not seem to exist. The reliability 
measures for the BCEI Finances Form ranged from Cronbach’s alpha .45 to .86213 (see 
Table 7). 
  
Limitations to this tool 
used in the BCEI exist.  
This tool requires recall of 
dollar amounts for specific 
items which may be 
difficult to remember.  In 
the parent study, many 
women had difficulty 
estimating the amount of 
money spent per month on 
breast cancer related costs.  
Reasons for poor recall 
included buying 
medications in bulk or 
infrequently, using credit 
cards, ordering by mail or 
having husbands who 
tended the finances. In future studies, this information could be captured differently.  If 
determining financial burden and not actual out of pocket costs is the goal, the form can 
be simplified to replace the reporting of out of pocket costs for each breast cancer 
related item with subjective questions regarding the subjects perception of overall 
financial burden.  An estimation of out of pocket costs can also be garnered by asking for 
a “ballpark” figure as opposed to exact amounts.223 
 
Data Management and Integrity  
 Once this study gains IRB approval, this doctoral student will obtain de-identified 
data from the Principal Investigator.  De-identified data is data that is anonymous and 
does not contain information that can identify a subject.  This is important to maintain 
the privacy of the subjects in the BCEI.  This de-identified data will include SPSS files 
for the Demographic, POMS-SF, BPI, QoL-BC and BCEI Finances Form surveys and 
field notes in the form of Word documents/files.  A copy of the SPSS data files will be 
downloaded onto single read-only CDs so data can not be overwritten.  Data will then be 
transferred and stored on the student’s home computer and the “master copy” will be 
placed in a fire-proof safe in the student’s home.  Data analysis will take place only on 
Table 7: Reliability Measurement for BCEI tools213 
Variables Measurement Tool Cronbach’s 
Alpha  
Overall Quality of Life QoL-BC total score .93 
Physical Well-being QoL-BC  Physical 
subscale score 
.99 
Psychological Well-being QoL-BC  Psych  subscale .93-.99 
Social Well-Being QoL-BC  Social subscale 
items 
.71-.99 
Spiritual Well-Being 
 
QoL-BC Spiritual subscale 
 
.70-.99 
   
Psychological distress POMS .95-.99 
   
Pain BPI .-85-.91 
   
Finances/ 
Medications 
Work, Finances, 
Insurance Tool 
.45-.86 
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the student’s computer.  A back-up copy of the working SPSS files will be placed on a 
portable “jump” drive and stored in the fire-proof safe.  Password protected files will 
also be used. 
Field notes in the form of Word documents will also be copied and placed on read-
only CD’s.  These files will be downloaded onto the student’s home computer for 
analysis in Ethnograph- a qualitative software program.  Back-up copies of the working 
files will also be kept on a portable jump drive and stored in a fire-proof safe. 
Files will be backed-up each time a new file is created or a current file altered. 
 
 
 
 
 
Data Analysis Plan 
 
The overall purpose of this research is to examine quality of life in a group of early 
stage breast cancer survivors, age 65 and older, who have recently completed treatment 
for their cancer.  This student’s dissertation research will use a descriptive design for 
analysis using mixed methods. Data will be drawn from a pre-existing data set, the 
Breast Cancer Education Intervention (BCEI) and will focus on the subset of older 
women (age 65 and older) with early stage breast cancer.  Quantitative analysis of 
surveys and qualitative descriptive and content analysis of field notes will be used to 
answer the research questions.  The main research variables are listed in Table 8. 
 
Pre-analysis data screening: 
Data will be screening to assess 
accuracy, missing data, outliers, 
and assumptions of fit 
(normality, linearity and 
homoscedasticity). 
 Data accuracy, missing 
data and outliers:  Data will be 
examined using descriptive 
statistics.  Frequencies will be run 
on all                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
variables to evaluate 
completeness of the data.  The 
original BCEI reported a missing data rate of 0.2%, so missing data is not expected to be 
an issue.  Outliers are also not expected to be an issue since the surveys used had very 
few open ended questions or those questions that contained open ended answers such 
as financial data are not included in the research questions and will not be considered 
for data analysis. 
 Assumptions of fit: Data will be explored to consider normality, linearity and 
homoscedasticity.  Descriptive statistics will be run.  Normality will be examined using 
histograms, normality plots and the Kolmogorov-Smirnov test.  Homoscedasticity 
Table 8: Main Research Variables and Data Source 
Main Research Variables Data Source 
Overall QoL QoL- BC 
Physical Well-being  QoL- BC subscale 
Fatigue  POMS subscale 
Pain BPI 
Psychological Well-being  QoL- BC subscale 
Psychological Distress POMS subscale 
Social Well-being  QoL- BC subscale 
Spiritual Well-being  QoL- BC subscale 
Current Life Experiences Field Notes 
Medications BCEI Finance Form 
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(homogeneity of variance) will be evaluated when comparing groups using Levene’s test 
for equal variances. 
Reliability analysis:  Reliability of the measures used in this sample of older women 
with breast cancer will be evaluated using Cronbach’s alpha.  Cronbach’s alpha is a 
measure of internal consistency and indicates if an instrument is measuring one or more 
traits.  The range for this measure is between .00 and 1.00 with higher scores indicating 
higher internal consistency.231   SPSS software will be used to calculate Cronbach’s 
alpha.  Each instrument will be assessed as a whole for internal consistency.  
Additionally, tools such as the QoL-BC tool will be assessed for consistency within each 
subscale. 
Power Analysis: The power of a statistical test indicated the “probability that it will 
yield statistically significant results (p.1).232    Power analysis is a method to reduce the 
risk and estimate the occurrence of Type II errors (accepting a false null hypothesis).  
The 4 components of power analysis are: 1) significance criterion (α); 2) the sample size; 
effect size (γ) and power (1-β).233   For this dissertation, several of these components are 
known.  The significance criteria which signifies the probability of rejecting a true null 
hypothesis (Type I error) is set at α = 0.05.  This means that in a sample of 100, the null 
hypothesis would be rejected 5 times when it is true.   The sample size is N=50, with 
Ex= 24 and WC = 26.  Although an effect size can not be calculated for this dissertation 
at this time, the effect size for the BCEI was .313 at 3 months.   It is expected that the 
effect size for the sample of older women used in this dissertation study will be different 
from that found in the BCEI.  Since a premise of this study is that women of different 
ages have unique needs, the probable difference in effect size may be due to the overall 
samples used in each study.  The BCEI had a large sample consisting of 261 women ages 
28 to 83.  This dissertation will focus on a specific subset of women (N=50) ages 65 to 
83.  The effect size is likely to change based on the overall differences inherent to each 
sample which may include perception of quality of life and report of symptoms.  Older 
women (age 65 and older) are likely to be different from younger women or a sample of 
women who average age is approximately 54 years old.  Once an effect size for the 
dissertation study can be calculated, a power analysis will be conducted during the data 
analysis phase of the proposed research. 
 
Data analysis of specific research questions: Analysis of the research questions 
will be conducted using parametric and non-parametric statistics (See Table 9). 
Demographics: Demographics contain nominal data and will be evaluated using 
descriptive statistics and frequencies for the overall sample and the 2 groups (EX and 
WC).  Comparisons between the EX group and WC group will be done using Chi Square 
test. 
Research Questions:  The measurement tools contain both ordinal and interval data. 
 
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or 
older.  
Research Question #1.1:  What is the QoL of older breast cancer survivors at 
baseline? 
Research Question #1.2: How does QoL change over time? 
Research Question #1.3: How does QoL compare between groups over time? 
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1.1 The goal of this research question is to describe how older women with breast 
cancer report their quality of life after being treated for early stage breast cancer.  
The global measure of QoL contained in the QOL-BC tool will be averaged (mean 
score) at M1 to determine overall QoL for the sample.  Score range will also be 
determined.   
1.2 This research question will describe how overall QoL changes over time.  The 
entire sample will be examined as a group and QoL scores at M3 and M6 will be 
compared to baseline.  Paired t- tests will be used to compare baseline QoL 
scores to QoL scores at M3 and M6.  If needed, non-parametric statistics may be 
used such as the Wilcoxon signed-rank test. 
1.3 This research question will describe how overall QoL compares between a group 
who received an intervention (EX) and a group who did not (WC).  Repeated 
Measure Analysis of Variance (RM-ANOVA) will be used to determine group 
differences over time (M3 and M6).  If needed, non-parametric tests such as the 
Kruskal-Wallis test will be used. 
 
Aim #2: Describe quality of life within the domains of physical, psychological, social 
and spiritual well-being in female breast cancer survivors age 65 or older.  
Research Question 2.1:  What is the QoL of older breast cancer survivors within the 
domains of physical, psychological, social and spiritual well-being at baseline? 
Research Question # 2.2: How does QoL within these domains change over time? 
Research Question # 2.3: How does QoL within these domains compare between 
groups over time? 
 
2.1 The goal of this research question is to determine how older women with breast 
cancer report their QoL within the domains of the quality of life at M1.  Scores for 
each item in each subscale in the QoL-BC will be calculated as an average (mean 
score).  The scores within each subscale will then be added to make a total 
subscale score.  Ranges will also be computed.  In addition, within each subscale, 
items will be ranked according to level of concern (high to low concern).   
2.2 This research question will describe changes in the subscale scores within the 
entire sample over time.  Subscale scores within the entire sample at M3 and M6 
will be compared to baseline subscale scores.  Paired t-tests will be used.  If 
needed, non-parametric statistics such as the Wilcoxon signed-rank test will be 
used. 
2.3 This research question will describe how changes in subscale scores compare 
between 2 groups (EX vs. WC) over time (M3 and M6).  RM-ANOVA will be used 
to determine group differences over time. If needed, non-parametric tests such as 
the Kruskal-Wallis test will be used. 
 
Aim #3: Describe additional life experiences that may relate to quality of life in female 
breast cancer survivors age 65 and older. 
Research Question #3.1: Describe other life experiences of older breast cancer 
survivors as described by research nurses. 
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Research Question #3.2: Describe the types of medication used by older breast 
cancer survivors age 65 and older.  
 
3.1 The goal of this research question is to describe other life experiences of older 
breast cancer survivors as they related to quality of life.  Data will be obtained 
from field notes documented by research nurses throughout the duration of the 
study.   
3.2 The goal of this research question to describe the types of medication used by 
older breast cancer survivors age 65 and older.  Data will be obtained from the 
BCEI Finances Form.  Frequencies will be used to describe this data. 
 
Qualitative Data Analysis Procedure:  The goals of the research questions 
presented in Aim #3 are largely descriptive.  As posed, the questions do not lend 
themselves to one of the well-known methods of qualitative analysis such as 
phenomenology, grounded theory or ethnography.  During this analysis there will be no 
attempt to determine the lived experience of older women with breast cancer, provide a 
holistic view of that population’s culture or determine the social processes within a 
social setting.  Instead, this dissertation will use qualitative description234, 235  and 
qualitative content analysis is used to discover themes in the research nurses field 
notes.236, 237   Qualitative description is used when straight description of a phenomenon 
is desired.235 One characteristic of using qualitative description is that it is a low-
inference procedure meaning the “facts” are presented in everyday language as opposed 
to other methods such as phenomenology, ethnography or grounded theory that present 
or interpret events in other terms.235   
Process for content analysis of field notes: Qualitative content analysis of field notes 
will be based on a systematic process set forth by Schilling238 in which there are 5 levels 
of analysis that include turning transcripts into raw data, condensing records, 
developing a preliminary category system, formally defining the categories and 
analyzing and interpreting data.  Due to the nature of the field notes as being a second 
hand account (nurse observations) of patient experiences, the steps will be modified. 
The following describes the process for analyzing the field notes for this dissertation:  
1) Field notes will be entered into Ethnograph and used as raw qualitative data. 
2) Data will be read thoroughly prior to coding.  Since the field notes are not a 
traditional narrative (in the subjects own words) and are expected to be brief, data will 
not be further reduced.  
3) Themes or events will be generated from the data and codes will be applied that 
describe the theme using language closely reflecting the language used by the nurses in 
the field notes. For example, if the nurse observed and noted that the patient was 
concerned with an ill family member, recently experienced the death of their spouse, or 
was worried over a follow-up appointment, the codes used to describe the experience 
will specifically state the event i.e., “concerned with husband’s illness”, “spouse recently 
died”, or “worried about follow-up mammogram.”  Codes and themes will reflect the 
actual event or experience noted by the research nurse in the field note. 
4)  Categories will be developed and defined and the previously used codes will be 
placed in these categories.  For example, a several subjects may be worried about the 
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health of family members; hence, the overall category may be “worried about the health 
of family member.” 
5) These themes and categories will be used describe other life experiences that may 
relate to quality of life in older breast cancer survivors. 
Consistent with basic content analysis, reliability will be verified by either a fellow 
doctoral student who is naive to the data or a member of the dissertation committee.   
The procedure for reliability is to 1) review 5 field notes, 2) compare the themes and 
codes identified by the doctoral researcher with the actual field notes. 
 
 
Study Limitations  
Several limitations exist for this dissertation research.   
Secondary Analysis: The primary limitation of this dissertation is that the data set 
was originally intended for different research questions.  However, a strength of this 
dissertation research is that the data set “fits” the current set of research questions and 
the overall conceptual framework used in the BCEI is suitable for examining quality of 
life in older breast cancer survivors.   
Additionally, using a preexisting data set may cause a researcher to question the 
integrity and quality of the data.  Fortunately, this student is very familiar with data set 
and was involved in data management and cleaning procedures.  The student is 
confident that the data set is sound and few instances of missing data exist.   
Sample Size: This dissertation will be using a subset of a larger population of early 
stage breast cancer survivors.  The sample of women age 65 and older is small.  Data 
from 50 older women will be analyzed and statistical significance is not guaranteed.  
However, both parametric and non-parametric statistical procedures are available and 
worked into the data analysis plan to provide the most rigorous data analysis possible 
with the limited sample size. 
Reliability of Measurements: While the tools used in the original study (BCEI) have 
been used in populations with breast cancer, their reliability specifically in older women 
has not been reported.  For example, the Quality of Life- Breast Cancer instrument has 
not been used specifically in a population of older women and it is uncertain if the items 
TABLE 9: Summary of Data Analysis Plan 
Research 
Questions 
Goals Analysis Method 
1.1  Within group- Overall QoL score Means 
1.2  Within group changes- Overall QoL score Paired T-tests/ Wilcoxon signed 
rank test 
1.3  Between group changes- Overall QoL score RM-ANOVA/ Kruskal-Wallis test 
2.1  Within group- QoL subscale score 
 Within group- Item scores within subscales 
Means 
Means 
2.2  Within group changes- QoL subscale scores Paired T-tests/ Wilcoxon signed 
rank test 
2.3  Between group changes- QoL subscale scores RM-ANOVA/ Kruskal-Wallis test 
3.1  Within group- Current life experiences Qualitative Content Analysis 
3.2  Within group- Medications Means 
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contained within each domain is relevant to a population of older women surviving with 
breast cancer. 
In addition, the content of the field notes taken by the Research Nurses during the 
BCEI is unknown.  These notes have not been examined prior to this study.  These notes 
were originally written to document face to face visits and telephone calls between 
nurses and subjects.  Notes were also used to document specific issues subjects were 
encountering and interventions suggested by the Research Nurses during the course of 
the study.  The contents of these notes may vary in quality and usability. 
Generalizability: The results of this research will not generalizable outside of the 
setting in which it was collected.  However, it is hoped that this research will foster new 
research questions concerning older women with breast cancer and lead to intervention 
testing in future research endeavors.  
 
Summary of Research Design and Methods 
The overall purpose of this research is to examine quality of life in women with early 
stage breast cancer who are age 65 and older and are within the first year of 
survivorship. This student’s dissertation research will use a descriptive design for 
analysis using mixed methods.  Parametric and non-parametric statistical tests will 
examine QoL in this sample of older women surviving with breast cancer. Thematic 
analysis of field notes will investigate additional life experiences experienced by older 
breast cancer survivors. 
 
Timetable- (See Table 10) 
 
TABLE 10: Projected Timetable for Dissertation Completion 
August 2006  Prepare research protocol 
Sept 2006  Defend Dissertation Proposal 
October 2006  Submit to UCF IRB 
November 2006  Begin data analysis 
December 2006  Complete data analysis  
January 2007  Begin writing of results, findings, conclusions 
 Elicit dates for dissertation defense from committee 
 Request Dissertation Defense date no later than March 2nd 
February 2007  Continue writing of results, findings, conclusions 
 Begin development of papers for publication 
March 2007  Complete dissertation within parameters of UCF Dissertation 
guidelines 
 Write abstracts of 3 papers for publication and submit to 
journal editors 
 Complete writing of results, findings, conclusion 
April 2007  Defend Dissertation no later than April 6 
 Complete changes and modifications requested by 
Dissertation Committee 
 Submit hard copies to dissertation committee 
 Complete all final reports required by SON and UCF 
May 2007  Graduation 
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Human Subjects Research 
Protection of Human Subjects  
Approval for this dissertation research will be obtained from the University of 
Central Florida Institutional Review Board (IRB) prior to the start of any research 
activities. 
Potential risks 
No risk to the subject can be predicted at this time.  This dissertation research will 
use de-identified quantitative and qualitative data. 
Protection against risks 
Not Applicable 
Importance of knowledge to be gained 
This dissertation research is important because little is known about quality of life in 
older breast cancer survivors.  Although the sample for this study is small, it may help 
clarify some of the ambiguity concerning older women with breast cancer found in the 
literature.  The results of this research are expected to contribute to the limited 
knowledge concerning older breast cancer survivors to gain a better understanding of 
this population and their concerns and needs after being treated for early stage breast 
cancer. 
 
Inclusion of Women and Minorities 
Women are the focus of this research and minority women are included.  The parent 
study achieved an 18% minority participation rate. The sample of older women will also 
be examined for minority participation. 
Inclusion of Children 
No children under the age of 21 were included in the original BCEI. 
Data Safety and Monitoring Plan   
According to the NIH Policy for Data and Safety Monitoring240 a data safety and 
monitoring plan is needed for clinical trials (intervention studies) to ensure the safety of 
research participants as well as the integrity and validity of data in clinical trials 
supported by the NIH.  The data and monitoring safety board functions separately from 
the Institutional Review Board.  This dissertation will not employ a DSMB because of 
the inherent low risk to subjects involved in an analysis of pre-existing de-identified 
data.  There will be no recruitment of subjects, no opportunity for significant adverse 
events involving subjects and no patient contact.  In the event that an adverse event 
(AE) that had not been previously discovered in the BCEI is found, the Principal 
Investigator of the BCEI will be notified so the AE can be reported to the UCF IRB. 
 
Vertebrate Animals 
Not Applicable 
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Mar 2004 Paper Presentation. Dow, K. H., & Loerzel, V.W.  Changing recruitment strategies 
in longitudinal research.  12
th
 Annual Research Day: Spinning the Web: Nursing 
Theory, Research and Practice.  Sigma Theta Tau International, Theta Epsilon 
chapter. Orlando, FL. 
 
INVITED (NON-REFEREED) REGIONAL/STATE/LOCAL PAPERS: 
 
Nov 2006 Invited Speaker, Loerzel, V.W. ―Quality of life in older breast cancer survivors: A 
review of the literature.‖ Sigma Theta Tau, Theta Epsilon Chapter, Fall General 
Meeting, Orlando, FL. 
Dec 2005 Invited Speaker, Dow, K.H. & Loerzel, V.W. ―Quality of life interventions for 
breast cancer survivors: A collaborative effort.  M. D. Anderson Cancer Center 
Orlando, Oncology Grand Rounds, Orlando, FL. 
Oct 2005 Poster Presentation, Loerzel, V.W. & Dow, K.H. ―Lymphedema incidence in early 
stage breast cancer survivors: Secondary analysis from the BCEI.‖  Research 
Renewal and Roses, UCF SON Alumni Conference, Orlando, FL.   
1999-2002 Invited Speaker, ―Principles of patient and family education.‖  Orlando Regional 
Healthcare System, Oncology/Chemotherapy Symposium.  Orlando, FL 
Spring 2001 Invited Speaker, ―Current treatment options‖ First Connection Peer Volunteer 
Training.  Central Florida Chapter of the Leukemia and Lymphoma Society, 
Orlando, FL. 
2000-2002 Invited Speaker, ―Immediate side effects of chemotherapy.‖ Orlando Regional 
Healthcare, Chemotherapy Verification Program. Orlando, FL. 
2001-2002 Invited Speaker, ―Oncologic emergencies.‖ Orlando Regional Healthcare System. 
Orlando FL. 
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1998-2001 Invited Speaker, ―Learning about cancer: pathophysiology and diagnosis.‖ I Can 
Cope. American Cancer Society, Orlando, FL. 
Spring 2002 Invited Speaker, ―Blood cell transplantation.‖  The University of Central Florida. 
Medical Technologist Conference, Orlando, FL. 
May1999 Invited Speaker, ―Cancer surgery: An overview.‖  Orlando Regional Healthcare 
System.  Oncology/Chemotherapy Symposium.  Orlando, FL. 
Apr 1999 Invited Speaker, ―General cancer update.‖  Orlando Regional Healthcare System, 
55+ program, St. Cloud Hospital.  St. Cloud, FL.   
1998-1999  Community Presentation, ―Cancer prevention and early detection: A focus on breast 
self exam.‖ Orlando Regional Healthcare System.  Orlando, FL. 
Apr 1998 Invited Speaker, ―Cancer screening and early detection.‖  Orlando Regional 
Healthcare System, 55+ program, Orlando. FL. 
March 1998 Invited Speaker, ―Immediate side effects of chemotherapy.‖  Chemotherapy 
Symposium: Beyond the Basics.  Orlando Regional Healthcare System and M. D. 
Anderson Cancer Center Orlando. Orlando, FL. 
Feb 1998 Invited Speaker, ―Understanding cancer treatments.‖ I Can Cope.  M. D. Anderson 
Cancer Center Orlando and the American Cancer Society. Orlando, FL. 
Jan 1998 Invited Speaker.  ―Blood cell transplantation.‖ VNA Home Healthcare.  Orlando, 
FL. 
Nov 1997 Invited Speaker. ―Blood cell transplantation.‖ Oncology Nursing Grand Rounds, M. 
D. Anderson Cancer Center Orlando. Orlando, FL. 
July 1996 Invited Speaker, ―Oncologic emergencies.‖ Oncology Nursing Review.  Sponsored 
by the Cleveland Chapter of the Oncology Nursing Society and Cleveland State 
University.  Cleveland, OH.  
  
 
ACEDEMIC LECTURES AND TEACHING EXPERIENCE: 
 
 Courses: University of Central Florida, School of Nursing 
Spring 2007 Adjunct Instructor, Nursing Research/Critical Inquiry (NUR-3165 0W61) 
 
Fall 2006 Adjunct Instructor, Principles of Oncology Nursing (NUR-3795 0W91) 
Adjunct Instructor, Health Assessment Lab (NUR-3065L-0018) 
Adjunct Instructor, Health Assessment Lab (NUR-3065L-0019) 
 
Sum 2006 Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).   
 
Fall 2005            Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).   
 
Spring 2005 Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).   
 
Sum 2003 Adjunct Instructor, Health Assessment Lab (NUR-3065L) 
 
 
 
 Lectures: University of Central Florida, School of Nursing 
Fall 2006 Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for 
undergraduate students of acute nursing.   
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Spring 2006 Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for 
undergraduate students of acute nursing.   
 
Spring 2005 Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for 
undergraduate students of acute nursing.   
 
Nov 2004 Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for 
undergraduate students of acute nursing.   
 
2002-2003 Invited Speaker, ―Breast health assessment‖ Lecture for undergraduate students of 
nursing health assessment.   
 
   
 
VIII.  PROFESSIONAL ACTIVITIES & COMMUNITY SERVICE 
 
PROFESSIONAL ORGANIZATIONS/ MEMBERSHIP 
 
Year Organization 
1994 – Present Oncology Nursing Society 
1994-1996 Cleveland Chapter, Oncology Nursing Society  
1997 – Present Central Florida Chapter, Oncology Nursing Society  
1993 – Present Sigma Theta Tau International 
2002 – Present Theta Epsilon Chapter 
2002 – Present Southern Nursing Research Society 
1993,  
2004 – Present 
American Nurses Association and Florida Nurses Association 
2006 -- Present Doctoral Student Nursing Organization 
 
 
PROFESSIONAL SERVICE ACTIVITIES 
 
Oncology Nursing Society 
 
 
National Service 
 Oncology Nursing Certification Corporation 
2003 - 2007 Member, OCN® Test Development Committee 
2004 - 2007 ONCC Item Writing Mentor 
2002 ONCC Item Writing Workshop Participant 
 
 
 
 
Local/Regional Service 
 Oncology Nursing Society 
2007 Past-President, Central Florida Chapter 
2006 President, Central Florida Chapter 
 183 
2005 President-Elect, Central Florida Chapter 
2005 Member- ONS Congress local Planning Committee 
2004 Director at Large, Central Florida Chapter 
2003 Nominating Committee Co-chair, Central Florida Chapter 
2001-2002 Newsletter Chair, Central Florida Chapter 
1999-2000 Nominating Committee Chair, Central Florida Chapter 
1996 Secretary, Cleveland Chapter 
1995-1996 Member, Community Outreach, Cleveland Chapter 
 
 
EDITORIAL REVIEW:   
 
2006- Present Review Board Member, Cancer Nursing (International peer reviewed journal) 
2004-2006 Review Board Member, Clinical Journal of Oncology Nursing. (National peer 
reviewed journal). 
 
 
COMMUNITY AND INSTITUTIONAL SERVICE: 
 
2006-2007  
Community Member, Patient Services Committee, The Leukemia & Lymphoma Society, 
Orlando 
  
2005-2006  
University Member, Planning Committee, 3
rd
 Annual Breast Cancer Update 
School of Nursing Elected Student Representative, Doctoral Committee 
Community Member, Patient Services Committee, The Leukemia & Lymphoma Society, 
Orlando. 
 Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando. 
  
2004-2005  
School of Nursing Elected Student Representative, Doctoral Committee 
Community Invited Speaker, ―Breast cancer education intervention study: Quality of life in 
breast cancer survivors.‖ Summer Undergraduate Research Academy 2004.   
 Invited Speaker, ―Breast Cancer Awareness.‖  4th Annual Breast Health Awareness 
Day, Sponsored by: Colonial Medical Supplies, Orlando, FL. 
 Member, Patient Services Committee, The Leukemia & Lymphoma Society, 
Orlando. 
 Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando. 
 
 
2003-2004  
University Invited Speaker, ―Women‘s health/breast cancer.‖ Open forum on breast cancer for 
students, faculty and staff, Bluestocking Luncheon Series. The University of Central 
Florida Women‘s Studies Program 
School of Nursing Elected Student Representative, Doctoral Committee 
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 Invited Speaker, ―Collaborative partnerships: University and community cancer 
program relationships to strengthen recruitment and retention of research subjects‖ 
The University of Central Florida, School of Nursing, Professional Development 
Series. 
Community Invited Speaker, ―Cancer prevention and early detection‖ University High School 
Student Health Awareness Series.  Orlando, FL.  Quarterly- January, April, June, 
November. 
 Member, Patient Services Committee, The Leukemia & Lymphoma Society, 
Orlando. 
 Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando. 
  
2002-2003  
Community Invited Speaker, ―Cancer prevention and early detection‖ University High School 
Student Health Awareness Series.  Orlando, FL.  Quarterly- January, April, June, 
November. 
 Member, Patient Services Committee, The Leukemia & Lymphoma Society, 
Orlando. 
 Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando. 
 
 
 
Orlando Regional Healthcare System/ M. D. Anderson Cancer Center Orlando 
 
Year Committee  
1998-2002 Chair and Co-chair, Oncology Nursing Practice Council- MDACCO 
1999-2002 Coordinator, Oncology Nursing Grand Rounds 
2001-2002 Member, Institutional Review Board- MDACCO 
1999-2002 Member, Process Improvement Committee 
2001-2002 Member, Radiation Oncology Conference Planning Committee 
2000-2002 Co-coordinator, JCAHO Record Audits 
2000-2001 Coordinator, Patient Education Process Improvement Committee 
2000-2001 Member, M. D. Anderson Cancer Center Orlando Education Council 
  
 Service 
1997-2002 Coordinator, Blood and Marrow Transplant Patient Coordinator and liaison to The 
University of Texas, M. D. Anderson Cancer Center, Blood and Marrow Transplant 
Center 
1998-2002 Coordinator, Oncology Patient Education 
2001-2002 Co-auditor, Concordance Study, M. D. Anderson Cancer Center Orlando and The 
University of Texas, M. D. Anderson Cancer Center 
1998-2001 Coordinator, Wait-Time Study, M. D. Anderson Cancer Center Orlando 
2000 Co-Chair, Danskin Triathlon- ―Team Survivor‖ Orlando, FL. 
1999-2000 Co-Chair, National Cancer Survivor Day at M. D. Anderson Cancer Center Orlando. 
1999-2002 Member, Patient Services Committee, The Leukemia & Lymphoma Society, Orlando. 
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